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Abstract
The incidence of gastrointestinal (GI) cancers has been steadily increasing in the
UK since the mid 1970’s. These include cancers of the colon and oesophagus.
Colon cancers have a high incidence rate, being the fourthmost common cancer in
the UK for both men and women. Oesophageal cancers in comparison are much
rarer, however they have a poor survival rate primarily due to a late diagnosis.
The key to improving survival for these cancers and many others is to detect and
remove the disease at the early stages, to prevent the cancer from advancing. At
present the ‘gold standard’ for diagnosis is a biopsy followed by histopathology.
This technique is invasive, time consuming and highly subjective. It is therefore
important to look towards non-invasive methods for early and rapid diagnosis.
Optical techniques have begun to show such promise. By probing the interactions
of tissues with light, diagnostic information is able to be obtained non-invasively.
Techniques such as Raman spectroscopy utilise inherent molecular vibrations to
extract biochemical information from tissues. Raman spectroscopy, however, is
currently fundamentally limited by long acquisition times, due to the inherently
weak signals produced. Using coherent Raman techniques such as coherent anti-
Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS), the
molecular vibrations are coherently driven to provide an enhancement in signal.
This thesis explored spectral signatures from snap frozen oesophageal sections
in the fingerprint (450 cm−1 to 1850 cm−1) and high wavenumber (2800 cm−1 to
3050 cm−1) regions using spontaneous Raman and compared with spectra from
hyperspectral SRS. The diagnostic potential for each technique was assessed
for four major pathology groups, normal, Barrett’s oesophagus, dysplasia and
adenocarcinoma. Samples were classified using a principal component fed linear
discriminant analysis (PCA-LDA) approach with a leave-one-out cross validation.
Comparisons were made to haematoxylin and eosin (H&E) stained sections. Ra-
man in the fingerprint region was found to be the most promising for diagnosis.
There were minimal changes in the high wavenumber region between pathology
groups which was also reflected in the SRS spectra and proved to be insufficient
for classification.
Further comparisons weremade between spontaneous and coherent Raman tech-
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niques using frozen colon sections. The morphological and structural information
available was explored using a k-means cluster analysis. Both spontaneous and
coherent Ramanwere able to distinguish important structural features in the colon,
such as the epithelial cells that form the colonic glands and surrounding connec-
tive tissue. Both are important visual markers for cancer diagnosis in the current
approach. SRS demonstrated higher spatial resoultion and faster acquisition
times in comparison to spontaneous Raman.
This work has discussed the many advantages of using coherent Raman tech-
niques for tissue applications, but has also highlighted some of the limitations for
spectral measurements, arising from the complexity of the system.
4
Acknowledgements
There are a great number of people who deserve to be thanked for the help,
guidance and words of encouragement that have been so generously provided to
me throughout this PhD. I would like to begin by expressing my sincere gratitude
to my supervisor Nick Stone, thank you for giving me the opportunity to work with
you and for taking the time to share some of your tremendous knowledge with
me. It has been an absolute pleasure working with someone who is so passionate
about their research with boundless amounts of energy, but also so patient and
supportive. I would like to also thank my second supervisor Julian Moger. Thank
you for your invaluable expertise of the intricate workings of the multiphoton lab
and advice for the more technically challenging parts of this project.
Outside of Exeter I would like to thank the Biophotonics research group at Glouces-
ter hospitals, Catherine Kendall, Hugh Barr, Oli Old, Becky Griggs, Leanne Full-
wood and Martin Isabelle for your contributions to the collection, preparation and
careful transport of tissue samples that have been used throughout this project.
Neil Shepherd for tissue pathology annotations and Gavin Lloyd for all your beau-
tifully crafted Matlab scripts. Without you all, this work would not have been
possible.
As a member of the Biophysics research group, I have been lucky to be part
of a truly fun and caring group, full of many great scientists from all different
backgrounds. I want to say thank you to all members of Biophysics past and
present. My time here at Exeter would have been far less enjoyable without
our interesting scientific and not so scientific lunch time discussions, Friday pub
sessions and various weekend outings. However I must highlight a few individuals
within Biophysics who have made a big impact throughout my PhD. A massive
thank you to Natalie and Barbara for the hours you dedicated to teaching me the
ropes in the multiphoton lab and for the numerous times you helped me trou-
bleshoot when things went a little wrong, I would also like to thank you, Laureline,
Sam and David Woods for generally making me feel so welcome when I first
joined the group. Sarah and Chuck thank you for continuing to provide much
needed moral support in the lab up until this day. Dave Colridge thank you for
always finding a resolution to any technical issues I may have experienced, be it
5
computing problems or access to the building and Ellen for the wonderful way you
manage the wet lab facilities. Krupakar thank you for your advice with regards
to the colon measurements and Ben for time spent performing Raman system
calibrations. Jen for the bucket loads of tea, a good chat and for just reassuring
me that everything will be ‘grand’. Louise and Inge for brightening up the day.
Lauren for sharing the highs and lows of PhD life and getting through it together.
Martha and Sahand for being the life and soul of the group and always providing a
much needed hug. Alex Clowsley for always being there to lend an ear and Ryan
for a cup of tea brewed to perfection. I could not have asked for a better set of
people to spend this time with and have created some fantastic friendships thank
you.
To my incredible parents, words cannot really thank you enough for everything
that you have done for me. Mum you are my rock, thank you for always being at
the other end of the phone whenever I needed you, and for always encouraging
me to do my best. Dad thank you for never giving up, even when things get tough
and for teaching me that nothing worthwhile comes easily. And to my sister Sarah
thank you for understanding the pressures of writing up and giving some sound
advice.
Last but certainly not least thank you too my best friend and long suffering partner
Jon. Thank you for always being there for me, for taking care of me and keeping
me focused whilst I’ve been writing, for many reasons if it wasn’t for you I would
not have been able to complete this thesis, so from the bottom of my heart thank
you.
6
Contents
List of Figures 11
List of Tables 17
Acronyms 19
1 Introduction 21
1.1 Cancer of the gastrointestinal tract . . . . . . . . . . . . . . . . . . 23
1.1.1 Oesophagus . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.1.2 Colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
1.2 Current diagnostic techniques . . . . . . . . . . . . . . . . . . . . . 33
1.2.1 Endoscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
1.2.2 Histopathology . . . . . . . . . . . . . . . . . . . . . . . . . 33
1.3 Grading and staging of GI tract cancers . . . . . . . . . . . . . . . 34
1.4 Novel optical diagnostic techniques . . . . . . . . . . . . . . . . . . 35
1.4.1 Raman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
1.4.2 Coherent Raman techniques . . . . . . . . . . . . . . . . . 37
1.5 Thesis aims . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2 Literature review 39
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.2 Raman spectroscopy . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.3 Coherent anti-Stokes Raman scattering . . . . . . . . . . . . . . . 44
2.4 Stimulated Raman scattering . . . . . . . . . . . . . . . . . . . . . 46
2.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
7
Contents
3 Background theory 49
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2 Raman scattering . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.3 Coherent anti-Stokes Raman scattering . . . . . . . . . . . . . . . 53
3.3.1 Signal generation . . . . . . . . . . . . . . . . . . . . . . . 55
3.3.2 Origins of the nonresonant background . . . . . . . . . . . 57
3.4 Stimulated Raman scattering . . . . . . . . . . . . . . . . . . . . . 59
3.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4 Instrumentation and experimental 63
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.2 Raman microspectrometer . . . . . . . . . . . . . . . . . . . . . . 63
4.2.1 Instrumentation . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.2.2 Streamline mapping protocol . . . . . . . . . . . . . . . . . 69
4.2.3 System calibration and spectral processing . . . . . . . . . 69
4.3 Coherent Raman set-up . . . . . . . . . . . . . . . . . . . . . . . . 73
4.3.1 System calibration . . . . . . . . . . . . . . . . . . . . . . . 77
4.3.2 Performing a hyperspectral stack . . . . . . . . . . . . . . . 81
4.3.3 Laser power normalisation . . . . . . . . . . . . . . . . . . 81
4.3.4 Large area montage . . . . . . . . . . . . . . . . . . . . . . 83
4.4 Multivariate techniques . . . . . . . . . . . . . . . . . . . . . . . . 83
4.4.1 Principal components analysis . . . . . . . . . . . . . . . . 84
4.4.2 Linear discriminant analysis . . . . . . . . . . . . . . . . . . 84
4.4.3 K-means cluster analysis . . . . . . . . . . . . . . . . . . . 85
4.5 Tissue collection and preparation . . . . . . . . . . . . . . . . . . . 87
4.5.1 Oesophagus . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.5.2 Colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.5.3 Measurement protocol . . . . . . . . . . . . . . . . . . . . . 89
8
5 Oesophagus 91
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
5.2 Raman of the oesophagus . . . . . . . . . . . . . . . . . . . . . . . 94
5.3 Tissue viability over time . . . . . . . . . . . . . . . . . . . . . . . . 96
5.3.1 Control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
5.3.2 Room temperature . . . . . . . . . . . . . . . . . . . . . . . 99
5.3.3 Fridge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
5.3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
5.3.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
5.4 785 nm versus 830 nm . . . . . . . . . . . . . . . . . . . . . . . . . 102
5.4.1 785 nm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
5.4.2 830 nm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
5.4.3 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
5.5 Raman fingerprint versus high wavenumber . . . . . . . . . . . . . 111
5.5.1 Fingerprint region . . . . . . . . . . . . . . . . . . . . . . . 113
5.5.2 High wavenumber region . . . . . . . . . . . . . . . . . . . 116
5.5.3 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5.6 Coherent Raman . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5.6.1 SRS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5.6.2 CARS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.6.3 System variance . . . . . . . . . . . . . . . . . . . . . . . . 126
5.6.4 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
5.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
5.8 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
6 Colon 135
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
6.2 Paraffin embedded samples . . . . . . . . . . . . . . . . . . . . . . 135
6.3 Large area montage . . . . . . . . . . . . . . . . . . . . . . . . . . 137
6.4 Raman of the colon . . . . . . . . . . . . . . . . . . . . . . . . . . 139
6.5 K-means cluster analysis . . . . . . . . . . . . . . . . . . . . . . . 142
6.5.1 Raman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
6.5.2 CARS and SRS . . . . . . . . . . . . . . . . . . . . . . . . 152
6.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
6.7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
9
Contents
7 Discussion, conclusions and future perspectives 159
7.1 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
7.2 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
7.3 Future perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . 164
References 167
Appendix A PCA-LDA data A1
A.1 785 nm vs 830 nm . . . . . . . . . . . . . . . . . . . . . . . . . . . A1
A.2 Raman vs coherent Raman . . . . . . . . . . . . . . . . . . . . . . A2
A.2.1 Two group model . . . . . . . . . . . . . . . . . . . . . . . . A2
A.2.2 Three group model . . . . . . . . . . . . . . . . . . . . . . . A3
A.2.3 Four group model . . . . . . . . . . . . . . . . . . . . . . . A4
Appendix B Ethical approval A5
B.1 Oesophagus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A6
B.2 Colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A8
10
List of Figures
1.1 Percentage of cancer cases for the 20 most common cancers in
the UK during 2014. . . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.2 The gastrointestinal tract. . . . . . . . . . . . . . . . . . . . . . . . 23
1.3 A three-dimensional diagram showing the 4 different layers that
make up the wall of the oesophagus. . . . . . . . . . . . . . . . . . 24
1.4 The incidence and survivial rates for oesophageal cancers . . . . 25
1.5 Average number of new cases per year (2007-2009) in relation to
the age at diagnosis for oesophageal cancer. . . . . . . . . . . . . 26
1.6 The view of an oesophagus containing normal and acBO cells as
viewed through an endoscope. Typical biopsy sampling for Bar-
rett’s oesophagus (BO) . . . . . . . . . . . . . . . . . . . . . . . . 27
1.7 Diagram depicting the multi-step progression of oesophageal cells
from normal squamous to invasive adenocarcinoma, for patients
suffering from BO. . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
1.8 Haematoxylin and eosin (H&E) stained oesophagus histology sec-
tions, demonstrate the morphological changes that occur between
normal, BO and adenocarcinoma. . . . . . . . . . . . . . . . . . . 28
1.9 Flowchart summarising the diagnosis of and screening guidelines
for BO. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
1.10 The structure of the colon wall. Haematoxylin and eosin (H&E)
stained colon histology sections to demonstrate cellular structures
in the colon. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
1.11 The relative five year survival rates for patients diagnosed at differ-
ent stages of colon cancer. . . . . . . . . . . . . . . . . . . . . . . 32
1.12 Average number of new cases per year (2007-2009) in relation to
the age at diagnosis for colorectal cancer . . . . . . . . . . . . . . 32
1.13 Flow-chart to summarise themulti-step process to prepare samples
for histological assessment. . . . . . . . . . . . . . . . . . . . . . . 34
1.14 Table summarising the tumour, node, metastasis (TNM) classifica-
tion for cancer stages in the colon and oesophagus. . . . . . . . . 35
11
List of Figures
3.1 Examples of the different vibrational modes of molecules for the
mass on a spring approach. . . . . . . . . . . . . . . . . . . . . . . 50
3.2 Schematic of spontaneous Raman scattering. . . . . . . . . . . . . 52
3.3 Schematic of the CARS process. . . . . . . . . . . . . . . . . . . . 55
3.4 The CARS spectral lineshape as a function of the detuning. . . . . 58
3.5 Schematic of the stimulated Raman scattering (SRS) process. . . 59
4.1 Renishaw InVia system for spontaneous Raman measurements . 64
4.2 Objective contribution from the 50x long working distance lens . . 65
4.3 A comparison of the spectral resolution of gratings in the Renishaw
InVia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4.4 Raman spectra for three different substrates, calcium fluoride, glass
and stainless steel . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.5 Laser lines on a reflective silicon surface for the normal and stream-
line modes, for the 785 nm laser. . . . . . . . . . . . . . . . . . . . 68
4.6 Emission spectra from the in-built neon light source of the Renishaw
InVia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.7 The instrument response correction using standardised green glass. 71
4.8 Raman spectrum of phenylalanine before and after the system re-
sponse correction. . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
4.9 Baseline correction using asymmetric least squares fitting. . . . . . 73
4.10 Experimental set up for Coherent Raman measurements . . . . . 74
4.11 Photographs of the coherent Raman experimental set up . . . . . 75
4.12 Time averaged power measurements before and after the scan unit 78
4.13 Transmission through the 60x water immersion lens . . . . . . . . 78
4.14 Laser damage on a tissue sample using different pump powers. . 79
4.15 A SRS hyperspectral stack of phenylalanine powder . . . . . . . . 82
4.16 Principal component analysis process . . . . . . . . . . . . . . . . 85
4.17 Spontaneous Raman spectra of polystyrene and PMMA beads. . . 86
4.18 K-means cluster analysis of a polystyrene and PMMA mixture . . . 86
4.19 Contiguous sections cut from frozen tissue blocks and mounted for
H&E, Raman and CARS/SRS, for primary and reserve sets. . . . . 88
4.20 H&E, white light image from the InVia and the transmitted light from
the photodiode on the CARS/SRS set up. . . . . . . . . . . . . . . 90
5.1 Mean Raman spectrum of normal oesophageal tissue in the finger-
print region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
12
5.2 Mean Raman spectrum of normal oesophageal tissue, in the high
wavenumber (hwn) region, with the major peak assignments la-
belled. The spectrum was measured using the 785nm laser with
the 300 l/mm grating. . . . . . . . . . . . . . . . . . . . . . . . . . . 93
5.3 Spontaneous Raman measurements of four regions demonstrat-
ing different structures within the oesophagus, measured using a
785nm illumination. . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
5.4 Raman time series of oesophageal tissue at a single position on
the sample. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
5.5 White light image of the tissue sample stored at room temperature 99
5.6 White light image of the tissue sample stored in the fridge . . . . . 100
5.7 Raman mapping of tissue for the control, room temperature and
fridge samples. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
5.8 Mean spectrum for 4 pathology groups, normal, BO, dysplastia
and adenocarcinoma (cancer) in the oesophagus using the 785nm
illumination, with a 30 s exposure. . . . . . . . . . . . . . . . . . . 104
5.9 Difference spectrum for (a) normal versus BO, (b) normal versus
adenocarcinoma (cancer), (c) dysplasia versus cancer for the 785 nm
laser. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
5.10 The four most significant principal components as determined by
ANOVA for the 785 nm illumination. . . . . . . . . . . . . . . . . . . 106
5.11 785 nm confusion matrix and PCA-LDA scores plots . . . . . . . . 106
5.12 Mean spectrum for 4 pathology groups, normal, BO, dysplastia
and adenocarcinoma (cancer) in the oesophagus using the 830nm
illumination, with a 30 s exposure. . . . . . . . . . . . . . . . . . . 108
5.13 Difference spectrum for (a) normal versus BO, (b) normal versus
adenocarcinoma (cancer), (c) dysplasia versus cancer for the 830 nm
laser. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
5.14 The four most significant principal components as determined by
ANOVA for the 830 nm illumination. . . . . . . . . . . . . . . . . . . 110
5.15 830 nm confusion matrix and PCA-LDA scores plots . . . . . . . . 110
5.16 Mean spectra of normal, BO, dysplastic and cancerous tissue from
the oesophagus in the fingerprint region. . . . . . . . . . . . . . . . 112
5.17 Two group model, four most significant principal components de-
termined using ANOVA in the fingerprint region. . . . . . . . . . . . 112
5.18 PCA-LDA for Raman in the fingerprint region for a (a) two, (b) three
and (c) four group model. . . . . . . . . . . . . . . . . . . . . . . . 114
5.19 Mean spectra of normal, BO, dysplastic and cancerous tissue from
the oesophagus in the high wavenumber (hwn) region. . . . . . . . 117
5.20 Two group model, four most significant principal components de-
termined using ANOVA in the high wavenumber (hwn) region. . . . 117
13
List of Figures
5.21 PCA-LDA for Raman in the hwn region for a (a) two, (b) three and
(c) four group model.. . . . . . . . . . . . . . . . . . . . . . . . . . 119
5.22 Mean SRS spectra for four different pathology groups, normal, BO,
dysplasia and cancer. . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.23 PCA-LDA for SRS for a (a) two, (b) three and (c) four group model. 123
5.25 Images of oesophageal tissues from four different pathology groups:
normal, Barrett’s oesophagus (BO), dysplasia and cancer. Images
represent intensities at 2930 cm−1, measured using Raman, CARS
and SRS. haematoxylin and eosin (H&E) stained sections are in-
cluded for comparison (scale bar, 1000µm), the region measured
is highlighted by an orange box. . . . . . . . . . . . . . . . . . . . 125
5.24 Mean spectra of normal tissues using CARS. . . . . . . . . . . . . 126
5.26 Mean spectra of polystyrene beads measured using spontaneous
Raman and SRS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
5.27 Polystyrene beads measured on different days using SRS . . . . . 128
5.28 Assessing the performance of the OPO . . . . . . . . . . . . . . . 129
5.29 Comparison of changes in laser power from the OPO whilst tuning 130
6.1 Spontaneous Raman spectrum of paraffin in the high wavenumber
region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
6.2 SRS measurements of deparaffinised colon tissue . . . . . . . . . 137
6.3 Comparison of colon tissues measured using SRS with that of H&E 138
6.4 Mean spectrum of colon tissue in the fingerprint region using a 785
nm excitation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
6.5 Two colon tissue samples, sample (i) and sample (ii) measured
using Raman mapping with a 785 nm excitation. . . . . . . . . . . 141
6.6 Determining the most suitable number of clusters for k-means clus-
tering of normal colon tissue measured using Raman in the finger-
print region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
6.7 Comparison of k-means clustering of normal colon tissuemeasured
using Raman in the fingerprint region, (a) before and (b) after the
application of a baseline correction. . . . . . . . . . . . . . . . . . 145
6.8 Two further colon examples using the optimised k-means clustering
of normal colon tissues using Raman in the fingerprint region with
7 clusters and baseline subtracted data. . . . . . . . . . . . . . . . 146
6.9 Mean spectrum of colon tissue in the high wavenumber region . . 147
6.10 Determining the most suitable number of clusters for k-means clus-
tering of normal colon tissue measured using Raman in the high
wavenumber region. . . . . . . . . . . . . . . . . . . . . . . . . . . 148
14
6.11 Comparison of k-means clustering of normal colon tissuemeasured
using Raman in the high wavenumber region, (a) before and (b)
after the application of a baseline correction. . . . . . . . . . . . . 150
6.12 Optimised k-means clustering of normal colon tissues using Raman
in the high wavenumber region with 6 clusters and data without a
baseline correction. . . . . . . . . . . . . . . . . . . . . . . . . . . 151
6.13 Images of colon tissue at 2930 cm−1 for Raman, CARS and SRS . 153
6.14 Comparison of the results of k-means cluster analysis for normal
colon measured using spontaneous Raman in the hwn region with
(a) no baseline correction, (b) baseline correction and (c) using
SRS. Raman and SRS are measured using contiguous sections. . 156
7.1 Imaging artefacts that can occur in SRS measurements. . . . . . . 161
7.2 A summary of different Raman techniques detailing their spectral
content vs acquisition time. . . . . . . . . . . . . . . . . . . . . . . 162
15
List of Figures
16
List of Tables
2.1 The most common fluorophores found in the oesophagus and their
associated peak excitation wavelengths. . . . . . . . . . . . . . . . 40
4.1 Example confusionmatrix for a two group linear discriminant model,
indicating positions of true negative/positive and false negative/pos-
itive results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.1 Tentative peak assignments of the most prominent peak in the Ra-
man spectrum for normal tissue . . . . . . . . . . . . . . . . . . . . 92
5.2 Tentative peak assignments of the most prominent peaks in the
Raman spectrum for normal tissue in the high wavenumber region. 93
5.3 The sensitivities and specificities for four pathology groups for the
785 nm illumination. . . . . . . . . . . . . . . . . . . . . . . . . . . 107
5.4 The sensitivities and specificities for three pathology groups for the
830 nm illumination. . . . . . . . . . . . . . . . . . . . . . . . . . . 111
5.5 The sensitivities and specificities for three pathology groups in the
fingerprint region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.6 The sensitivities and specificities for four pathology groups in the
fingerprint region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
5.7 The sensitivities and specificities for three pathology groups in the
hwn region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
5.8 The sensitivities and specificities for four pathology groups in the
hwn region. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5.9 The sensitivities and specificities for three pathology groups using
SRS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.10 The sensitivities and specificities for four pathology groups using
SRS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
6.1 Tentative peak assignments of the most prominent peaks in the
Raman spectrum for colon tissue. . . . . . . . . . . . . . . . . . . 140
6.2 Tentative peak assignments of the most prominent peaks in the
Raman spectrum for normal tissue in the high wavenumber region 147
17
List of Tables
6.3 Comparision of the various experimental parameters used for spon-
taneous Raman and SRS measurements. . . . . . . . . . . . . . . 157
A.1 The number of spectra assigned to each pathology group, actual
group vs predicted group for the 785 nm excitation. . . . . . . . . . A1
A.2 The number of spectra assigned to each pathology group, actual
group vs predicted group for the 830 nm excitation. . . . . . . . . . A1
A.3 The number of spectra assigned to each pathology group, actual
group vs predicted group for the fingerprint region. . . . . . . . . . A2
A.4 The number of spectra assigned to each pathology group, actual
group vs predicted group for the hwn region. . . . . . . . . . . . . A2
A.5 The number of spectra assigned to each pathology group, actual
group vs predicted group for SRS. . . . . . . . . . . . . . . . . . . A2
A.6 The number of spectra assigned to each pathology group, actual
group vs predicted group for the fingerprint region. . . . . . . . . . A3
A.7 The number of spectra assigned to each pathology group, actual
group vs predicted group for the hwn region. . . . . . . . . . . . . A3
A.8 The number of spectra assigned to each pathology group, actual
group vs predicted group for SRS. . . . . . . . . . . . . . . . . . . A3
A.9 The number of spectra assigned to each pathology group, actual
group vs predicted group for the fingerprint wavenumber region . . A4
A.10 The number of spectra assigned to each pathology group, actual
group vs predicted group for the high wavenumber region . . . . . A4
A.11 The number of spectra assigned to each pathology group, actual
group vs predicted group for SRS . . . . . . . . . . . . . . . . . . . A4
18
List of Acronyms
AC adenocarcinoma
ANOVA analysis of variance
AOM acoustic optical modulator
BO Barrett’s oesophagus
CARS coherent anti-Stokes Raman scattering
CCD charged-coupled device
CR cosmic rays
ESS elastic scattering spectrosccopy
FOV field of view
GI gastrointestinal
GOJ gastroesophageal junction
hwn high wavenumber
H&E haematoxylin and eosin
LDA linear discriminant analysis
LIA lock-in amplifier
LUT look up table
NIR near infrared
OCT optical coherence tomography
OPO optical parametric oscillator
PCA principal components analysis
PMMA polymethyl methacrylate
PMT photomultiplier tube
ROI region of interest
SCC squamous cell carcinoma
19
List of Acronyms
SI squamous island
SMG submucosal gland
SRG stimulated Raman gain
SRL stimulated Raman loss
SRS stimulated Raman scattering
TNM tumour, node, metastasis
UV ultraviolet
20
CHAPTER 1
Introduction
In the UK, 1 in 2 people will get cancer in their lifetime [1] and in 2012 the mortality
rate for cancer overtook that of circulatory diseases, such as heart disease and
stroke [2]. The biggest risk factor associated with the development of cancer is
age, with 89% of all cancers being diagnosed in people over the age of 50 and
36% of those in patients over 75 [3].
Cancer is a term used to define an abnormal growth of cells that have subse-
quently lost their intended function. These growths are most commonly referred
to as tumours and are classified as either benign or malignant according to their
behaviour. Benign tumours exhibit localised growth only at a primary site, which
tends to be slow and non-invasive. Malignant tumours on the other hand have
more aggressive growth and can breakthrough basement membranes of tissues
to invade underlying structures, these malignant cells are also able to detach
from the primary tumour site and spread to other organs in the body via the
blood or lymphatic systems to form secondary growths, in a process known as
metastasis [4].
Cancer progresses through a continuum of stages referred to as the carcinogen-
esis sequence. Cancer can be initiated by a single genetic mutation within a cell
causing damage to DNA that programs the normal cell cycle. Such cells are able
to override normal check points in the cell cycle that would prevent any genetic
defects from replicating. Cells with damage to their DNA sequence under normal
conditions are either repaired or undergo apoptosis [5]. Cancer cells, however,
have gone undetected by the normal defences in the body, they ignore cell sig-
nalling and continue to proliferate in an uncontrolled manner. Mutations in genes
that promote cell division can leave them permanently in the ‘on’ position, resulting
in increasing cell proliferation. Alternatively, suppressor genes that inhibit cell
division can become mutated, which prevents the gene from halting cell division.
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Six major markers have been identified for cancer progression, these are as fol-
lows [6]:
• Cells provide their own growth signals
• They ignore cell signals that prevent growth
• Evade cell death (apoptosis)
• Can replicate without limits
• Create new blood vessels (angiogenesis)
• They invade and spread to other parts of the body (metastasise)
The vast majority of cancers are epithelial in origin, making up 85% of all cancers
[1]. Epithelial cells form the protective lining of organs and are most commonly
in contact with carcinogens, which can cause damage to DNA. There are three
main types of epithelial cell termed according to their general shape, these are
squamous, cuboidal and columnar cells, each adapted for a specific function in
the body. For the purpose of this project the focus is on two of these; the squamous
epithelium, such as those found in the oesophagus and columnar epithelium, such
as those found in the colon. Figure 1.1 shows a breakdown of the different types
of cancers diagnosed in 2014 in the UK. GI tract cancers, consisting of bowel,
oesophageal and stomach cancers, accounted for 15% of all new cancer cases,
with bowel cancer being the fourth most common cancer.
For many cancers, there are precursor lesions which begin as benign growths,
but have the potential to become malignant. These can be used as a method of
early detection for certain cancers, such as colon and oesophageal cancer [8,9].
Cancer progresses through a continuum of stages and takes time to develop. For
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Figure 1.1: Percentage of cancer cases for the 20most common cancers in the UK during
2014, GI tract cancers accounted for 15 % of cases [7].
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this reason it is important to have an early diagnosis, to identify abnormal growths
before they have the opportunity to spead, thus improving the prognosis of the
patient.
Here, the cellular structures of tissues that make up the oesophagus and colon
are introduced, the development of oesophageal and colon adenocarcinoma are
explored and finally a discussion on the current diagnostic method and what im-
provements novel optical methods could offer.
1.1 Cancer of the gastrointestinal tract
Oesophagus
Colon
Gall
Bladder
Liver
Appendix
Rectum
Small 
Intestine
Pancreas
Stomach
Figure 1.2: The gastrointestinal tract,
with the various organs that facilitate the
digestive process labelled [10].
The gastrointestinal (GI) tract includes all
tissues from the oesophagus to the anus,
including the stomach, intestine, colon
and rectum. The GI tract is responsible
for the digestion of food entering the
body and the formation and excretion of
waste with specialised cells for this role.
A diagram is included in figure 1.2 to
highlight the various organs that make up
the digestive tract. This PhD has focused
on tissues from the oesophagus and the
colon.
1.1.1 Oesophagus
The oesophagus is a muscular tube that transports food from the mouth to the
stomach. The wall of the oesophagus can be seen in figure 1.3. It is made up of
four distinct layers:
• Mucosa: Stratified squamous epithelial cells form the innermost lining, fol-
lowed by a thin layer of connective tissue (collagen), the lamina propria
and finally a thin layer of smooth muscle (actin and myosin), the muscularis
mucosa. The mucosa is about 500 to 800µm thick.
• Submucosa: Dense connective tissue, containing blood vessels, mucus
glands and lymphatic channels.
• Muscularis propria: Muscular layer responsible for motor-function.
• Adventitia: External fibrous layer covering the outermost of the oesophagus.
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Figure 1.3: A three-dimensional diagram showing the 4 different layers that make up the
wall of the oesophagus [11].
Unlike other organs, in the GI tract the oesophagus lacks a serosa, which makes
the spread of cancers to surrounding tissues and lymphatic nodes, much more
likely [12]. Through an endoscope, the oesophagus appears as a smooth light
pink surface, with blood vessels visible from the submucosa. Where the oesopha-
gus meets the stomach, the gastroesophageal junction (GOJ), there is a transition
zone of squamous epithelium and columnar epithelium that line the stomach.
Oesophageal cancers
Oesophageal cancers are relatively uncommon and account for only 2% of new
cancer cases in the UK [1]. They are of importance, however, as they are relatively
symptomless and are therefore often diagnosed in the more advanced stages,
when the cancer has metastasised to other parts of the body [14]. So despite
being relatively rare, they have a high mortality rate. Furthermore, the rate of
incidence has been steadily increasing, especially in the Western world. Figure
1.4(a) shows the incidence rate of oesophageal cancer per 100,000 people from
1979 to 2012. The overall trend is towards an increase in incidence, but it is
apparent that there is a clear gender difference, with a much higher rate for men.
Figure 1.4(b) shows the survival rates at one, five and ten years after diagnosis for
oesophageal cancers compared to all other cancers combined for 2010 to 2011.
Survival rates overall are lower for oesophageal cancers, with a dramatic drop
between one and five years from 42% to 15% respectively.
There are two common types of oesophageal cancers. These are squamous
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Figure 1.4: (a) Incidence rates of oesophageal cancer (1979-2012), in the UK. (b) 1, 5
& 10 year net survival rates for oesophageal cancers vs. all cancers (2010-2011). (c)
Oesophageal cancers account for 3% of all new cases (2012). All statistics from [13].
cell carcinoma (SCC) and adenocarcinoma (AC). Each type follows a different
disease pathway and originates in different locations in the oesophagus. SCC,
prevalent in the upper oesophageal tract, develops from mutations in the squa-
mous epithelial cells that form the lining of the oesophagus. AC, on the other hand,
occurs lower in the oesophagus, above the gastroesophageal junction (GOJ),
following a precursor condition called BO. BO is an important pre-malignant step.
Patients suffering from BO are considered to be at a higher risk for cancer progres-
sion than the general population and as a result are enrolled in regular surveillance
programmes at great cost to health care services. In recent years, the number of
new cases of AC in England has overtaken that of SCC, with AC now accounting
for 55% of oesophageal cancers, in comparison to 28% for SCC [1]. For this
reason, the focus here is the multi-step disease progression of AC.
Risk factors
The biggest risk factor associated with the development of oesophageal cancer,
as with the majority of other cancers, is age. Defects in DNA that form cancer take
a while to accumulate, with increasing numbers of cancer cases resulting from the
fact that people are living longer. The relationship between age at diagnosis and
the development of these cancers can be seen in figure 1.5. Most new cases of oe-
sophageal cancer are diagnosed in people over the age of 45, with a much higher
incidence in men than women for all age groups, apart from 80+, due to the fact
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Figure 1.5: Average number of new cases
per year (2007-2009) in relation to the age at
diagnosis for oesophageal cancer [1].
that women tend to have a longer
life expectancy than men [1]. The
majority of oesophageal cancers are
preventable, [15] with 89% of cases
being linked to lifestyle factors such
as smoking, alcohol consumption,
poor diet and obesity [16–20]. There
is also suggested to be a link
to the consumption of high tem-
perature drinks [21, 22]. A high
intake of fruit and vegetables is
associated with a reduction in risk
[16]. One of the most identifiable
risk groups are those individual that
suffer from gastroesophageal reflux
disease (GORD) a type of acid reflux, which can lead to BO, which is a known
precursor for oesophageal adenocarcinoma. BO is discussed in more detail in
the following section.
Barrett’s oesophagus and the progression of adenocarcinoma
BO or columnar lined oesophagus is a condition that results from chronic gastro-
oesophageal acid reflux sustained over a prolonged period of time [23], that occurs
at the lower end of the oesophagus just above the stomach. It is characterised
by a change in the normal squamous cells to that of columnar epithelium, termed
intestinal metaplasia, in an attempt to adapt to the more acidic conditions. Al-
though the exact origins of BO are unknown, It is believed that metaplastic cells
arise from oesophageal stem cells, that undergo an altered differentiation [24–26].
Stem cells are thought to be located at the basement membrane and progress
towards the lumen of the oesophagus and may also be present in glands found in
the mucosa of the oesophagus [27]. BO has been identified as being a precursor
for oesophageal carcinoma and patients suffering from BO have an increased
risk of oesophageal cancer [28]. Studies have shown that individuals with BO
have a 30-50 fold higher risk of developing cancer than the general population.
However, more than 90% of BO patients will never go on to develop cancer [29],
but under go a highly invasive biopsy procedure at great costs to health services
[30]. BO is initially identified during endoscopy. Macroscopically, when viewed
using an endoscope, the columnar epithelium of BO appear a dark red in colour.
The normal squamous epithelium is a light pink colour, in comparison. These
differences are illustrated in figure 1.6(a), that shows the view down an endoscope
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in a region where BO is present. This region must be visibly greater than 1 cm
above the GOJ [31]. For a diagnosis of BO to be confirmed, histological biopsies
must be taken of the BO region. It is recommended that quadrant biopsies are
taken at intervals of less than 2 cm for the whole length of the BO segment, in
addition to any visible lesions [31]. The results of such a procedure are show in
figure 1.6(b). This samples less than 5% of the mucosa and may miss up to 57%
of early lesions [32].
(a)
(b)
Figure 1.6: The view of the oesophagus
through an endoscope. (a) columnar
epithelial appear a dark red in colour and
can be distinguished visually from that of
normal squamous cells which appear pink
[33]. (b) Typical biopsy sampling for BO.
At a histological level, BO is diagnosed
by the change in the normal squamous
epithelium to columnar epithelium. There
are three types of mucosal metaplasia
that constitutes BO, these are intestinal,
cardiac and fundic mucosa, relating to
the region in the body where these cells
are normally found. Intestinal metaplasia
is the most common type in adults and
most likely to progress through to AC.
In addition to epithelial metaplasia, other
features visible at histology include goblet
cells and mucous cells [23]. The vast ma-
jority of biopsies sent to the pathology lab
are normal. Currently, the best biomarker
to indicate a patient with a high risk for
progression to AC is dysplasia. This is
an abnormal change in the morphology
of the BO cells. AC develops through
a multi-step process, with increasing
grades of dysplasia. For diagnosis,
dysplasia is categorised as being either
low58 or high grade. The classification of
dysplasia is highly subjective.
These changes can be seen in figure 1.7. Adenocarcinoma develop through
a continual process, from metaplasia to dysplasia and finally adenocarcinoma.
So patients diagnosed with BO undergo regular screening to identify these pre-
cancerous changes. H&E stained oesophagus sections that demonstrate the
morphological changes that occur between normal, BO and adrnocarcinoma are
shown in figure 1.8.
Symptoms of reflux alone are not enough to warrant costly endoscopic investiga-
tion. Patients are initially screened to identify other high risk factors associated
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Figure 1.7: Diagram depicting the multi-step progression of oesophageal cells from
normal squamous to invasive adenocarcinoma, for patients suffering from BO [34].
with the development of BO, to separate that from those with chronic reflux. At
least three of these risk factors, including 50 years or older, white race, male, and
obesity must also be present, although if the patient has a family history of BO
these criteria are reduced [31]. If patients are deemed high risk from the screening
process, they are entered into a surveillance programme, the aim of which is
the early detection of dysplatic changes that could lead to the development of
adenocarcinoma [36]. The only method currently accepted for regular surveillance
is endoscopic monitoring and histological assessment [31]. According to the diag-
nosis and screening guidelines summarised in figure 1.9, patients diagnosed with
intestinal metaplasia and a BO segment shorter than 3 cm are assessed every
3-5 years. Patients with a BO segment over 3 cm are assessed more frequently,
every 2-3 years, due to the increased risk of cancer associated with the length of
(a) Normal (b) Barrett’s oesophagus (c) adenocarcinoma
Figure 1.8: Haematoxylin and eosin (H&E) stained oesophagus histology sections,
demonstrate the morphological changes that occur between normal, BO and adenocar-
cinoma. Images from [35].
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the BO segment [31]. All cases of dysplasia are reviewed by a second pathologist.
1.1.2 Colon
The colon or the large bowel forms the final part of the digestive system, just
before the anus. Its role is to extract any remaining water and salts and to prepare
the remaining undigested food to be eliminated from the body. The colon can be
subdivided into four parts, due their position rather than a specific function. These
are ascending, transverse, descending and sigmoid colon. The sigmoid colon
attaches to the rectum. Figure 1.10(a) illustrates the different layers that make up
the colon. Similar to the oesophagus, the colon is made up of four layers, these
are:
• Mucosa: Columnar epithelial cells and goblet cells that form colonic glands
called crypts, that penetrate into the lamina propria, containing blood vessels
and lymphatic nodes.
• Submucosa: Containing more blood vessels and connective tissues.
• Muscularis: Two layers of muscle, a top circular layer with a lower longitudi-
nal layer.
• Serosa: protective layer surrounding the colon
Goblet cells are responsible for the excretion of mucins, that form the major com-
ponent of mucous into the colon, to protect the lining of the colon. Figure 1.10(b)
and (c) show H&E stained sections of normal colon tissues. Image (b) is a longitu-
dinal section, that shows a cross section through the different layers of the colon
wall. The long colonic glands can be seen spanning the depth of the mucosa,
with a clear cellular boundary at the muscularis, separating the mucosa from the
submucosa. Image (c) is a transverse section, cut in the mucosal plane, from
which the distribution of the glands can be seen.
Colon (bowel) cancer
Colon cancer is the fourth most commonly diagnosed cancer. Figure 1.11 shows
the percentage of patients who survived longer than five years after their diagnosis
and the stage at which they were diagnosed. This figure highlights the importance
of an early diagnosis. There is a clear decline as cancers are detected later
and survival plummets from 95-100 % at stage one to 7-8 % at stage four. The
relative survival is marginally higher for women than men. The staging criteria are
discussed in more detail in section 1.3.
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(a) (b)
(c) (d)
Figure 1.10: (a) Diagram to illustrate the structure of the colon wall. (b) H&E stained
section of colon, demonstrating the cellular structure of normal colonic crypts. Images a
and b from [37]. (c) Transverse section of colon mucosa stained using H&E. Image from
[38] (d) LHS of image: normal ordered colon structure, RHS of image: adenocarcinoma,
consisting of disordered tissues structures. Image from [39].
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Figure 1.11: The relative five year survival rates
for patients diagnosed at different stages of
colon cancer (2002-2006) [40].
Cancer develops in the glandular
epithelial cells that line the inside
of the colon. Proliferation of cells
begins on the surface of the colon
and develops into adenomas, which
are benign growths, but have the po-
tential to become malignant. Ade-
nomas are the precursor lesions for
colorectal cancers. Most adenomas
will disappear over time, but some
go on to develop a stalk that pro-
trudes into the lumen of the colon, to form cancer. It is not until dysplastic cells
break through the mucosae and into the submucosa that adenomas are classified
as carcinomas, this process is called the ‘adenoma-carcinoma sequence’. This
process can be seen in the H&E stained section in figure 1.10(d). The left hand
side of the image contains normal regions of tissue, with a very ordered structure.
In comparison to the right hand side, which contains an adenocarcinoma, whereby
the structure of the tissue is completely disordered and cells have broken through
into the submucosa. Carcinomas are malignant, they have invaded the local
tissue and broken through into the submucosa where they detach cells from the
primary site and into the blood and lymphatic systems, through metastasis. Those
cells that are successful in creating secondary sites usually travel to the liver
through the portal vein.
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Figure 1.12: Average number of new cases
per year (2007-2009) in relation to the age at
diagnosis for colorectal cancer [1].
Like oesophageal cancers, the risk
of colorectal cancers increases with
age, with 85% of cancers in the
colon occurring in those over 60
[1]. Figure 1.12 shows the average
number of new colon cancer cases
per year as a function of the age of
the patient at diagnosis. The trend
for increasing incidence with age
can be clearly seen. Furthermore
as the data is separated by gender,
it can also be observed that colon
cancer is more prevalent in men
than women. The higher amount of
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new female cases in the 85+ group is again due to the tendency for women to
live longer than men. It is apparent that the number of new cases increases with
age and is more common in men than women. Just over half of all colorectal
cancer cases are preventable [15] with 54% of cases being linked to lifestyle
factors such as alcohol consumption and smoking [41, 42]. Strong associations
have also been made between eating red and processed meats and the incidence
of colon cancer [20]. A high intake of fruit and vegetables and physical activity is
documented to reduce the risk of colon cancer [43,44].
1.2 Current diagnostic techniques
1.2.1 Endoscopy
Endoscopy is used both as an investigative method to locate tumours and as a
surgical tool to remove suspicious growths to prevent cancer spread. Any tissues
that are removed must then be sent to a pathologist for histopathological analysis
to determine whether the growth is cancerous and if so, diagnose the stage of the
cancer. Correct staging is vitally important, as it dictates which types of treatments
need to be undertaken and the likely prognosis of the patient.
The endoscope is passed through the anus and into the colon, or swallowed by
the patient to look at the oesophagus. The endoscope itself is a flexible tube
with a white light and camera that feeds to an output so operators can see real
time images of tissue linings. Through the endoscope, there are various channels
and accessory points for procedures such as the removal of small biopsy tissues.
Tissue surfaces are surveyed by eye for any apparent morphological changes.
Any suspicious looking tissue is removed. It is often not possible to see early
cancerous changes in endoscopic images. It has been estimated that 33 biopsies
are required for 90% confidence of diagnosis [45]. The identification of cancers
using this method is subjective and dependant on the skill and expertise of the
operator.
1.2.2 Histopathology
The processes involved in sample preparation for histological analysis are sum-
marised in figure 1.13. Once prepared, samples are analysed by a histopatholo-
gist using a light microscope. They look for subtle morphological changes in the
cells of tissue and from visual inspection determine the grading of the tissue, in
accordance to the criteria described in subsection 1.3. Using this method, they
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Fixation: To prevent 
enzymes breaking the 
sample down once it has 
been removed it must be 
fixed.
Dehydration: The water 
present in samples needs to 
be removed, this is done by 
placing the tissue in several 
different solutions with 
increasing ethanol 
concentration until it reaches 
a 100% ethanol solution.
Clearing: Tissue is placed 
in a solvent mixture of 
alcohol and the embedding 
agent, which causes the 
tissue to become more 
transparent.
Embedding: Tissues are 
mixed with an embedding 
agent (usually paraffin or 
plastic resin), upon setting 
this embedding agent 
becomes rigid enabling the 
sample to be sectioned. 
Sectioning: Tissue 
sectioned with a microtome 
that cuts the samples 1-10 
μm thick. 
Staining: The sample has 
to be stained to be viewed 
under a microscope as the 
component of the cell are 
essentially colourless. 
Hematoxylin and Eosin (H & 
E) is a common used stain. 
Hematoxylin stains the DNA 
and other acidic structures 
blue. Eosin stains other parts 
of the cytoplasm and 
collagens pink. 
Figure 1.13: Flow-chart to summarise the multi-step process to prepare samples for
histological assessment, adapted from [37].
are able to determine how far the cancer has penetrated through the mucosa,
which is then used to determining the T number in the TNM classification for the
staging of cancers.
These processes take time, with waiting times for patients up to a couple of weeks
[1]. This potentially causes a lot of unnecessary stress to patients if the growth
turns out to be benign. Histology relies on pathologists being able to correctly
identify the morphology of cancerous cells using a light microscope. This is again
a highly subjective method and depends on the expertise of the pathologist. It
has been well documented that there is a high level of disagreement between
pathologists concerning the grading of cancers, both between different patholo-
gists (inter-observer variation) and for the same pathologist at two different times
(intra-observer variation) [46,47].
1.3 Grading and staging of GI tract cancers
Cancer cells are graded according the extent of the dysplasia present, that is, the
degree of abnormality. There are three grades; low grade, the majority of cell are
well differentiated and look mostly like normal cells; intermediate grade, higher
degree of abnormality in cells; high grade, cells are poorly differentiated and no
longer resemble normal cells. [1,48]
Cancer is staged according to the tumour, node, metastasis (TNM) classification.
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TNM Oesophageal cancer Colorectal cancer
T1 T1a Mucosa/ submucosa Submucosa
T1b
T2 Muscularis Muscularis
T3 Adventitia Serosa
T4 T4a Spread to outer layers of lungs or heart Beyond the peritoneum (outer 
membrane of the bowel) & grown on 
other parts of the bowel
T4b Spread to outer layers of windpipe, 
spine or major blood vessels
N0 No cancer cells in lymph nodes
N1 Spread to 1 or 2 lymph nodes Spread to 1-3 lymph nodes
N2 Spread to 3-6 lymph nodes Spread 3 or more lymph nodes
N3 N3a Spread to 7 or more lymph nodes
N3b
M0 No spread to other organs
M1 Spread to other organs (metastasis)
Figure 1.14: Table summarising the tumour, node, metastasis (TNM) classification for
cancer stages in the colon and oesophagus [13,40,49].
For oesophageal and colon cancers, there are five stages, which are numerically
labelled from 0 to 4. Stage 0 is termed a carcinoma in-situ, where dysplastic cells
are localised to the mucosa [48]. Each cancer is staged differently, according
to the structure and position of the tissue affected in the body. The stages and
their corresponding TNM classification for the oesophagus and colon can be seen
in figure 1.14. With reference to this figure, ‘tumour’ in the TNM classification
refers to the size of the tumour and depth of invasion; for the oesophagus and
colon, the extent of invasion through the mucosa, submucosa and further into the
muscularis and to outer membranes of the organs, in general the depth of invasion
increases with cancer stages. ‘Node’ refers to the number of neighbouring lymph
nodes affected, the more cancerous nodes, the higher the cancer stage. Finally
‘metastasis’ refers to cancerous cells that have spread to secondary sites through
the blood and lymphatic system. This describes the final most severe stage, stage
4. For effective treatment, cancers need to be diagnosed at either stage 1 or 2.
1.4 Novel optical diagnostic techniques
The current ‘gold standard’ for diagnosis based on endoscopy and biopsy, is inva-
sive, time consuming and subjective [46,47], requiring removal of large amounts
of tissue for diagnosis and surveillance. Optical techniques offer the potential to
assess tissues in-vivo through non or minimally invasive techniques. These novel
techniques have been termed an ‘optical biopsy’ [50]. Light incident on tissues
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can interact through absorption and scattering processes with molecules forming
the tissue and can be used to probe tissue morphology. Techniques such as
fluorescence that probes endogenous fluorophores, such as elastin and collagen
within tissues [51,52], optical coherence tomography (OCT) that measure reflec-
tions at tissue boundaries [53,54] and elastic scattering spectrosccopy (ESS) that
measures the elastic scattering of a broadband light source [55–57], have been
extensively used for diagnosis in the GI tract. These techniques however have a
low chemical specificity. Vibrational spectroscopy techniques such as infrared [58]
and Raman spectroscopy, provide biochemical fingerprints of molecules based on
the types of bonds present. Infrared spectroscopy is a complementary technique
to Raman. Water however, is a strong infrared absorber which somewhat limits its
applications in-vivo due to the large water content in tissue. Here the applications
of Raman spectroscopy for the diagnosis of GI tract cancers are discussed.
1.4.1 Raman
Raman spectroscopy is proving to be a valuable tool for biomedical applications.
Over recent years there have been numerous studies highlighting the potential of
Raman for disease discrimination and more specifically the diagnosis of cancers.
These studies have been summarised in various review articles [59–61].
The Raman process can be described as an inelastic scattering of an incident
photon, from a monochromatic light source, such as a visible or near infrared
laser. When such a photon interacts with a molecule by virtue of the vibrational
modes of that molecule, it can either lose or gain energy from the scattering event,
depending on the initial state of the molecule. The resulting scattered photon
is of a different frequency to that of the incident one, this difference is termed
the ‘Raman shift’. A Raman spectrum is a plot of the intensity of the scattered
photons as a function of the Raman shift, measured in wavenumber, with units
of cm−1. Each molecule has a unique chemical fingerprint, with peaks in the
Raman spectrum at precise positions. Different molecules have different charac-
teristic peaks corresponding to the vibrational modes of the bonds present. Each
molecule therefore has a unique chemical fingerprint and Raman can distinguish
between different biological molecules.
Raman has been proven to be excellent at detecting pure molecules such as
amino acids, as the signal is proportional to the concentration of Raman scat-
terers, so is able to provide quantitative information. Tissue samples are more
complex, and are constructed of several different molecules in low concentra-
tions. This results in a small signal envelope with complex overlapping peaks. To
be able to extract the chemical information from these spectra, it is essential to
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use multivariate techniques such as principal components analysis (PCA). The
Raman signal can be improved by increasing laser power. However, a balance
needs to be made to achieve the best possible signal without causing damage
to the tissue. An alternative may involve using lower laser powers but extending
the exposure time for a single spectrum. Using Raman for tissue imaging creates
several challenges. Tissues are inhomogeneous and highly scattering. They have
a high absorption, so background fluorescence from endogenous fluorophores
can be a problem. Laser photons can be absorbed by these fluorophores and
emit photons of longer wavelengths, which result in a broad background signal,
that can easily overwhelm the Raman peaks [62]. To overcome the inherent
fluorescence near infrared laser sources (785/830 nm) are used. For fluorescence
to occur, a molecule needs to be excited to an electronic state, near infrared
wavelengths tend to have insufficient energy to be able to excite those molecules,
therefore offer a significant reduction in fluorescence background. Using near in-
frared wavelengths also reduces sample damage in comparison to shorter visible
wavelengths [63].
Micro-Raman mapping provides us with a great amount of chemical information
about the tissue. Raman, however, is a weak process with typically only 1 in
106 photons undergoing inelastic scattering. So, signals are small and require
sensitive charged-coupled device (CCD) camera detection and long acquisition
times. To be able to make Raman more clinically attractive, faster measurement
times are needed, which involves some sort of enhancement of the Raman signal.
Surface-enhanced Raman scattering (SERS) can provide an enhancement in the
Raman signal and has been shown with high sensitivity and specificity in the oe-
sophagus [64]. However, this technique is only able to probe the surface of tissues
and requires the addition of metallic nanoparticles to provide the enhancement.
An alternative approach and the one used in this thesis, is coherent Raman.
1.4.2 Coherent Raman techniques
The term ‘coherent Raman’, is a collective term that includes various coherent
anti-Stokes Raman scattering (CARS) techniques and SRS. All are non-linear
techniques, so give rise to signals that have a non-linear dependence on the total
incident power. Both CARS and SRS provide an enhancement in Raman signal
and therefore much faster acquisition times. Coherent Raman techniques achieve
an enhancement in Raman signal by actively driving a particular Raman active
molecular vibration, using two lasers of different wavelengths, with a difference
frequency that matches that vibrational wavelength. In CARS, a blue-shifted anti-
Stokes signal is measured, whilst in SRS an energy transfer between the two
laser beams is measured. Both use ultrafast near infrared pulsed lasers with a
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high peak power, but biologically tolerable average powers. The CARS and SRS
techniques discussed here are predominantly imaging techniques and produce
great chemical contrast of the CH stretching vibrations, located in the hwn region
(2800 cm−1 to 3050 cm−1). To access spectral information, a hyperspectral stack
must be performed, by sequential tuning of one of the laser wavelengths. CARS
is fundamentally limited, however, by the presence of a nonresonant background,
which distorts the spectral lineshape. This nonresonant background effectively
limits narrowband CARS measurements to the hwn. SRS on the other hand,
does not suffer from this background and as a result, the extracted SRS spectrum
matches the spontaneous Raman spectrum. Although SRS is a better candidate
for imaging in the fingerprint region, currently narrowband SRS is still limited to
single wavenumber imaging in this region [65]. Larger Raman cross-sections for
CH bonds in the hwn region, result in much more intense Raman signals, com-
pared to that of the fingerprint region [66], therefore, longer acquisition times are
required. This, combined with the cumbersome tuning methods, that are neither
fast enough or broad enough for spectral SRS, in their current form, make spectral
measurements of the fingerprint regions impractical [67, 68]. These techniques
are discussed in greater detail throughout the thesis.
1.5 Thesis aims
Spontaneous Raman has proven capable to discriminate between normal and
diseased tissues in the oesophagus with high sensitivities and specificities [9,69–
71]. However, the practical applications of Raman are hindered by long acquisition
times. This thesis aims to explore the potential for coherent Raman techniques,
primarily SRS, to provide more rapid spectral and spatial information of GI tract
tissues, with the hope of using spectral information for disease discrimination
of several different pathology groups in the oesophagus. This thesis aims to
address the discriminatory ability of the high wavenumber region (2400 cm−1 to
3800 cm−1) using spontaneous Raman and compare to spectral information avail-
able from hyperspectral SRS, using multivariate statistics. Finally explore the
spatial information available from coherent Raman techniques and compare it with
spontaneous Raman and the current histopathogy approach.
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CHAPTER 2
Literature review
2.1 Introduction
To put into context the significance of this work, it is important to discuss pre-
vious literature in the field. Spontaneous Raman spectroscopy has been used
extensively for biological applications. As a result, there are vast amounts of
literature available that are beyond the scope of this thesis. Here, the focus will
be on literature that explores the use of Raman for the diagnosis of disease, most
appropriately that of cancer. As the biological applications of coherent Raman
techniques are relatively more recent, a brief history and discussion of the ad-
vancement of coherent Raman techniques is also provided, in addition to a review
of the most pertinent literature on coherent Raman applications and the distinct
advantages of using such techniques.
2.2 Raman spectroscopy
The Raman effect was first observed experimentally by C.V. Raman, publishing
his work in 1928 [72]. A theoretical description of the effect had previously been
described in 1923 by Smekal [73] and, it was also observed by two Russian
scientists, Landsberg and Mandelstam [74], around the same time as Raman.
However, they were not credited with it’s discovery and C.V. Raman alone was
subsequently awarded the Nobel prize in Physics, in 1930, with the effect being
named after him. Raman noticed a modification in the frequency of scattered light
frommolecules, when excited by amonochromatic source. This shift in frequency,
now termed the Raman shift, provides a unique vibrational fingerprint that can be
used for molecular identification. Since then, Raman spectroscopy has proven
to be an incredibly valuable technique for the extraction of inherent biochemical
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information. Being both label-free and non-invasive, it lends itself well to in-vivo
clinical applications.
The scope of the applications of Raman spectroscopy for the identification of
disease in the literature is vast. Here the focus is on its application as a tool to
uncover the biochemical changes that occur during the process of carcinogenesis,
moving towards cancer diagnosis and screening. Raman has already been shown
to be able to differentiate between normal and diseased tissues for many different
areas, such as brain, bladder & prostate [75, 76], breast [77, 78], oral cancers
[79], lung cancer [80], head and neck cancers [81] but, most applicable here,
oesophagus [82] and colon [83, 84]. As of yet, no such ‘cancer’ peak has been
discovered. Instead changes are identified using several peaks from a whole
spectrum. Spectral differences are observed as a combination of peak shifts,
intensity changes and peak broadening. There are several reviews published
on the clinical applications and advances of Raman [59–61]. All of the above
publications use near infrared wavelengths, such as 785 nm or 830 nm, to in-
crease penetration depth and reduce photodamage to samples. Near infrared
wavelengths also avoid one-photon fluorescence, from endogenous fluorophores
in tissues, termed auto-fluorescence. Fluorophores such as amino acids, collagen
and elastin, can absorb laser photons and result in a broad emission of photons
that are of a longer wavelength, this can saturate the already weak Raman signal.
The excitation wavelengths of these fluorophores, is typically from the ultra-violet
through to shorter visible wavelengths. A table of the most common fluorophores
found in the oesophagus and their peak excitation wavelengths, are shown in
table 2.1. The most dominant fluorophore in the oesophagus, which absorbs at
visible wavelengths, is collagen, found mainly in the submucosa [85].
Fluorophore Biological origin Peak excitation (nm)
NADH metabolic coenzyme 340
FADH metabolic coenzyme 460
Collagen structural protein 335
Porphyrin heme biosynthesis byproducts 390
Elastin structural protein 285
Tryptophan amino acid 305
Table 2.1: The most common fluorophores found in the oesophagus and their associated
peak excitation wavelengths [85–87].
The Raman spectra of pure compounds reveal a molecular fingerprint with dis-
tinct peaks at particular wavenumbers. However, when measuring a mixture of
compounds such as in tissues, the spectral information becomes more complex
with several overlapping peaks. To be able to separate these peaks, Raman is
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commonly combined with multivariate techniques such as principal components
analysis (PCA) [71,88], linear discriminant analysis (LDA) [89] and k-means clus-
ter analysis [76, 90]. To make discriminant models, one common approach is
to use principal component fed linear discriminant analysis [9, 69, 91, 92]. The
performance of the Raman classifier models are frequently described in terms
of sensitivity and specificity. For a more detailed description refer to the section
4.4.2. Models are cross-validated to avoid over fitting data [93]. The potential for
Raman to discriminate between normal and diseased groups, in the oesophagus,
has been shown with a high sensitivity and specificity [94]. Stone et al. [69]
reported sensitivities of 73-100 % and specificities of 92-100 %, for eight different
pathology groups in the oesophagus, including that of Barrett’s oesophagus (BO)
and dysplasia.
Raman spectroscopy in the fingerprint region, has been used to identify biochem-
ical changes between normal and cancerous tissues, such changes include a
greater amount of glycogen, carbohydrates, protein disulphide bonding and carote-
noids in normal tissues, in comparison to higher amounts of DNA, hydroxyapatite,
phenylalanine, α-helix and unordered proteins in cancerous tissues [69, 71, 95].
These changes are consistent with known biological indicators of cancer progres-
sion. For example a greater amount of DNA is related to the increased size of
the nuclei of cancerous tissue cells. Furthermore, increased cell proliferation
could account for the lower amounts of glycogen and carbohydrates present, as
these act as energy sources for the cells. The presence of unordered proteins
in cancerous tissues is also apparent from the more disordered structures seen
in haematoxylin and eosin (H&E) images in comparison to the highly ordered
structures of normal tissues. As Raman probes the biochemistry of the tissue,
it may have the potential to identify cancerous changes before they are visible
using the current histological approach [9].
A limitation in current Raman modelling methods is the fact that their capabili-
ties are compared to an imperfect ‘gold standard’. It has been shown that by
using multiple pathologists to make a decision, termed consensus pathology, an
improvement can be made on the performance of disease classification models
[69]. Using concensus pathology any samples that can’t be agreed upon by the
pathologists are rejected from the study. In a study of nine pathology groups [9],
each sample was initially assessed by three independent pathologists, who were
blind to the diagnosis of the others, before Raman measurements. The degree
of agreement between pathologists was measured using kappa statistics. PCA-
LDA discriminate models were constructed, one based on a majority pathology,
whereby at least two of the pathologists agree on the diagnosis of the sample
before it is included in the model and the second, a consensus pathology, whereby
all the pathologistsmust agree on the diagnosis of the tissue sample to be included
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in the model. For the majority model 72% of the Raman spectra were correctly
classified, compared to 89% for the consensus model.
By utilising Raman mapping techniques [71], whereby each pixel in an ‘image’
represents a entire Raman spectrum, more diagnostic information is available. A
‘chemical’ image of these tissues can be used for a visual diagnosis in a similar
way to stained tissues. To look at the morphological structure of the tissue, in line
with the current H&E diagnostic approach, but with the added benefit of chemi-
cal specificity. Raman mapping is performed by raster scanning a laser across
the sample, using a motorised stage and point or line mapping. By selecting a
particular peak intensity, maps can be plotted, showing the distribution of that
compound across the mapped area. By applying a pseduo-colour map, the look
up table (LUT) correlates with a high or low concentration of the sample. Plotting
PCA scores of Raman maps allows visualisation of the variance across different
regions of tissue. Further improvements in mapping times have been achieved
using simultaneous stage movement and CCD readout [88].
For Raman to continue to progress into clinical translation, there is a need to move
towards measurements that eliminate the need to excise tissue. One method
is to perform Raman measurements in-vivo, an alternative approach is to utilise
biofluids, such as, blood, serum, saliva, sputum, tears and urine, that are readily
available from the body. Removal of such fluids are minimally invasive and allow
repeat sampling. Biofluids can contain many biomolecules, that have been se-
creted or shed from diseased tissues [96], as many biofluids come in direct contact
with diseased tissue, therefore, these biomolecules can be of interest for disease
diagnosis [60]. Many examples exist in the literature for cancer discrimination. For
instance, Raman of serum has been shown to distinguish between normal and
cancerous samples with high sensitivity and specificity for breast [97], colorectal
[98], cervical [99] and oral cancers [100]. Other examples include, urine studies
of bladder [101] and oral cancers [102], and sputum for measurements of lung
cancer [103].
Additional challenges arise from measurements made in-vivo, these include col-
lection of the weak Raman signal and long acquisition times that are not partic-
ularly viable. Working towards in-vivo measurements, fibre optic probes have
been designed that are able to be inserted down the accessory channel of an
endoscope and improvements in detectors and filters have allowed for reductions
in measurement times to less than 1 s [104, 105]. The benefit of Raman is the
reduction in the need for tissue removal. This is especially appropriate for BO
where a vast majority of the exercised tissue during surveillance is of a normal
pathology [106]. Being able to target more effectively suspicious BO lesions, in
particular BO regions with high grade dysplasia, would be of huge benefit during
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surgery and reduce costs and time in pathology labs. The probes developed
aim to do exactly that, by taking Raman spectra of tissues and using these to
determine whether the tissue needs to be removed for pathological examination.
In-vivo measurements have been made using a confocal Raman probe [105].
Raman spectra from the oesophagus using this probe was taken of 373 patients
to create a spectral library. The probe makes gentle contact with the surface of
the tissue. Biopsies were taken of the measured region and sent for histological
examination to confirm the pathology. This probe resulted in a sensitivity of 87%
and a specificity of 84.7% for discrimination of high grade dysplasia from BO. The
biochemical changes that are used for discrimination in-vivo seem to reflect that
of ex-vivo studies [95].
The majority of publications in the literature using Raman spectroscopy focus on
measurements with the fingerprint region, which is typically defined as 400 cm−1
to 1800 cm−1. This region has a wealth of biochemical information useful for diag-
nosis. The high wavenumber (hwn) region, defined as 2400 cm−1 to 3800 cm−1,
is less commonly used, but may offer several benefits, especially for in-vivo ap-
plications. In the fingerprint region, fluorescence from silica fibres can overwhelm
weak Raman signal. Measurements made in the high wavenumber region have a
reduction in this fluorescence, which may make the use of the high wavenumber
(hwn) regionmore appealing for in-vivo probemeasurements. The hwn region can
offer complementary information to that of the fingerprint region, but interpretation
in this region can be tricky as peaks are broadband and overlapping. It contains
information about the C-H stretching vibrations. Therefore, it provides information
on proteins and lipids within the sample. O-H stretching primarily due to water
is also visible in the hwn region. Raman in the hwn has already been applied to
different types of cancers, including that of the brain [76], larynx [92], oesophagus
[82], prostate [76] and those of the head and neck [79, 107]. In the larynx [92],
spectra of normal tissues were compared to those of laryngeal cancer in the
hwn region. Difference spectra between the two pathology groups revealed a
greater intensity for bands between 2810 cm−1 to 2900 cm−1 for cancerous tissues
and greater intensities for bands between 2900 cm−1 to 3020 cm−1 for normal
tissues.These differences were assigned to changes in the protein and lipid con-
tents. Intensities at 2920 cm−1 and 2940 cm−1 are higher in normal tissues and
2845 cm−1 and 2890 cm−1 are higher in cancerous tissues. Using a PCA-LDA
leave-one-subject-out cross validation, a sensitivity of 90.3% and a specificity of
90.9%, were reported, for identification of normal vs cancer in the larnx. Others
[107], looking at the O-H vibrations in oral cancers, found a higher intensity of the
OH stretching vibration at 3450 cm−1 in cancerous tissues in comparison to normal
tissues, and reported a sensitivity of 99% and a specificity of 92%. A study looking
at in-vivo diagnosis of squamous cell carcinoma in the oesophagus [82], looked at
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the benefits of combining the fingerprint and the hwn regions for diagnosis using a
PLS-DA leave-one-patient-out cross validation, a sensitivity of 97% and specificity
of 97.4% was reported for combined fp and hwn regions. This is higher than for
each of the regions on their own. They too observed a difference in water content
between normal and cancerous tissues.
2.3 Coherent anti-Stokes Raman scattering
Coherent anti-Stokes Raman scattering (CARS) is reported to have a 105 times
stronger signal than Raman [108]. This is due to the coherent nature of the signal
generation. This enables much faster acquisition times, up to video-rate, which
allows the observation of real time processes. CARS uses molecular vibrations
primarily from CH bonds, commonly found in lipids and proteins as a contrast
mechanism. This make it an excellent technique for probing biological samples
that are abundant in these types of molecules.
Although the practical applications of CARS are considered relatively novel in
comparison to those of spontaneous Raman, the theory of the CARS process
was first published back in 1965, by Marker and Turhune, whilst working for the
Ford motor company [108]. However, it wasn’t until 1982, with the inclusion of a
microscope to the configuration, that the CARS techniques began to evolve to re-
semble systems that might be seen in a lab now [109]. The advancement of CARS
had to wait for technology to catch up. A paper published in 1999 by Zumbusch
et al. [110], made significant progress in the compatibility of CARS for biological
applications. With the inclusion of a high numerical aperture objective the phase
matching conditions were relaxed. Zumbusch et al. also employed a solid state
near infrared (NIR) laser, and was the first to perform three-dimensional imaging of
tissues, demonstrating improvements in sensitivity by using near infrared lasers.
These lasers, however, were femtosecond lasers and as a result had a large
bandwidth, of about 60 cm−1. This is much larger than that of a Raman band,
typically 10 cm−1. In 2001 Cheng et al. [111], used NIR picosecond pulses. The
picosecond pulses have lower peak power, but it was demonstrated theoretically
and experimentally that by using picosecond pulses, there was an increase in
both the spectral resolution and the sensitivity. This is as a result of the non-
resonant background scaling quadratically and the resonant signal reaching a
saturation point with increasing spectral width. Therefore, the ratio of signal to
background is more favourable for picosecond pulses. An epi-detected configu-
ration offers further reductions in the non-resonant background contribution [111].
Mainly due to the highly scattering nature of tissue, a significant amount of the
forward generated CARS signal is directed in the backwards direction, to allow epi-
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detection [112]. The percentage of backscattered light increases with increasing
sample thickness.
As advances in technology and improvements in system performance have made
CARS more viable, several applications have emerged that include those of med-
ical imaging. Several studies have used CARS for cancer including those of
the breast [113], lung [114], head and neck [115], prostate [116] and colon [90].
For medical applications, many multimodal approaches have also been explored,
combining CARS with other complementary non-linear techniques such as sec-
ond harmonic generation (SHG) and two-photon fluorescence (TPF), which pro-
vide contrast for structural elements such as elastin and collagen, respectively
[115,117–120].
Like Raman, CARS is non-invasive and label free, so has great potential to be
used in-vivo. In-vivo studies have been conducted imaging the skin [112], spine
and brain [121], with submicron resolution. CARS has also been used to identify
intracellular components, such as the nucleus and mitochondria [122,123]. Deliv-
ery of CARS signals in-vivo is more complex than that of Raman, due to several
criteria that must be met to achieve a CARS signal, such as the phase matching
conditions.
CARS, however, is fundametnally limited by the presence of a nonresonant back-
ground, from the electronic response of the sample [67]. The Raman bands from
CH bonds in the hwn region are much more intense, than those in the fingerprint
region, due to larger cross sectional areas and polarisabilities [66]. This in com-
bination with the abundance of CH bonds present in biological tissue, especially
lipids and the square dependence of the CARS signal with the number of Raman
scatterers, results in a very stong CARS signal in the hwn region, allowing for rapid
single wavelength imaging. The nonresonant background limts the detection limit
for CARS and essentially the signal from the fingerprint region is not much greater
than that of the nonresonant background [67]. The nonresonant background also
makes quantative analysis of CARS signals nontrivial, as it coherently mixes with
the resonant signal and results in a distorted spectral line shape, that can’t be
simply subtracted [124]. This combined with the quadratic dependence of CARS
on concentration, compounds the complexity. Computation methods such as,
maximum entropy [125] and Kramers-Kronig [126] approaches have been devel-
oped to retrieve the resonant signal from the nonresonant background. In addition
to techniques that attempt to suppress the nonreonant background, these include,
frequency modulated CARS [127], phase-sensitive CARS [128], multiplex CARS
[129] and previously mentioned epi-detected CARS [112]. One successful and
popular alternative to CARS, that has been proven to be nonresonant background
free is stimulated Raman scattering (SRS) and will be discussed in the following
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section.
2.4 Stimulated Raman scattering
Stimulated Raman scattering (SRS) was first observed in 1962 by Woodbury and
Ng [130] . However, it did not emerge as a promising tool for use on biological
tissues until the first biological applications were reported in 2008 [131,132]. Since
then, the number of publications applying SRS to biological samples has steadily
increased, as the technique is growing in popularity [133].
SRS is a particularly attractive alternative to CARS acquired using high frequency
lock-in detection ensuring that SRS does not suffer from a non-resonant back-
ground. SRS offers several advantages over CARS. Firstly, being background
free means that there is a clear signal on resonance that vanishes off resonance.
This allows a detection limit close to the shot noise and hence an improvement
in sensitivity, which surpasses the detection limit for CARS [131,134]. Secondly,
SRS produces spectra that match these of spontaneous Raman [132]. Finally,
the signal has a linear response to the concentration of Raman oscillators in the
focal volume [65, 131]. These factors combined allow for more straightforward
quantitative analysis.
Imaging capabilities of SRS have been shown to be sufficient to resolve tissue
morphologies and structures with subcellular resolution [135]. Comparisons of
SRS images with conventional histology showed excellent correlation for the iden-
tification of several different cancers including those of the brain [135–139], skin
[140, 141], liver and pancreas [142]. SRS has been shown to be particularly
successful in identifying brain tumours. These show changes from more lipid
rich white matter at 2850 cm−1, to a more protein rich tumour 2930 cm−1. The
ratio between the two wavenumbers was shown to be a good indicator of tumour
infiltration [136]. Furthermore, images are able to visualise cell nuclei and cell
boundaries to quantify changes in nuclear shape and size, important biomark-
ers for the diagnosis of the progression of cancers using the protein contrast at
2945 cm−1. Several studies [138, 141] have focused on extracting quantitative
information about nucleic acids and DNA in cells and tissues, using information
such as the size, shape and density of nuclear features which can be resolved
using SRS. This information has useful implications in the diagnosis of cancers.
In addition to analysis based on morphological information,SRS is also able to
provide chemically specific information which allows the concentration of DNA in
the nucleus to be explored. This highlights different points in the cell cycle and
can indicate increased cell proliferation and apoptosis [141].
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Thicker samples such as those that might be encountered in-vivo require mea-
surement of epi-scattered signals. This has been demonstrated for SRS in tissues
with the requirement that they are highly scattering. Multiple scattering events in
the forward direction re-directs some of forward propagating photons in the epi
direction. Detection of these photons requires a quarter waveplate and polarising
beam splitter to separate the incident laser light from that of the backscattered
light [131]. To further improve the collection efficiency of the backscattered light,
a photodiode detector was placed before the objective with a central aperture to
allow the laser light to reach the sample [143].
SRS, although still in its infancy, has demonstrated great promise for clinical ap-
plications and, with custommade lock-in amplifiers, SRS can be acquired at video
rate [143,144], which allows for real time measurements at single wavenumbers.
Video rate acquisition allows for the observation of dynamic processes such as
drug delivery. The clinical prospects for SRS have been further summarised in
several review articles [133,145–150].
2.5 Summary
Raman techniques have enormous benefits for clinical applications, which have
been demonstrated on various tissue types. These techniques are all able to
provide label-free, non-invasive chemical information about tissues. Spontaneous
Raman is an inherently weak process, but coherent Raman techniques can offer
an enhance in Raman signal, at single wavenumbers and hence offer improve-
ments on imaging times. CARS however, suffers from a nonresonant background
that somewhat limits it application, to highly concentrated molecules in the hwn
region. SRS on the other hand is background free and due to the linear signal
relationship with the concentration of Raman scatterers, is able to produce spectra
that match that of spontaneous Raman, making it highly suited to quantative
applications.
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CHAPTER 3
Background theory
3.1 Introduction
When monochromatic light, such as a laser, is incident on a molecule it can
interact by being absorbed or scattered. Absorption requires the incident light
to have the same energy as the difference between the ground and excited state
in the molecule. If this is a vibrational state the relevant technique is infra-red
(IR) absorption. Raman on the other hand is an inelastic scattering process.
The oscillating electric field of the incident light polarises the electron cloud and
induces a dipole moment. The Raman effect arises from a change in polarisability
of a molecule during the vibrational mode. During Raman scattering, energy is
transferred either from the incident photon to the molecule or from the molecule
to the incident photon. Raman techniques can be broadly defined as being either
linear or nonlinear. This refers to the relationship between the incident and signal
intensities. Spontaneous Raman is a linear technique in that, the signal intensity
is linearly proportional to the intensity of the incident beam. coherent anti-Stokes
Raman scattering (CARS) and stimulated Raman scattering (SRS) on the other
hand are nonlinear processes. They have a quadratic or higher order dependence
on the intensity of the incident laser beams. This non-linearity, amongst other
factors, unique to CARS and SRS, is responsible for the observed enhancement
in Raman signal, that allows for a more rapid detection. This chapter outlines the
theoretical background that describes the origins of the different Raman signals
and how an enhancement is achieved. Each technique will now be approached
individually.
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3.2 Raman scattering
A simple approach to decribe the behaviour of molecular vibrations is using Hooke’s
law and Newton’s second law of motion, considering the atoms and the bonds
between them as masses on springs. This is depicted in figure 3.2(a). Hooke’s
law states that:
m1m2
m1 +m2
(
∂2x1
∂t2
+
∂2x2
∂t2
)
= −k(x1 + x2) (3.1)
where k is the bond strength, m1 and m2 are the atomic masses of the two atoms
and x1 and x2 are their displacements from equilibrium. By replacing the reduced
mass, μ= m1 m2 / m1 + m2 and Q = x1 + x2, equation 3.1 can be rewritten as:
µ
∂2Q
∂t2
= −kQ (3.2)
This takes the form of a second order differential equation which has the solution:
Q = Q0cos(2piνvibt) (3.3)
Where νvib is the frequency of vibration:
νvib =
1
2pi
√
k
µ
(3.4)
From equation 3.4, it is apparent that the vibrational frequency is proportional to
the bond strength and inversely proportional to the reduced mass of the molecule.
The stronger the bond, the higher the frequency of the vibration. The more mas-
sive the atoms the lower the frequency. Vibrational spectroscopy therefore pro-
Symmetric Asymmetric Scissoring TwistingRocking Wagging
Stretch In-plane bending Out of plane bending
Figure 3.1: Examples of the different vibrational modes of a nonlinear molecule for the
mass on a spring approach. Note: Not all of these vibrations result in a change in the
polarisability of the molecule, therefore not all are Raman active.
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vides unique molecular signatures that depend both on the mass of the atom
and the strength of the bond. The number of vibrational modes depends on the
number of atoms in a molecule, Na. For linear molecules, the number of possible
vibrations is 3Na-5 and for nonlinear molecules is 3Na-6. Figure 3.1 shows the
different vibrational modes of a nonlinear triatomic molecule.
A classical approach to Raman scattering considers the interaction between an
incident electric field and the charged particles of a molecule. An incident electric
field with a frequency, νp, can be expressed as:
E = E0cos(2piνpt) (3.5)
The result is for positively charged particles to move in the same direction as the
applied field and negatively charged particles in the opposite direction, causing a
displacement of electrons from their equilibrium position, which in turn induces a
dipole moment [67]. The magnitude of the dipole moment depends on the extent
of the displacement, such that weakly bound electrons will experience a larger
displacement. The dipole moment will oscillate at the same frequency as the
incident electric field, which can be described by considering a simple harmonic
oscillator, whereby the nuclear mode Q is assumed to be [151]:
Q = Q0cos(2piνvibt) (3.6)
where νvib, is the frequency vibration. The induced dipole moment, P, is a product
of the incident electric field and the polarisability, α, of the molecule, and will emit
or scatter photons at the same frequency as the incident light:
P = αE (3.7)
The polarisability is a measure of the ease with which an incident electric field can
distort the electron cloud, and is perturbed by the nuclear mode, as the electrons
are bound to the nucleus. Expanded by a first order Taylor series, the polarisability
can be written as:
α = α0 +
∂α
∂Q
Q (3.8)
where α0 is the static polarisability and the [∂α/ ∂Q] term in equation 3.8 acts as
a coupling term between the electrons and the nuclei. Combining equations 3.5,
3.6, 3.7 and 3.8, the dipole moment can be written as [151,152]:
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Figure 3.2: Schematic of spontaneous Raman scattering (a) Classically Raman
scattering can be described as a harmonic oscillator. An incident beam ~νp is scattered
into three components Rayleigh (νp), Stokes (νp-νvib) and anti-Stokes (νp+νvib). (b)
Vibrational energy level diagrams for the Stokes and anti-Stokes processes.
P = α0E0cos(2piνpt)︸ ︷︷ ︸
Rayleigh
+
∂α
∂Q
E0Q0
2
[
anti-Stokes︷ ︸︸ ︷
cos2pi(νp + νvib)t+
Stokes︷ ︸︸ ︷
cos2pi(νp − νvib)t]︸ ︷︷ ︸
Raman
(3.9)
From equation 3.9, the first term describes the elastic process of Rayleigh scatter-
ing, whereby the emitted photon is of the same frequency as the incident photon,
νp. This is the most intense process. The second term describes the much
weaker Raman interaction, with only 1 in 106-108 photons undergoing Raman
scattering [153]. These terms are proportional to [∂α/ ∂Q], so for a molecule to be
Raman active, there must be a change in the polarisability during the vibration.
This is one of the selection rules for Raman scattering [153]. The Raman interac-
tion can be further divided into Stokes and anti-Stokes processes. The (νp+νvib)
term describes the anti-Stokes process in which the emitted photon, νaS, is blue-
shifted, so is of a higher frequency than the incident photon, νp. The (νp-νvib) term
describes the Stokes process, whereby the emitted photon, νS, is red-shifted, so
is of a lower frequency than the incident photon, νp. For the anti-Stokes process,
the molecules must initially be in an excited state, whilst for the Stokes they are
in the ground state. As at room temperature, the majority of molecules reside
in the ground state, the Stokes process tends to dominate and as a result is the
conventional detection method.
Raman scattering can also be described by considering a quantised change in
the vibrational energy of a molecule. Molecules are constantly vibrating, due to
thermal fluctuations. When no external electromagnetic field is applied so the
moleculae is at equilibrium this corresponds to the zero point energy, which is the
lowest mode of vibration. The relationship between the change in energy, ΔE, and
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frequency is given by the following equation:
∆E = hνp (3.10)
To obey energy conservation, the change in energy must equal the difference
between the final and initial states of allowed transitions. Figure 3.2(b) shows the
vibrational energy changes that occur as a result of the Raman process. Raman
scattering is a two photon process, an incident photon νp promotes the molecule
to a virtual energy state, represented by a dashed line in figure 3.2(b). This state
is non-existent and so instantaneously a new photon is emitted at a different
wavelength νs or νas depending on whether the molecule resides in the ground
or an excited state initially, returning the molecule to one of the allowed energy
states. As the virtual state is not real, its energy depends on the frequency of
the incident beam. This describes Stokes and anti-Stokes scattering respectively.
The difference between the final and initial wavelengths equals that of a Raman
vibrational mode, νvib. The total Raman intensity can be described by the following
equation:
Itot = NI
∫
σdiff dνvib (3.11)
where N is the number of Raman scattering molecules, I is the incident laser
intensity and σdiff is the Raman cross-section. With reference to equation 3.11, it
is apparent that the Raman signal scales linearly with the input laser intensity and
the number of scattering molecules, N. In Raman, the scattered components are
incoherent.
Raman spectroscopy measures the difference in frequencies between the scat-
tered and incident photons. This difference is termed the Raman shift and is
conventionally measured in wavenumber, units of cm−1. TheRaman spectrum are
plots of scattering intensity as a function of the Raman shift. Different molecules
have different characteristic peaks corresponding to the vibrational modes of the
bonds present. Therefore, each molecule has a unique Raman fingerprint. Ra-
man, however, is limited by weak signals, which require long acquisition times. To
enhance the signal, coherent Raman techniques are considered.
3.3 Coherent anti-Stokes Raman scattering
CARS is a nonlinear process and is the first of the coherent Raman techniques
to be discussed. CARS is able to produce signal intensities of typically more than
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five orders of magnitude greater than spontaneous Raman [151]. The relation-
ship between the polarisation and the electric field can be extended to consider
nonlinear terms using a Taylor expansion and is expressed as:
P = 0
[
χ(1)E + χ(2)E2 + χ(3)E3 + . . .
]
(3.12)
where χ(1) is the linear susceptibility and χ(2), χ(3) are the nonlinear susceptibilites.
The linear susceptibility is responsible for linear interactions with materials such as
absorption. Second order interactions include two-photon fluorescence (TPF) and
second harmonic generation (SHG) and third order interactions include Raman
and coherent Raman techniques. It must be noted that although Raman is as a
result of a third order interaction with the material, it is a linear process. That is,
there is a linear relationship between the incident intensity and the resulting signal
intensity. CARS and SRS on the other hand are nonlinear processes.
CARS is a four wavemixing process. This means that three electric fields combine
to form a fourth. The signal originates from the interaction of a pump (νp), Stokes
(νS) and probe (νpr) field with the molecule, which in turn produces an anti-Stokes
field (νaS), at a new frequency (νaS=νp-νS+νpr) [154]. The pump and probe fields
are provided by the same laser source, for the experiments described in this
thesis.
Energy level diagrams for the CARS process can be seen in figure 3.3(c). Upon
Comparison with figure 3.2(b), it can be noted that the initial process is similar
to that of spontaneous Raman. However, in CARS, the Stokes process is not
spontaneous, but instead originates from an applied laser field. The enhancement
in CARS comes from the actively driven nuclear vibrations, provided by the two
incident electric fields. As is the case of spontaneous Raman, an incident electric
field induces a dipole moment, which oscillates with the same frequency as that of
the electric field. When two electric fields are incident on a molecule, they actively
drive the nuclear oscillations at the ‘difference frequency’, or the beat frequency
of the two fields. This provides an effective time varied force that oscillates at
the beat frequency, which in turn causes oscillations of the nuclear mode. Its
amplitude is dependent on the amplitudes of the incident fields and the change
in polarisability. In the case of CARS, the beat frequency between the pump and
Stokes fields is chosen to match that of a Raman active molecular vibration (ν=νp
- νS). For a CARS signal to occur, both the pump and Stokes beams must be
overlapped in time and space at the sample. This makes up part of the phase
matching conditions that will be discussed in section 3.3.1.
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Figure 3.3: Schematic of the CARS process. (a) The beat frequency matches that of a
Raman vibration. (b) The phase matching conditions for CARS in the forward direction.
(c) The energy level diagrams of the three terms that make up the third-order susceptibility.
3.3.1 Signal generation
TheCARS signal can be described by the optical mixing of electromagnetic waves.
The behaviour of electromagnetic waves is governed byMaxwell’s equations [155]
and from these an expression for the nonlinear wave equation can bewritten [151]:
∇×∇× E(r, t) + n
2
c2
∂2E
∂t2
= − 1
0c2
∂2P (3)
∂t2
(3.13)
where P(3) is the third order polarisation1 2. From this equation, it can be seen that
there is a relationship between the electric field and the third order polarisation of
the molecule. A solution to the wave equation is to consider the electric field as a
plane wave, expressed by:
E(z, t) = EaSe
i(νaSt−kaSz) (3.14)
where νaS is the frequency of the anti-Stokes field and kaS is the wave vector.
Substituting equation 3.14 into the nonlinear wave equation, equation (3.13) and
applying the slowly varying envelope approximation (SVEA)3 yields:
1∇×∇× E(r, t) = ∇(∇ . E(r, t))−∇2E(r, t)
2∇(∇ . E(r, t)) assumed to be negligible
3
∣∣∣∂2E(z)∂z2 ∣∣∣ << ∣∣∣k ∂E(z)∂z ∣∣∣
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EaS(L) = −i νaS
naS0c
P
(3)
aS . L
sin[∆kL/2]
∆kL/2
e−i∆kL/2 (3.15)
where L is the interaction length, nas if the refractive index and Δk the wave vector
mismatch between the incident and CARS field (Δk= kaS-2kp+kS). From equation
3.12, the third order polarisation can be written as:
P (3)(νaS) = 0χ
(3)E2p(νp)ES(νS) (3.16)
and by substituting equation 3.16 into equation 3.15, the electric field can be
written as:
EaS(L) = −i νaS
naSc
χ(3)E2p(νp)ES(νS) . L
sin[∆kL/2]
∆kL/2
e−i∆kL/2 (3.17)
The resonant third order nonlinear susceptibility, χr(3), describes the optical re-
sponse of the material to an applied laser, it is given as:
χ(3)r (νas) =
(N/3m)[∂α/∂Q]20
ν2vib − (νp − νS)2 − 2i(νp − νS)γ
(3.18)
Where N is the number of Raman scatterers. The CARS intensity is found by
taking the square of the modulus of the electric field, and is expressed as [151]:
IaS(L) =
naSc
8pi
|EaS(L)|2 ∝ ν
2
aS
naSc2
∣∣χ(3)(νaS)∣∣2 I2pIS . L2(sin[∆kL/2]∆kL/2
)2
(3.19)
Equation 3.19 highlights three important properties of the CARS signal. Firstly,
that the intensity of the signal has a quadratic relationship with the pump beam
and a linear relationship with the Stokes beam; resulting in an overall cubic depen-
dence on the input intensities. Secondly, that because the third order nonlinear
susceptibility, χr(3), defined by equation 3.18, is proportional to the number of
Raman scatters, N, CARS has a quadratic dependence on the number of Raman
active molecules. Thirdly, to achieve the maximum signal, all of the incoming
waves must be in phase. This final property arises from the term ɸ=ΔkL that
defines the phase matching conditions. As can be seen from equation 3.19, the
final term is a sinc function4. Therefore, the total CARS intensity becomes larger
as ɸ tends to zero. So the smaller the wave vector mismatch between the incident
and emitted fields, the greater the signal. These phase matching conditions are
4sinc = sin(x)/x
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relaxed under tight focusing, such as by using high numerical aperture objectives,
which have the effect of reducing the interaction length, L, to the order of the
anti-Stokes wavelength, so the effects of the wave vector mismatch become less
important. As a result of phase matching, the emitted CARS signal has a well-
defined propagation direction. All waves emitted from the sample in different
positions are of the same phase. They are coherent and they sum constructively in
the forwards direction and destructively in all other directions. This enables much
more efficient signal collection. The Epi-scattered CARS signal is, as a result of
one of three mechanisms [112]:
1. Interactions with small scatters. Scatterers smaller than the wavelength of
the pump laser, or sample interfaces can result in the incomplete destructive
interference of the back scattered signal.
2. A backwards propagating signal is generated at sharp discontinuities of the
third order susceptibility.
3. Multiple scattering events in highly scattering materials, that re-direct the
signal in the backwards direction.
Most applicable to this work and for tissues in general, is the third mechanism.
For this mechanism, the percentage of back scattered signal increases with sam-
ple thickness. Epi-CARS is useful for reducing the effects of the nonresonant
background and is the only detection method for thick tissues [111].
CARS is a nonlinear process, and this dependence provides the enhancement
in Raman signal. CARS signal is intense for highly concentrated molecules, but
it may struggle for single molecule applications, due to the nonresonant back-
ground, discussed further in section 3.3.2.
3.3.2 Origins of the nonresonant background
The main limitation of CARS is the presence of a nonresonant background. The
nonresonant background arises from the third order susceptibility, which charac-
terises the nonlinear optical response of a medium and governs the wave prop-
agation. It is dependent on the electronic and molecular structure of the medium
[156]. The total nonlinear susceptibility is composed of a resonant and nonreso-
nant part:
χ(3) = χ(3)r + χ
(3)
nr (3.20)
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Figure 3.4: The CARS spectral lineshape as a function of the detuning. (a) The amplitude
of the resonant, nonresonant and the mixing term as a function of the detuning. Γis
the Raman linewidth and νR the Raman resonance. (b) Resulting CARS spectrum as
a function of the detuning, produced from the sum of the resonant and nonresonant
contributions. Figure from [124].
The nonresonant part is as a result of electronic oscillations that still occur in the
absence of resonant nuclear modes and is frequency independent. When close to
a real electronic state, there may also be two-photon absorption. The third order
susceptibility can be written as [154]:
χ(3) =
Ar
∆− iΓr︸ ︷︷ ︸
Raman
+ χ(3)nr +
At
νt − 2ωp − iΓt︸ ︷︷ ︸
two-photon absorption
(3.21)
where Δ, is the detuning term (Δ=ν-νp-νS), Γr and Γt the linewidths for Raman
and two photon electronic transition, respectively, and Ar and At are the Raman
and two photon absorption cross sections [154]. The first term in equation 3.21
describes the resonant part of the CARS signal. It can be seen that it’s at a
maximum when approaching a Raman resonance, and the detuning term, Δ,
tends to zero. The second term is the nonresonant term and is independent of
Raman shift, and the third is two-photon absorption. The energy levels for these
three terms are shown in figure 3.3(c). The CARS signal intensity is proportional
to the square modulus of the nonlinear susceptibility [154]:
I(νaS) ∝
∣∣χ(3)∣∣2 = ∣∣χ(3)r (νaS)∣∣2 + ∣∣χ(3)nr ∣∣2 + 2χ(3)nrRe{χ(3)r (νaS)}︸ ︷︷ ︸
mixing term
(3.22)
CARS signal is made up of the resonant and nonresonant parts along with a
mixing term that is responsible for the dispersive line shape of CARS spectra [151].
Figure 3.4 shows plots of the components of the CARS spectrum as a function of
the detuning. The resonant contribution peaks at the vibrational resonance of the
molecule, but it is complex and contains real and imaginary parts. Summing all the
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Figure 3.5: Schematic of the SRS process. (a) Energy level diagram for the SRS
process. (b) The difference in wavelengths of the input laser beams match that of a
Raman vibration, the output is a loss in the pump beam and a gain in the Stokes beam.
(c) The Stokes beam is modulated, a small loss in the pump beam is detected, using
highly sensitive lock-in detection.
contributions highlights why extracting spectral information fromCARS techniques
is not trivial.
3.4 Stimulated Raman scattering
Stimulated Raman scattering (SRS) is the second coherent Raman technique to
be discussed. SRS can be summarised as a two-photon process, analogous
to stimulated emission. Figure 3.5 summarises SRS as a series of schematics.
A pump photon, νp, is absorbed, exciting the molecule to a virtual energy level
and a new photon, νS, is emitted when the molecule returns to a lower energy
level. The difference between the final and initial state of the molecule νvib must
match that of a Raman vibrational mode. It is apparent that this is identical to the
spontaneous Raman process described in figure 3.2(c). However, the emission
of the Stokes photon is stimulated rather than spontaneous, as in SRS the Stokes
mode is already occupied by the applied laser field, whereas it is empty in the
spontaneous process [67].
SRS also requires that the pump and Stokes beams are overlapped in time and
space at the sample. The SRS signal arises from same Raman interactions
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described previously for CARS. Therefore the two processes occur simultane-
ously [157]. However, instead of detecting light at a new frequency, as is the case
for CARS, SRS is detected by measuring a small energy transfer, which results in
a change in the amplitude of the pump and Stokes beams. As can be observed
from figure 3.5, a pump photon is absorbed by the molecule and a Stokes photon
is emitted, the result is a reduction in the intensity of the pump beam stimulated
Raman loss (SRL) and an increase in the Stokes beam stimulated Raman gain
(SRG). When detecting the pump beam, the Stokes beam is modulated at a
known frequency. The effect is to turn the SRS signal ‘on’ and ‘off’, as SRS can
only occur when both beams are present. The loss in the pump beam occurs at
the same known frequency as the modulation of the Stokes beam, as illustrated
in figure 3.5(c). The change in intensity of the pump beam, ΔIp, is the SRS signal.
A filter, after the sample, blocks the Stokes beam. To be able to detect such small
signals, highly sensitive lock-in detection is used; this extracts the SRS signal from
the much larger background signal of the pump laser. Phase matching conditions
for SRS are automatically fulfilled as the excitation and detection wavelengths are
the same.
The change in intensity of the pump beam is given by [67]:
∆Ip ∝ −NσRamanIpIs (3.23)
where σRaman, is the Raman scattering cross-section of the molecule. From this
equation, it is evident that, like spontaneous Raman measurements, the SRS
signal scales linearly with the number of Raman scatters, N, so quantitative mea-
surements are possible. There is also a linear dependence with the intensity of
the incident pump and Stokes beams, resulting in a quadratic relationship with the
overall incident intensity.
Unlike CARS, SRS does not suffer from a nonresonant background, as the signal
is only produced when the difference between the pump and Stokes beamsmatch
that of a Raman vibrational mode. SRS, however, is not completely background
free, as it can be affected by other nonlinear interactions such as two-photon
absorption.
3.5 Summary
CARS is a nonlinear process with a cubic dependence on the incident laser inten-
sity and a quadratic dependence on the number of Raman scatterers. The signal
produced by the CARS process is coherent and in phase, and is emitted with a
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defined direction. Due to phase matching conditions, signal is only produced in
the plane of focus, this enables three-dimensional optical sectioning capabilities,
which eliminates the need for tissue sectioning. The SRS process is stimulated
rather than spontaneous and is generated from actively driven vibrations. Unlike
CARS, SRS does not suffer from a nonresonant background, that can distort
spectral line shapes, so spectral information that matches that of spontaneous
Raman can be extracted. The signal is linearly proportional to the number of
Raman scatters, so quantitative measurements are possible. The SRS signal
has a quadratic dependence on the incident intensity.
Spontaneous Raman Coherent Raman
One continuous wave laser Two pulsed ps lasers
Spontaneous process Stimulated process, actively driven
molecular vibrations at Raman modes
Linear relationship of the signal with the
incident intensity, IRaman∝I
Nonlinear relationship of the signal
with the incident intensity, ISRS∝I2 and
ICARS∝I3
Incoherent, emitted phases are random
with respect to one another
Coherent, exhibit a well-defined phase
relationship
Linear relationship with the number of
Raman scatters, IRaman∝N
CARS, ICARS∝N2 and SRS, ISRS∝N
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CHAPTER 4
Instrumentation and experimental
4.1 Introduction
The previous chapter outlined the theoretical origins of spontaneous and coherent
Raman signals. This chapter extends the theoretical basis, to provide a descrip-
tion of the instrumentation and experimental protocol, used throughout this thesis
to measure Raman signals. Detailed descriptions are included of the spontaneous
and coherent Raman experimental set-ups and the detection methods used for
each approach. This chapter also includes data pre-processing methods and an
introduction to the multivariate techniques, used for analysis, such as principal
components analysis (PCA), linear discriminant analysis (LDA) and k-means clus-
tering.
4.2 Raman microspectrometer
Spontaneous Raman measurements were performed using a commercially avail-
able confocal Raman microscope (InVia, Renishaw, UK). The Raman microscope
is situated in an air conditioned room which is maintained at 21 °C, stable to within
±1 °C. This instrument offers a degree of flexibility depending on the measure-
ment requirements, these include a choice of excitation wavelength, diffraction
grating and microscope objective. The system has the choice of two diode lasers
both at near-infrared wavelengths, 785 nm and 830 nm, with an output power
at source of 300 mW (approximately 130 mW at the sample). Each laser has
a separate beam path, which requires individual calibration performed using the
instrument software, Wire (version 4.0, Renishaw, UK). This means that switching
between lasers is easy and rapid.
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785nm 830nm Raman signal
DG
NF
SL
microscope CCD
Figure 4.1: Renishaw InVia system for spontaneous Ramanmeasurements, insert shows
the various components that make up the spectrometer and the beam paths for the
785/830 nm lasers and resulting Raman signal [DG: diffraction grating, NF: notch filter,
SL: streamline lens]
The internal workings of the Raman microscope, highlighting the important optical
components, and beam paths of the laser photons and resulting Raman photons,
is shown in figure 4.1. With reference to this figure, the laser light enters from
the bottom right of the instrument and passes through a series of lenses and
mirrors, before it is reflected off a notch filter (NF) and enters the microscope.
The objective lens focuses the light onto the sample, in the form of a line. The
back scattered Raman signal is collected by the same microscope objective and
passes through a notch filter, that allows the Raman signal to be transmitted, but
blocks the more intense elastically scattered light. Finally, a diffraction grating
projects the component wavelengths of the Raman light onto a Peltier cooled
deep depletion CCD for detection. The exposure time set in the Wire software
determines the amount of time that the CCD is exposed to the Raman signal;
longer exposure times increase the signal to noise ratio. Positioning of the sample
is controlled by a motorised xyz stage.
For sample visualisation, there is a camera located at the top of the microscope,
that displays the reflected white light. The instrument software allows large area
montages for determining the region of interest on the sample.
4.2.1 Instrumentation
Excitation wavelength selection
It is generally accepted that near infrared (NIR) laser sources are best suited for
biological tissue applications, due to improved one-photon fluorescence suppres-
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sion, that can result in a broad background in spectra. The asborption of photons
is wavelength dependent, and themajority of inherent fluorophores in tissues have
excitation wavelengths in the ultraviolet (UV) or shorter visable wavelengths. In
addition NIR wavelengths offer minimised photodamage, in comparison to those
in the visible range, due to the longer wavelengths and hence lower energy of
the laser. Therefore, both lasers in the Raman microscope have emission wave-
lengths in the NIR. However, despite this, there are still advantages and disad-
vantages for use of each of these wavelengths, which are relevant considerations
for tissue applications in the high wavenumber (hwn). For example, the CCD
is more sensitive to the 785 nm wavelength when compared to 830 nm and in
combination with the λ-4 relationship of the Raman scattering intensity, where λ is
the laser wavelength, the 785 nm laser is a factor of 1.2 more efficient than 830
nm, a greater signal to noise ratio is expected. It is essential to use the 785 nm
laser to measure in the hwn region. The longer wavelength of the 830 nm laser
and resulting shifted Raman photons are not of sufficient energy to be detected
by the CCD.
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Figure 4.2: A comparison of the objective
contribution from the 50x long working distance
lens for 785 nm and 830 nm laser excitations.
Spectra collected from a clean stainless steel
surface, 60 s exposure time, 300 l/mm grating.
There are several microscope ob-
jectives available, but a 50x 0.5
NA (N plan, Leica) long working
distance objective was selected for
Raman mapping and single spectra
applications and a 5x 0.12 NA (N
plan, Leica) objective for selecting
the region of interest and perform-
ing reflected white light montaging
using the camera mounted on the
top of the microscope. It be-
came apparent that there was a
background contribution from the
objectives, figure 4.2. The spectra
shown is from the 50x long working
distance objective for the 785 nm and 830 nm laser lines. These are, however,
somewhat amplified using longer acquisition times and stainless steel to reflect
more of the signal, to more clearly show the background. In practice these
contributions are less pronounced. However, they still have an influence on the
baseline of the resulting spectra, especially for tissues that exhibit a much weaker
signal. The sharper peaks in figure 4.2 at 1550 cm−1 and 2330 cm−1 are attributed
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to the O2 and N2 respectively from air.
Diffraction gratings
There are 3 gratings available 300, 600 and 1200 l/mm, each is selected depend-
ing on the application required. For each there is a trade off between the spectral
range and spectral resolution achievable. For Raman mapping with 785 nm,
the 300 l/mm grating is essential, despite its lower spectral resolution (7 cm−1).
It’s the only grating that offers a large enough spectral range (>3500 cm−1), to
enable measurement of the fingerprint and hwn regions in a single scan. This
removes the need to move the grating and perform an extended measurement,
which would otherwise increase mapping times and is not compatible with the
streamline mapping method, described in more detail in section 4.2.2. Figure 4.3
visually compares the spectral resolution of the three gratings using the 785 nm
laser line of a sample of phenylalanine. As expected, many more subtle sharper
peaks can be seen using the 1200 l/mm grating that appear more as broader
shoulder peaks using the 300 l/mm grating. For example the 3045 cm−1 peak in
(a) appears as a shoulder peak to the 3066 cm−1 peak. However, in (c) it can be
more clearly seen that there are two separate peaks. However, it is also apparent
that, in addition to extended scans, longer acquisition times are also required for
the 1200 l/mm grating, further increasing mapping times.
Substrate selection
The Raman spectra of prospective sample substrates were measured, in order
to determine the most appropriate for future experiments. Figure 4.4 compare
glass microscope, Raman grade calcium fluoride (CaF2) (Crystran, UK) and pol-
ished stainless steel slides. It is immediately apparent that glass is not a suitable
substrate for Raman measurements, especially in the fingerprint region, as there
is a large broad band peak across the region of interest. Stainless steel has
no visible Raman peaks. However, this is an opaque slide. CaF2 therefore fits
all measurement criteria in that, it’s transparent in the visible and IR range, has
a low background and a single Raman peak at 324 cm−1, which is outside the
region of interest, which for the fingerprint region begins at 450 cm−1. CaF2 was
also favourable as it was already part of an established histology protocol in the
pathology lab at Gloucester hospitals as part of previous calibrations.
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Figure 4.3: A comparison of the spectral resolution for the (a) 300, (b) 600 and (c) 1200
l/mm gratings on the Renishaw Invia for the fingerprint and high wavenumber regions,
spectra acquired using the 785 nm laser line with a 10s exposure time for 300 and 600
gratings and a 30s exposure time for the 1200 grating.
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CaF2
glass
stainless 
steel
Figure 4.4: Raman spectra for three different substrates, calcium fluoride, glass and
stainless steel, using the 785 nm laser line and 300 l/mm grating with an exposure time of
1 s. The insert in the top right hand corner shows the calcium fluoride peak at 324 cm−1
in more detail.
20 μm 20 μm
(a) Normal (b) Streamline
Figure 4.5: Laser lines on a reflective silicon surface for the normal and streamlinemodes,
for the 785 nm laser.
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4.2.2 Streamline mapping protocol
The Raman microscope system is capable of performing point, line or ‘streamline’
mapping. Mapping allows both spectral and spatial information to be obtained.
Each spectrum represents a pixel in an image. By selecting a peak of interest and
plotting the intensity of that peak, it provides visual identification of molecular distri-
butions across the sample. For point or line mapping, the motorised stage moves
the sample in the xy direction or depth profiling in the z direction, in discrete steps
and records a spectrum at each point. With this approach, there is a time delay
for stage movement and CCD read-out. Streamline mapping on the other hand
utilises synchronised stage movement and CCD readout for reduced mapping
times. An additional lens is inserted into the beam path that increases the length
of the laser line to illuminate more of the sample. The laser lines for the normal
and ‘streamline’ modes are shown in figure 4.5. The addition of the lens doubles
the length of the line. The CCD exposure time is for the line as a whole. As the
line moves down the sample, the spectrum is made up of accumulations over the
whole laser line and data are collected from multiple CCD pixels simultaneously.
The laser is raster scanned across the sample. This method of mapping means
that large areas of tissue can be easily scanned. Although streamline mapping
offers improvements, as is always the case with Raman, the main limitation is the
long acquisition times required for maps of sufficient size, resolution and spectral
quality. In addition, long maps over large areas are affected by the flatness of the
sample, which in turn change the focus and the resulting signal to noise of the
sample.
4.2.3 System calibration and spectral processing
Silicon calibration
For peak positioning to be reliable, an x-axis calibration is carried out before every
measurement, using an in-built silicon wafer. Silicon has a strong Raman peak
at 520 cm−1. The position of the peak is found by using the ‘peak fitting’ option in
the Wire software and an offset is applied if necessary.
X-axis calibration
Using a silicon wafer as a calibration target is an easy and rapid method for x-axis
calibration. However, as it only has one strong peak in the lower wavenumbers, it
is not always sufficient for a comprehensive calibration across the whole spectral
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Figure 4.6: Emission spectra from the in-built neon light source of the Renishaw InVia,
with a 0.01 s exposure time using the 300 l/mm grating for the (a) 785 nm streamline
configuration and (b) 830 nm streamline configuration.
range. For more accurate correction, an additional standard is needed, that is
reproducible and provides sharp peaks of a known position over a wide range
of wavenumbers. The Raman microscope has an in-built neon lamp that can be
used for calibration. The neon lamp emission spectra produced for the 785 nm and
830 nm configurations are shown in figure 4.6. Peaks occur at fixed wavelengths.
The laser is shuttered for these measurements. Measurements of the neon lamp
must be done using the same instrument set up as the sample being measured.
Corrections are performed post-measurement. Known peak positions from the
neon are selected and a polynomial function is fitted to the data to re-calibrate the
x-axis.
Technical difficulties with the auto-alignment function in the Wire software resulted
in an artificial stretching of the x-axis in some Raman tissue measurements. To
be able to compare between samples measured on different days, the neon emis-
sion spectrum was not sufficient. Therefore, an alternative x-axis calibration was
performed on those samples. The shift was not linear so a simple offset was
unable to be applied. Each map has the same x-axis, so correction was able
to be applied to the map as a whole. The positions of peaks corresponding to
CaF2, Phenylalanine, N2 and the CH stretch were identified in the mean spectrum
of the maps affected. Inputting the known position of those peaks as 324 cm−1,
1001 cm−1, 2330 cm−1 and 2930 cm−1 respectively, a cubic spline interpolation
was performed using the in-built ‘spline’ function in Matlab to produce a new x-
axis. These peaks were chosen as they cover the whole range of wavenumbers
measured and also are not expected to have any peak shifts due to disease
progression.
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Figure 4.7: The instrument response correction using standardised green glass. (a)
Measured gg spectrum acquired on a daily basis. (b) The absolute gg spectrum (model).
(c) The correction function.
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Figure 4.8: Raman spectrum of phenylalanine before and after the system response
correction.
Instrument response function
The detector and optics that make up the spectrometer have efficiencies that
change as a function of wavelength. This variation is termed the instrument re-
sponse. Thus all recorded spectra are a combination of the sample spectra and
an instrument response. The main contribution is due to the changing quantum
efficiency of the CCD across the spectral range. To correct for this, a daily mea-
surement of a standardised piece of green glass (gg) is performed, that emits
a broadband luminescence spectrum, shown in figure 4.7(a). The gg spectrum
needs to be recorded with identical parameters to that of the sample. The mea-
sured gg is divided by an absolute gg spectrum, shown in figure 4.7(b), to produce
a correction function, figure 4.7(c). The correction function is then multiplied by
the sample spectra. From figure 4.8, that compares a spectrum of phenylalanine
before and after correction, it is apparent that the effect is to raise the peaks
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towards the high Raman wavenumbers. This correction is therefore especially
important for measurements in the hwn region and essential if any quantitative
analysis is to be performed.
Cosmic ray correction
CCDs are particular susceptible to cosmic rays (CR), which result in intense non-
characteristic spikes in the spectrum. As these spikes account for a large amount
of variance, it is essential that they are removed before performing anymultivariate
analysis. In pixels affected by CR, the spectral information has been lost. A quick
and simple method to remove and replace CR is based on applying a median
filter to the data. With a 3x3 mask, this replaces the central pixel with the median
of the surrounding eight neighbours. This effectively removes CR as they are
usually much more intense than Raman bands. However, it also reduces the
spatial resolution. An alternative approach is to selectively replace pixels affected
by CR, to preserve as much of the spatial information as possible. The positions
of CR are identified using an ‘outlier’ method. Using a 3x3 mask the average of
the eight surrounding pixels is calculated and if the value of the central pixel is
above a user defined threshold, it is identified as a CR and its position is marked
by a ‘flag’ value in the original data matrix. Once a CR has been identified, it is
replaced with the median value of the surrounding neighbours.
Baseline subtraction
A baseline subtraction is applied to spectra, to remove the slowly varying back-
ground. This is as a result of fluorescence from endogenous fluorophores in
tissues, that can absorb laser photons and emit broadband radiation (more appli-
cable to shorter visible wavelengths) or stray light from scattering effects that enter
the spectrometer. There are numerous baseline subtraction techniques available,
and literature has been published to compare a selection of these for Raman and
multivariate applications [158, 159]. The most simple and widely used approach
is a polynomial fit, based on iterative least squares fitting [160]. Also common
is a first or second order differentiation, using a Savitzky-Golay method [161].
Further methods include, kernel smoothing, alternative least squares smooth-
ing, rolling ball algorithms, wavelets and Fourier transforms [162]. Baseline sub-
traction for data presented in this thesis was performed using asymmetric least
squares smoothing [163]. Two parameters are able to be changed by the user,
λ the smoothing parameter and p the asymmetry parameter. The optimum pa-
rameters are determined by visual inspection and selected for each data set.
Ten iterations were sufficient for convergence. Figure 4.9 shows Raman spectra
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(c) λ=10,000, p=0.0001
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Figure 4.9: Baseline correction using asymmetric least squares fitting, for different
parameters of λ and p. Top row: raw spectra with fitted baseline (dashed line), bottom
row: spectra with baseline subtracted.
before and after baseline subtraction for different λ and p values. This method like
most other baseline corrections is subjective as it is based on visual interpretation.
For spectra further analysed using PCA no baseline subtraction was applied.
Savitzky-Golay filtering
Savitzky-Golay filtering is a common method to reduce noise in Raman spectra.
A small window is defined, in which a polynomial fit of a specific order is applied.
This has the effect of smoothing any higher frequency noise, but if a window too
large is selected it can reduce the spectral resolution, removing smaller, weaker
peaks that may have diagnostic significance. If the window is too small however
the smoothing will have little effect on the data. Again its application requires a
compromise.
4.3 Coherent Raman set-up
The system used for coherent Raman measurements is described here. The
laser is a YB-fibre laser (Emerald engine, APE GmbH, Berlin, Germany) with 2
ps pulses and a repetition rate of 80 MHz, and a bandwidth of 10 cm−1. The laser
is split into two beam paths. The first is frequency doubled to pump an OPO
(Levante Emerald, APE GmbH, Berlin, Germany) at 515.5 nm and the second
uses the laser fundamental at 1031 nm, which acts as the Stokes beam. The OPO
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Figure 4.10: Experimental set up for Coherent Raman measurements. [AOM: acousto
optical modulator, OPO: optical parametric oscillator, DC: dichroic mirror, O: objective
lens, C: condenser lens, PD: photodiode, F: filter, PMT: photomultiplier tube, LIA: lock in
amplifier.]
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(a)
(b) (c)
Figure 4.11: Photographs of the coherent Raman experimental set-up. (a) Mirrors,
dichroic mirror and telescopes that guide the beams to the scan unit. (b) Lock-in amplifier
and inverted microscope. (c) Laser, OPO and modulator controllers.
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is tunable between 690 and 990 nm. Coarse tuning is performed by changing the
temperature of a non-linear crystal and fine tuning by changing the angle of a Lyot
filter. The output from the OPO acts as the pump beam. The beam paths for
both laser wavelengths can be seen in figure 4.10. Photographs of the coherent
Raman-set are also included, in figure 4.11. Coherent Raman requires that the
two laser beams be spatially and temporally overlapped at the sample, to achieve
this there is a delay path on the Stokes beam, to create the same path difference
that is generated within the OPO.
The sample is located inside a modified inverted microscope (IX71, Olympus). To
tightly focus the light onto the sample, there is a choice of two objective lenses,
a 20x air objective 0.75 NA (UPLSAPO, Olympus), with a working distance of
0.6 mm and a 60x water immersion lens 1.2 NA (UPLSAPO, Olympus), with a
working distance of 0.28 mm. Both objectives have coverslip correction. For
epi-coherent anti-Stokes Raman scattering (CARS), the signal is collected in the
backwards direction, the light passes from the sample back through the objective
lens. To transmit the pump and Stokes beams and to reflect the CARS, signal
there is a dichroic filter (750dcxr, Chroma technologies) before the objective. The
CARS signal is detected by a photomultiplier tube (PMT)(R3896, Hamamatsu
Photonic UK). Due to the short working distance of the 60x water immersion
lens, glass coverslips were used as sample substrates for all coherent Raman
measurements.
For stimulated Raman scattering (SRS), measurements the Stokes beam is mod-
ulated by an acoustic optical modulator (AOM) at a frequency of 1.7 MHz. The
signal is collected in the forwards direction by a condenser lens which is used
to focus the light onto a home built silicon photodiode. A glass coverslip at a 45°
angle after the condenser reflects some of the transmitted light to a reference pho-
todiode (DET100A/M, ThorLabs). Three condenser lenses are available, a long
working distance air lens 0.55 NA (IX2-LWUCD, Olympus), 60x water immersion
lens 1 NA (LUMPLFLN, Olympus), with a working distance of 2 mm and a 100x
oil immersion lens 1.4 NA (UPLSAPO, Olympus), with a working distance of 0.13
mm. It is desirable to have a condenser lens of a higher NA than the objective, for
more efficient signal collection, so the 100x oil immersion lens is primarily used
with the 60x water immersion objective. The modulated signal is extracted using a
lock in amplifier (SR844, Standford Research Systems). The stimulated Raman
loss (SRL) on the pump beam is detected, due to the better sensitivity of the
silicon diode to this wavelength region. A bandpass filter (ET890/220m, Chroma
technologies) is located after the condenser lens to block the Stokes beam with a
range of 890±220 nm.
To acquire images, the scan unit uses galvanometer mirrors to raster scan the
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laser across the sample. The scan unit and the mechanical stage is controlled
using Flouview software (Olympus). The scan speed (pixel dwell time), zoom,
PMT voltage and photodiode gain can all be adjusted in the Flouview software.
4.3.1 System calibration
Power loss through the system
Ultrafast high peak power lasers are used to produce efficient signal generation
in coherent Raman measurements, but under the expectation that they produce
biologically tolerable time averaged powers. It is clear, that by increasing the
laser power, the CARS and SRS signals will increase. However, photodamage to
the sample acts as an upper limit. A balance needs to be achieved between the
amount of signal that is required and minimising photodamage. Photodamage is
discussed more in the following section. As is the case for spontaneous Raman,
using NIR wavelengths is preferable for tissue measurements.
The power output from the OPO is variable, depending on the wavelength, crystal
temperature and Lyot filter position, so a power measurement is taken before
every scan, to ensure that laser damage is minimised. For this set-up, the most
convenient place to measure the laser power is on the optical bench before the
scan unit. To quantify the power at the sample, an estimation of power loss
through the scan unit and objective is needed. Time averaged power measure-
ments comparing the power before and after the scan unit are shown in figure
4.12. There is a wavelength dependence, but the relationship before and after
the scan unit is linear. The OPO was tuned to 781.9 nm (3100 cm−1), as it is the
lowest wavelength used for measurements in the hwn region. The transmission
percentage through the 60x water immersion objective is shown in figure 4.13.
Again, this is wavelength dependent, but provides an estimation of the power at
the sample.
Laser damage
The mechanisms of photodamage in CARS microscopy, have been published in
the literature [165]. However, as of yet there is no evidence of the photodamage
and power thresholds for the particular laser used in this system, with 2 ps pulses
and a 80 MHz repetition rate. Therefore, preliminary experiments were performed
to assess the laser power from the coherent Raman set-up that could be used
on tissues without causing any photodamage. As beams are tightly focused,
photodamage can readily occur if high laser powers are used on delicate biological
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Figure 4.12: Time averaged power measurements, measured before the scan unit on the
optical bench and after through an empty slot in the objective turret of the microscope.
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Figure 4.13: Transmission through the 60x water immersion lens. Data from the
manufacturer’s website [164]
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Figure 4.14: Transmitted light images to investigate laser damage on a tissue sample
using different pump powers. (a) First scan, (b) last scan, (c) difference between first and
last scan, (d) composite image. Laser damage visible for pump powers greater than 110
mW, any difference below this power are due to changes in focus.
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samples. Laser induced damage can be categorised according to the damage
mechanism, as being either photochemical, photothermal or photomechanical
[166]. Each mechanism is dependent on laser properties, such as wavelength,
power density and pulse duration, and tissue properties, such as, the scattering
and absorption coefficients [167]. Photochemical damage occurs as a result of a
laser photon being absorbed and resulting in a chemical reaction in the sample,
usually ultravoilet (UV) or short visible wavelengths are responsible for this type of
photodamage. This mechanism is responsible for photobleaching in fluorescent
molecules. Photothermal damage arises from heat deposited from the laser and
results in a temperature rise in the tissue, which can denature proteins and DNA,
this is the most probably cause of damage for infra-red laser wavelengths and
strongly depends on the power density of the beam. Photomechanical damage
arises from induced stress from the laser, which result in mechanical forces that
can disrupt cells and tissues. For the tissues used in this thesis photothermal
damage is most likely, as tightly focused infra-red beams are used.
Figure 4.14 shows transmitted light images of oesophageal tissue in the coherent
Raman microscope for a range of different pump laser powers. The sample area
was scanned with the laser 40 times to replicate the amount of laser exposure in a
typical hyperspectral stack. Slices at the beginning of the stack, in the middle and
at the end are shown and the sample is assessed for damage visually. The regions
of sample damage are circled in the difference images. A composite is included to
highlight any changes in tissue morphology. The pump beam was set to a wave-
length of 781.9nm, which was the shortest wavelength used for a hyperspectral
stack in this thesis. Laser damage was observed by holes in the sample that in-
creased in size with the number of slices. Below 110mW there appeared to be no
photodamage. But the exact damage threshold was difficult to determine and also
depends on the sample being measured. These measurements were performed
using the pump beam only. For actual SRS measurements, the threshold power
needed to be halved as there are two laser beams on the sample. These values
were set at the combined maximum for both beams and in practice much less
sample damage occurred with the Stokes beam at a higher power than the pump
beam due to the lower wavelength of the Stokes beam. Power measurements
on polystyrene beads for instance required much lower laser powers, with the
damage threshold for the pump beam being above 45mW. The ability to measure
the sample without causing damage sets a practical limit to the amount of power
that can be used, hence the amount of signal able to be achieved, as the aim is
to be non-invasive.
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4.3.2 Performing a hyperspectral stack
One of the main advantages of using SRS over CARS is the ability to extract spec-
tral information that matches that of spontaneous Raman without a nonresonant
background contribution. In conceptually the reverse process to Raman mapping,
a hyperspectral stack is performed by imaging the same field of view at different
vibrational frequencies, by changing the pumpwavelength of the OPO and plotting
the intensity of image pixels against wavenumber. To overcome any small sample
drift and to achieve a better signal to noise ratio, spectra are averaged over several
pixels. Figure 4.15 shows a typical hyperspectral stack ranging from 2895 cm−1
to 3096 cm−1 and the resulting spectra for a sample of Phenylalanine powder, on
a glass coverslip. The automated tuning of the OPO is controlled by a custom
made LabVIEW script, that performs incremental movements of the Lyot filter to
change the pump wavelength. Within LabVIEW the user specifies the number of
image frames and the step size of the wavelength change. The LabVIEW code
also monitors the power values displayed on the OPO and pauses the scan if it
drops below a user specified value. The user is required to manually change the
OPO crystal temperature if performing a wide range stack. The power output
of the OPO fluctuates, during a hyperspectral stack. To correct for this post-
measurement, a second photodiode is placed in the beam path after the sample,
to act as a power reference, to record the ‘transmitted’ light, which can then be
used for normalisation. The spectral resolution is dependent on the bandwidth of
the laser. To be able to distinguish Raman bands, the laser bandwidth is required
tomatch that or be smaller than the averageRaman linewidth. The fibre laser used
for this work had a spectral resolution of 10 cm−1, which is approximately the same
width as the average Raman band. So is well suited for spectral measurements.
This is especially important in the congested fingerprint region, but becomes less
important in the hwn region, where for tissues it is expected that the peaks will
be much more broadband. The OPO has a large wavelength range, and is able
to cover the whole hwn region and wavenumbers greater than 1000 cm−1 in the
fingerprint region.
4.3.3 Laser power normalisation
During measurement of a hyperspectral stack, the output power of the OPO fluc-
tuates, as it is tuned to a series of different wavelengths. The SRS signal is not
only dependent on the difference in wavelength between the pump and Stokes
beams, but also has a linear dependence on pump power. This produces a signal
as a function of both laser power and OPO wavelength. To extract the Raman
spectrum, the intensity as a function of wavelength only, is required. Therefore,
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Figure 4.15: A SRS hyperspectral stack (a) SRS images of phenylalanine powder taken
at different wavenumbers as part of a hyperspectral stack, (b) the resulting normalised
SRS spectra achieved by taking the average intensity from each frame.
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a laser power normalisation must be applied to remove the effects of changing
laser power. Normalisation is applied post measurement using ImageJ. Each SRS
image has a corresponding transmitted light image recorded simultaneously by a
reference diode positioned after the sample. The normalisation process is applied
frame by frame and can be summarised by the following equation:
SRSnorm =
SRS
(diode/maxdiode)
(4.1)
The maximum value for all diode frames is determined, each frame is then divided
by the maximum value, to rescale to values between 0 and 1. The SRS image is
then divided by the rescaled diode frames.
4.3.4 Large area montage
The field of view imaged, is determined by the field number and magnification of
the objective lens, in combination with the zoom factor in the Fluoview software.
For the 60x water immersion lens and a zoom factor of 1.5, the field of view was
158µm by 158µm, this configuration was used for the majority of the coherent
hyperspectral imaging. For the 20x air objective, with a zoom factor of 1.5, the
field of view was 470µm by 470µm, this configuration was used for large area
montaging. To be able to image a whole tissue section of several millimetres, a
large area montage is performed. To select the region of interest, it is important to
be able to visualise the tissue section as a whole, to be able to orientate it against
the haematoxylin and eosin (H&E) pathology images. Montaging is automated
using ‘Papp’ software in Fluoview. The user specifies the top and bottom corners
of the montage and Papp calculates the number of frames and the x,y step size
of the motorised stage according to the objective being used. Images are stitched
together using the ‘stitching’ plugin in imageJ.
4.4 Multivariate techniques
Multivariate techniques such as principal components analysis (PCA), linear dis-
criminate analysis (LDA) and k-means cluster analysis have been used exten-
sively throughout this thesis, as a method to reduce the size of data, but still
retaining the useful information. A brief description of each of these approaches
is provided here.
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4.4.1 Principal components analysis
Raman spectroscopy is able to probe the various elements that make up the
tissues of the body, such as lipids and proteins. However, the resulting spectra are
complex and multivariate. Consequently, the raw data produced using Raman are
difficult to interpret. To reduce the dimensionality of the data, PCA can be used.
PCA is a method of transforming the original variables, in this case the Raman
shifts, into new uncorrelated variables, termed the principal components (PCs),
which are a linear combination of the original variables [168]. It describes the
variance in the data, the first PC accounting for the largest amount of variance and
the second the largest variance of the remaining data, but must be uncorrelated
to the first and so on [169].
PCA was applied to data using an in-built Matlab function (‘PCA’). The number of
principal components was decided individually for each data set to be sufficient to
account for the largest amount of variance without too much loss of information.
The result of PCA is a set of ‘scores’ and ‘loadings’ for each PC summarised in
figure 4.16. These can be used to identify components of tissues. The scores,
once generated, are refolded to create a 3D matrix, similar to that of the original
hyperspectral stack. However, instead of wavenumber, the third dimension is
now the PC number. This can be used to create an image to visually identify
regions within the tissue. Score values can be represented by pseudocolour look
up tables. Loadings can also be plotted, as a function of Raman shift. Similar
to Raman spectra, the peaks can be used to identify elements within tissue, as
these peaks directly correspond to the Raman peaks, but unlike an actual Raman
spectrum include both positive and negative loadings. The PCs are not identified
as single elements, that represent spectra of pure elements, but rather a mixture,
that accounts for the largest amount of variance. The scores show the distribution
of all of the elements identified in the loadings.
4.4.2 Linear discriminant analysis
To test the ability for Raman to distinguish between the four different pathological
groups, a PCA fed linear discriminant analysis (LDA) model was used. To further
test this model, a leave one sample out cross validation was performed, whereby
all spectra from one sample are removed to form the test set and all other remain-
ing data are used to train the model. The performance of the model is quoted in
terms of the sensitivity and specificity, which are calculated as follows:
sensitivity =
TP
TP + FN
(4.2)
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Figure 4.16: Principal component analysis process, adapted from [65].
specificity =
TN
TN + FP
(4.3)
where for a two group model consisting of a normal and diseased (cancer) set:
• True positive (TP): Number of cancer samples predicted as cancer
• True negative (TN): Number of normal samples predicted as normal
• False positive (FP): Number of normal samples predicted as cancer
• False negative (FN): Number of cancer samples predicted as normal
Results can be presented as a confusion matrix as shown in table 4.1. True
negatives/positives and false negatives/positives are easily identified in a two
group model. This becomes more complex for models with three groups or more.
1 2
1 TN FP
2 FN TP
Table 4.1: Example confusion matrix for a two group linear discriminant model, indicating
positions of true negative/positive and false negative/positive results.
4.4.3 K-means cluster analysis
Prior to more complex tissue measurements, the ability of hyperspectral SRS to
identify different chemical signatures using k-means cluster analysis was investi-
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Figure 4.17: Spontaneous Raman spectra of polystyrene and PMMA beads. Raman
spectra including the fingerprint and hwn regions, zoomed in section of the hwn region.
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Figure 4.18: K-means cluster analysis of a polystyrene and PMMA mixture. (a) SRS
spectra of polystyrene and PMMA from the beads identified by the box. (b) Raman and
SRS composite image at 2944 cm−1 (fuchsia) and 3054 cm−1 (cyan) (scale bar, 20 µm).
(c) k-means clustering with three clusters, pseudocolor cluster images and mean spectra
of clusters.
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gated using a polymer microsphere mixture. Polystyrene (Phosphorex, US) and
polymethyl methacrylate (PMMA) (Phosphorex, US) beads, of 5 µm in diameter,
were measured using spontaneous Raman mapping and hyperspectral SRS. The
polystyrene and PMMA beads were stored in a water suspension. Equal vol-
umes, of each bead solution, were pipetted into a dish for mixing. Samples were
dropped dried, on either a CaF2 slide for Raman or a glass coverslip for SRS.
Different samples from the same batch were measured on each instrument. The
spontaneous Raman spectra for polystyrene is shown in figure 4.17(a) and for
PMMA in figure 4.17(b). The focus was on the spectral information available
in the hwn region, as this was the range to be measured using hyperspectral
SRS. The beads have clear spectral differences; PMMA having a prominent peak
at 2944 cm−1 and for polystyrene there is a distinct peak at 3054 cm−1. These
two peaks were used to identify the beads. Figure 4.18(b) shows an overlay
of Raman and SRS images at 2944 cm−1 (fuchsia) and 3054 cm−1 (cyan). The
different beads can be clearly identified in the pseudocolour images. SRS spectra
for the beads identified in the SRS images are shown in figure 4.18(a). They
match well with those of the spontaneous Raman. Differences in the relative peak
heights of polystyrene, for the Raman and SRS spectra are due to no instrument
response correction being available at the time of writting this thesis to be applied
to the Raman data, for the 600 l/mm grating in the hwn region, using the method
previously described in section 4.2.3. The results from k-means cluster analysis
of this data are shown in figure 4.18(c) using three clusters. The black cluster
has been assigned to the substrate background corresponding to CaF2 in the
Raman and glass in SRS. The cyan cluster has been assigned to polystyrene
and the fuchsia cluster to PMMA, for both spontaneous Raman and SRS. In
the Raman k-means pseudocolour image, k-means clustering has identified the
correct regions for the beads, however, the resolution of the actual beads has
been lost as pixels between the beads have been classified as bead rather than
background. With the improved spatial resolution offered by SRS, this is not the
case, and individual beads can be clearly distinguished. An integrated discussion
of k-means clustering on colon tissues can be found in section 6.5.
4.5 Tissue collection and preparation
All human tissues used in this study were removed during routine GI surgical
procedures conducted at Gloucestershire Royal hospital. All tissue collections
were ethically approved, by the Gloucestershire local research ethics commit-
tee for the oesophagus and Frenchay research ethics committee for colon. See
appendix for ethical approval B.1 and B.2. Tissue biopsies were snap frozen in
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Figure 4.19: Contiguous sections cut from frozen tissue blocks and mounted for H&E,
Raman and CARS/SRS, for primary and reserve sets.
liquid nitrogen and stored in a freezer at−82 °C. Tissue was transported to Exeter
either in dry ice or a liquid nitrogen dewar, and were returned straight to the freezer
upon arrival. From each biopsy block, 6 contiguous cross sections were cut using
a cryomicrotome, as shown in figure 4.19. The first section was mounted onto
glass and stained using haematoxylin and eosin (H&E) for pathological analysis.
The next two sections were cut to a thickness of 10 µm, with one mounted onto
CaF2 for Raman measurements and the other mounted onto a glass coverslip
for coherent Raman measurements. Serial sections were required for the two
different instruments, CaF2 to reduce the substrate background in Raman and
glass coverslips for coherent Raman, to cater for the short working distance of
the immersion lenses used in the experimental set-up. This procedure was then
repeated to produce a reserve set. For coherent Ramanmeasurements, a second
coverslip was applied to the sample, to enable use of the water and oil immersion
lenses. A single layer of parafilm was used as a spacer and was cut to create a
window to surround the sample. Coverslips were sealed by heating the parafilm,
using a localised heat source, to concentrate the heat on the parafilm, rather than
causing any heat damage to the tissue. Before measurements, samples were
removed from the freezer and allowed to passively return to room temperature,
for at least 30 minutes.
4.5.1 Oesophagus
Oesophageal samples were from patients that have either undergone an endo-
scopic mucosal resection, in which the top layer of the wall of the oesophagus
is removed, or an oesophageal resection, in which a whole portion of the oe-
sophagus is removed. Each tissue section, prior to measurement, was classified
by a pathologist as belonging to one of four predetermined pathology groups,
either normal, Barrett’s oesophagus (BO), dysplasia or adenocarcinoma. Digital
copies of the H&E stained sections were annotated by the pathologist to indicate
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tissue regions containing cells representative of the pathology group and used to
determine the region of interest (ROI) for Raman measurements. Only regions
of homogeneous tissue pathology were measured. All grades of dysplasia were
grouped together as there were limited sample numbers.
4.5.2 Colon
The colon samples consisted of biopsy sections classified as normal by a pathol-
ogist. Sections mounted on calcium fluoride were measured using Raman. Con-
tiguous sections mounted on glass coverslips were used for coherent Raman
measurements. A primary and reserve set were cut for these measurements.
4.5.3 Measurement protocol
Comparisons between different instruments with contiguous tissue sections re-
quired a reliable method to identify the same ROI between sections. Figure 4.20
shows the H&E sections, white light montages from the InVia system for sponta-
neous Ramanmeasurements and transmitted light images for the CARS/SRS set-
up. Montage images are formed from many field of view (FOV) stiched together.
The tissues all resemble one another, but with subtle differences as the area is
at slightly different depths in the biopsy block. The position of the ROI could be
determined using the stage coordinates for the CARS/SRS set-up. This method
was rapid and could be performed in less than five minutes.
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Figure 4.20: H&E, white light image from the InVia Raman system and the transmitted
light from the photodiode on the CARS/SRS set-up. Showing the morphological
similarities between contiguous sections. These images were used to identify regions
of interest for sample measurements.
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CHAPTER 5
Oesophagus
5.1 Introduction
This chapter explores spontaneous and coherent Raman measurements of oe-
sophageal tissue sections. Section 1.1.1 introduced the structure of the oesoph-
agus wall and provided a discussion of the morphological changes at a cellular
level, which are used as markers of cancer progression, by the current histological
approach. Oesophageal adenocarcinoma, the most prolific type of oesophageal
cancer, is of particular interest, as they have a high mortality rate and progress
through a pre-malignant step known as Barrett’s oesophagus (BO). As a result
patients with this condition are entered into extensive surveillance programs at
great cost to the NHS [170, 171]. It is apparent that the current histopathology
‘gold standard’ of diagnosis is highly invasive, time consuming and subjective.
The aim of this chapter was to explore the potential of spontaneous and coherent
Raman techniques to provide a rapid and non-invasive method of diagnosis for
oesophageal cancers. Results discussed include a comparison of the diagnostic
potential of 785 nm and 830nm excitations, two near infrared laser wavelengths
commonly used for spontaneous Raman tissue measurements. Further compar-
isons were made between spontaneous and coherent Raman, with regards to the
diagnostic information available for both techniques. The performance of spon-
taneous Raman is also compared between the fingerprint and high wavenumber
(hwn) regions. All classification models are determined using a principal compo-
nents analysis (PCA) fed linear discriminant analysis (LDA) approach. The focus
was on the imaging capabilities of both techniques and the spectral information
that they are able to provide, to weigh up their relative benefits and limitations.
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Figure 5.1: Mean Raman spectrum of normal oesophageal tissue, in the fingerprint
region, with the major peak assignments labelled. The spectrum was measured using
the 785 nm laser with the 300 l/mm grating.
Peak
position
(cm−1)
Vibrational mode Assignment
722 C-H bending adenine
752 symmetric breathing tryptophan
825 out of plane breathing/O-P-O stretch tyrosine/DNA
850 ring breathing/C-C stretch tyrosine/proline
934 C-C stretch proline/valine/glycogen
1001 symmetric ring breathing phenylalanine
1125 C-C stretching/ C-N stretch lipids/proteins
1265 C-H in-plane bending tyrosine
1336 CH3 CH2 wagging collagen/nucleotide
1447 CH2 bending proteins/lipids
1550 tryptophan
1656 C=O/C=C stretching amide I/lipids
Table 5.1: Tentative peak assignments of the most prominent peaks in the Raman
spectrum for normal tissue in the fingerprint region [69,172].
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Figure 5.2: Mean Raman spectrum of normal oesophageal tissue, in the high
wavenumber (hwn) region, with the major peak assignments labelled. The spectrum was
measured using the 785nm laser with the 300 l/mm grating.
Peak position (cm−1) Vibrational mode Assignment
2850 CH2 symmetric stretch lipids
2884 CH2 asymmetric stretch lipids
2930 CH3 symmetric stretch proteins
2958 CH3 asymmetric stretch proteins
Table 5.2: Tentative peak assignments of the most prominent peaks in the Raman
spectrum for normal tissue in the high wavenumber region [173].
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5.2 Raman of the oesophagus
A typical mean spontaneous Raman spectrum of normal oesophageal tissue in
the fingerprint region, is shown in figure 5.1, and for the hwn region in figure 5.2.
Spectra were from the stratified squamous epithelium that form the mucosa, the
innermost layer of the oesophagus. The resulting spectrum is a complex series
of overlapping peaks. The most prominent peaks have been labelled and are
tentatively assigned in table 5.1 for the fingerprint region and table 5.2 for the hwn
region. Various peaks in the fingerprint region, associated with amino acids such
as phenylalanine and tryptophan can be identified, along with those of proteins,
lipids, DNA and glycogen. Peaks associated with the CH vibrations of proteins
and lipids can be identified in the hwn region.
Figure 5.3 encapsulates some of the spectral signatures and morphological fea-
tures of different structures in the oesophageal epithelium using spontaneous
Raman, in the fingerprint region. The top left of the figure shows the whole tissue
section stained using haematoxylin and eosin (H&E), from which a pathologist
identified four regions that include both normal and diseased structures, which
are useful for diagnosis. These include submucosal gland (SMG), a BO segment,
squamous island (SI) and dysplasia. These regions are highlighted by yellow
boxes. Raman mapping was performed across areas of 140µm x 140µm in
size, using the 785nm laser, with a 60 s exposure time. White light images of
the mapping region are shown, with a corresponding Raman map based on the
1447 cm−1 peak of proteins and lipids. The mean spectrum from each of the
mapping regions is also included for comparison.
Region (c) was identified as BO, an important precursor condition for adenocarci-
noma. Although BO cells are pathologically normal, they can indicate patients at a
higher risk of developing cancer. Visible in the H&E are the distinctive glands in the
mucosa made from columnar epithelial cells, surrounded by the lamina propria.
These are important features for diagnosis and can be identified in the Raman
image too. No normal regions of squamous tissues were identified on this tissue.
Comparing the spectra from this region with that of the normal squamous cells
in figure 5.1, shows an absence of peaks relating to glycogen at 484 cm−1 and
936 cm−1, found in the normal squamous epithelium. The difference in the levels
of glycogen between normal and BO tissue is already used in the clinic during
endoscopy to help surgeons identify BO segments. A Lugol’s iodine stain, stains
the glycogen in the normal squamous cells providing contrast with respect to the
surrounding tissues [14, 36, 174]. So, it is encouraging that the Raman spectra
are also able to identify these molecular differences.
Region (b) was identified as dysplastic, which is an abnormal change in BO cells
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Figure 5.3: Spontaneous Raman measurements of four regions demonstrating different
structures within the oesophagus, measured using a 785nm illumination. Top left: whole
tissue section stained with H&E, yellow boxes (not to scale) indicate the positions of
the area sampled using spontaneous Raman. Region (a) submucosal gland (SMG), (b)
dysplasia, (c) Barrett’s oesophagus (BO) and (d) Squamous island (SI). Shown for each
region, top left: white light image of the sample area, bottom left: Raman image 140µm
x 140µm in size at the 1447 cm−1 peak, and right: mean spectrum from the sample area
over the fingerprint region.
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that can lead to cancer and define the highest risk group. Dark blue in the Raman
image signifies regions with low Raman intensity. These were determined to be
holes in the tissues, identifiable by higher levels of CaF2 and objective contribution.
Region (d) was identified as a squamous island (SI), which is defined as a region
of squamous epithelium within a segment of BO. These are common features
in BO patients, and can be seen at endoscopy as patches of lighter squamous
mucosa, surrounded by the darker pink colour of the columnar epithelial cells
[175]. Squamous islands arise from re-epithelialisation of the BO area, which may
occur at sites of previous biopsies or as a result of anti-reflux intervention. The
presence of squamous islands in BO patients however, is not thought to indicate a
reduction of cancer risk or a regression of BO [176]. It is interesting to note that the
spectra from this region do not match that of the normal squamous cells in figure
5.1 and have more similarities to the BO spectra. So, although the morphology
appears similar to normal tissue, the biochemistry may be different.
Region (a) was identified as a SMG, a normal gland found in the oesophagus
that secretes mucins, to add lubrication to the lining of the oesophagus and aid
the transport of food. SMG are located deeper into the oesophagus wall in the
submucosa, surrounded by connective tissue. These are different to BO glands
that are found in the very top layer of the wall of the oesophagus in the mucosa.
Stem cells are thought to be responsible for the development of BO oesophagus
and it is suggested that these originate in the SMG [24,27,36].
There were observable spectral differences between the different structures in the
oesophagus. The most apparent was in the region from 1550 cm−1 to 1650 cm−1,
containing peaks associated with tryptophan (1554 cm−1), guanine (1579 cm−1)
and cytosine (1613 cm−1), these peaks are significantly lower in the SMG, in
comparison to all other tissue structures. Also lower for the SMG was a peak
associated with DNA at 749 cm−1. The SMG had higher amounts of lipids and
proteins at the 1447 cm−1 peak. Spectrally it can be seen that the SMG appears
the most different, to the other tissue structures. This is intuitive as the dysplatic
and SI have progressed from BO and SMG are normal oesophageal structures
found in the submucoa. The Raman images identify the morphological detail that
concur with that of the H&E section, therefore, Raman is a useful tool for the
identification of different tissue regions.
5.3 Tissue viability over time
Experiments performed as part of this work required measurements on more than
one instrument, as it is not always possible to measure tissues on multiple in-
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struments on the same day, an experiment to assess tissue viability after removal
from the freezer was conducted. Measurements of the same area of pathologically
normal oesophageal tissue were made daily for a two week period. The spectral
quality of the tissue was assessed for a sample stored either at room temperature,
in an air conditioned room or in the fridge. Both samples were mounted on CaF2
and, when not being measured by the instrument, were stored in a plastic Petri
dish with a lid. All samples were removed from the freezer on the same day and al-
lowed to passively return to room temperature for approximately 30minutes before
measuring. A control sample was also measured to identify any potential spectral
changes due to repeated laser exposure. All measurements were performed
using the Raman microspectrometer with the 785 nm laser and 600 l/mm grating,
with an exposure time of 30 s, per line. Resulting spectra were detector sensitivity
corrected, vector normalised and a Savitzky–Golay filter was applied. To visualise
both the fingerprint and hwn regions, two maps were measured consecutively,
due to the insufficient spectral range of the grating. Therefore, each day two
maps were performed first in the fingerprint followed by the hwn region, for both
samples.
5.3.1 Control
To rapidly assess any effects of repeated laser exposure on the sample, a time
series was measured at a single point on the control tissue. In total, 28 spectra
were consecutively acquired. This is equivalent to the intended laser exposure
of two maps performed daily over 14 days. The raw spectra for the control time
series measurements are plotted in figure 5.4(a), from scan 1 in blue to scan
28 in red. The most discernible change between spectra was a reduction in the
background forming the baseline, with the most significant difference between
scans 1 and 2. It would appear that the background is reduced, up to a point,
with increased laser exposure, and stabilises after approximately 20 scans. For
vector normalised spectra in figure 5.4(b), the overall difference in the height of
the baseline between scans is reduced and the spectra overlap when a baseline
subtraction is performed, figure 5.4(c). From this spectra it is apparent that there
were no changes in peak positions or intensities. This is highlighted by plotting
the difference between the first and last scans in figure 5.4(d), any differences are
as result of noise in the spectra.
To ensure that this response was not isolated to one spot of tissue equivalent to
the laser line in size, a mapping study was performed, which incorporates a larger
area of tissue. Because of time constraints, the mapping areas were relatively
small, 800 points in total. Again 28 scans were performed in total consecutively,
14 in the fingerprint and 14 in the hwn region and alternated between the two
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Figure 5.4: Raman time series of oesophageal tissue at a single position on the sample,
using the 785nm illumination and 600 l/mm grating, with a 30 s exposure time. (a)
Raw data, (b) vector normalised data, (c) baseline subtracted and (d) difference spectra
between the first and last scans.
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Figure 5.5: White light image of the whole tissue sample stored at room temperature with
a close up section of the measured region on day 1 and day 14.
regions. Plots of the mean spectra for the control sample mapping are shown in
figure 5.7(a) and 5.7(b), for the fingerprint and hwn regions, respectively. Similar
to the time series, the baseline of the Raman spectra reduced with increasing
laser exposure for both the fingerprint and hwn regions.
5.3.2 Room temperature
To identify the same mapping region in the specimen, a white light montage is
performed; the resulting image for the tissue sample stored at room temperature
is shown in figure 5.5. On the left is an image of the whole tissue, measured using
the 5x objective. The insert to the right, shows a zoomed in image of the region
of interest measured using the 50x objective, and the mapping area is indicated
by a white box. The top image is from day 1 and the bottom image is from day
14. Visually there appeared to be no change in the morphology of the tissue.
However, the focus was on any spectral differences. The mean spectra for each
of the 14 days is shown in figure 5.7(c) for the fingerprint region and 5.7(d) for
the hwn region. For both regions there appears to be no significant change in
peak intensities. The spectra follow the same trend as the control sample, and
the reducing background also accounts for the largest change.
5.3.3 Fridge
The white light image for the tissue sample stored in the fridge is shown in figure
5.6. Again, the mapping area is indicated by the black box. In this sample, there
appears to be a visual difference between the sample on day 1 compared to that
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Figure 5.6: White light image of the whole tissue sample stored in the fridge with a close
up section of the measured region on day 1 and day 14.
of day 14, the latter showing a substantial number of cracks, which suggested
that the tissue has become more dehydrated. Measurements of the OH region
(3400 cm−1 to 3600 cm−1) in the hwn, would have provided more information on
the water content of tissues. However, at the time of measurement this was not a
focus, so wavenumbers above 3200 cm−1 were not recorded. The mean spectra
for each of the 14 days is shown in figure 5.7(e), for the fingerprint region and
5.7(f) for the hwn region. There is more variation in this sample compared to the
others, especially in the region from 450 cm−1 to 850 cm−1. This could be due to
slight cell to cell variations in mapping areas as the sample appeared to dry out,
and so because of this the mapping regions may have slightly moved.
5.3.4 Discussion
The most significant changes in the oesophageal spectra with repeated laser
exposure were in the broadband background and this was observed for all three
conditions measured here. When removed post measurement using a baseline
subtraction, spectra overlapped. The background is problematic as it can hide and
distort smaller Raman peaks, but from experiments performed here it is apparent
that it can be reduced with increased laser exposure. The origins of this back-
ground is routinely suggested to be as a result of fluorophores within the tissue,
that can absorb laser photons and emit at a longer wavelength, termed autofluo-
rescence. Fluorescence emission is broadband and can be orders of magnitudes
stronger than Raman [177]. The reduction in background with repeated laser
exposure is therefore suggested to be as a result of photobleaching of inherent
fluorophores. Table 2.1, from section 2.2 of the literature review, summarised
some of the common fluorophores endogenous to the oesophagus, and their peak
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Figure 5.7: Raman mapping of oesophageal tissue using the 785nm illumination and 600
l/mm grating, with a 30 s exposure time. Mean spectra in the fingerprint region for the (a)
control, (c) room temperature and (e) fridge samples and in the hwn region for (b) control,
(d) room temperature and (f) fridge samples.
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excitation wavelengths. They include amino acids, NADH, porphyrins, elastin and
collagen. Collagen is the most dominant fluorophore in the oesophagus, which is
found mainly in the submucosa [85,177]. These fluorophores however, have their
peak excitations in the ultraviolet (UV) or shorter visible wavelength range. Exci-
tation with a 785 nm laser would therefore, not provide sufficient energy to excite
the molecules. It has been argued that this evolving background can instead be
explained by morphological rather than chemical changes in tissues upon laser
illumination [178]. Stray light associated with the laser source and Raman bands
themselves, can enter the spectrometer uncollimated and be detected by the
charged-coupled device (CCD) as a broad background. Bonnier et al [179], at-
tributed the evolving background to a ‘photothermal annealing effect’, suggesting
that exposure to the laser induced morphological changes in the tissues, that
although not observable microscopically, resulted in a difference in scattering
properties of the tissues. Measurements for all three conditions were performed
with the 785 nm laser only, as an extension it would have been interesting to as-
sess the background changes in samples, with respect to excitation wavelength,
using the 830 nm laser.
5.3.5 Summary
Measurements of tissues stored for 14 days either at room temperature or in the
fridge were compared to a control sample. There appears to be no detrimental
effect on the quality of the Raman spectra over this period. Themost significant ef-
fect was due to the amount of laser exposure on the sample, which predominantly
reduced the background. All subsequent tissues were measured within 3 days of
being removed from the freezer. Control measurements show no photodamage
effects of laser exposure on the sample for a 785 nm illumination and powers of
100 mW at the sample, with a 60 s exposure time. No spectral differences could
be seen between day 1 and day 14 for both the room temperature samples in
the fingerprint and high wavenumber regions. Any differences between fridge
samples were attributed to differences in the spectral baseline.
5.4 785 nm versus 830 nm
The Raman microscope had two near infrared laser illumination wavelengths at
785 nm and 830nm. Oesophageal tissues were used to compare the diagnostic
performance of the two laser wavelengths. In total, 47 maps were measured
from 21 oesophageal samples. Frozen sections were prepared as described
in section 4.5.1. Each sample was assigned to one of four different pathology
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groups, categorised as either normal, BO, dysplastic or adenocarcinoma. Digital
copies of H&E sections were annotated by a pathologist to identify regions to
measure according to the tissue pathology.
Sections were mounted onto CaF2 for Raman measurements. Before Raman
measurements, a white light montage of the whole tissue area was taken using
the 5x objective. With reference to the H&E stained sample, this allowed for
the orientation of the tissue to be visualised and the region of interest identified.
Streamline Raman mapping was performed using the 785 nm and 830nm laser
lines, with the 300 l/mm grating, on sections of 140µm x 140µm, with a step size
of 1.4µm, 30 s CCD exposure time, with 100% laser power. Identical regions
were measured, first using 830 nm and then 785nm. This was to prevent any
potential sample damage from the 785 nm laser line, but also (based on section
5.3) to reduce the background for the 785 nm measurements.
The Raman data was subject to the following preprocessingmethods, in this order,
cosmic ray removal using a two dimensional median filter, peak shift correction, in-
terpolation to 1 cm−1 spacing, instrument response correction using the procedure
described in section 4.2.3, truncation to 450 cm−1 to 1850 cm−1, Savitzky-Golay
filter (2nd order, 9 point window) and vector normalisation. All data were mean
centred before PCA, no baseline correction was applied.
5.4.1 785 nm
The mean spectra for each of the four pathology groups, normal, BO, dysplasia
and adenocarcinoma, using the 785 nm laser are shown in figure 5.8. For com-
plex samples, Raman spectroscopy can not be used to assign specific molecular
changes, but can instead identify spectral changes of several molecules com-
bined that arise from disease progression. Clear spectral differences can be
seen between normal tissues and the other pathological groups. Two of the most
prominent peaks in normal tissues at 484 cm−1 and 936 cm−1 are associated with
glycogen, the energy source of the cell. In addition to glycogen, higher amounts
of collagen at 1331 cm−1 and Amide I corresponding to the α-helix of proteins are
also seen in normal tissues. Several peaks associated with DNA are present,
these are lower in normal tissues than cancerous tissues, at 669 cm−1, 748 cm−1
and 966 cm−1. DNA contributions can also be observed in the region around
1600 cm−1, which contains peaks associated with guanine, adenine, nucleic acids
and amino acids tyrosine and tryptophan. Higher amounts of Amide III, associated
with unordered proteins, can be seen at 1260 cm−1, in cancerous tissues. BO
involves a transition from normal squamous epithelial cells to columnar epithelial
cells, as these are different cells types this explains the large spectral differences
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Figure 5.8: Mean spectrum for 4 pathology groups, normal, BO, dysplastia and
adenocarcinoma (cancer) in the oesophagus using the 785 nm illumination, with a 30
s exposure.
between them. The progression through to adenocarcinoma is then a continuum
of changes of these BO cells. This might account for the larger difference between
normal tissue and the other pathology groups and the more subtle differences
between BO, dysplasia and cancer. Despite the fact that the data has been
baseline subtracted, the effects of the objective background can still be seen in
the hump in the region from 1000 cm−1 to 2000 cm−1, with reference to figure 4.2.
To further highlight any spectral differences between groups, difference spectra
are plotted in figure 5.9. Part (a), shows the differences between normal and
BO tissues, (b) the difference between normal and cancer and (c) the difference
between dysplasia and cancer. The difference spectra take the form of a series
of peaks and troughs. The positive peaks represent molecules that are more
abundant in one tissue type, whilst negative peaks represent molecules that are
more abundant in the other.
To reduce the dimensionality of the data sets, PCA can be performed that sepa-
rates data into a certain number of principal components according to their vari-
ance. These PCs can then be displayed as a series of scores and loadings, that
may help to identify spectral differences in tissues. To test the ability for Raman to
distinguish between the four different pathological groups, a PCA fed LDA model
was used. The full spectral range of 450 cm−1 to 1850 cm−1 was included for the
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Figure 5.9: Difference spectrum for (a) normal versus BO, (b) normal versus
adenocarcinoma (cancer), (c) dysplasia versus cancer for the 785 nm laser.
fingerprint region to ensure that no spectral information was lost. In order not to
overfit the data and to further test this model, a leave-one-sample-out (LOSO)
cross validation was performed, whereby all spectra from one sample are re-
moved to form the test set and the remaining data are used to train the model.
The first 25 principal components were selected for linear discriminant analysis,
with a total variance of 94.84%. To determine the significance of each principal
component, analysis of variance (ANOVA) was used, with a p value of 0.001
(99.9% significance). All of the first 25 PCs were within this significance value, 25
PCs were chosen by visual inspection of the PC loadings. PCs beyond the 25th
no longer had any spectral like features and were associated with the noise in
the measurements. The four most significant principal components are shown in
figure 5.10, in order of significance determined by ANOVA, and were determined
to be PC1, PC8, PC2 and PC3. PC1 relates to the background contribution from
the objective. With reference to figure 4.2. Similarities in the line shapes can
be observed and the ‘bump’ around 800 cm−1 that does not have the shape of
a typical Raman peak. PC2 contains peaks associated with glycogen, proteins,
lipids and collagen in the positive loadings and peaks associated with tryptophan
and DNAwith negative loadings. PC3 has a distinctive contribution from glycogen,
but also lipids and collagen in the negative direction, and in the positive direction
DNA bases cytosine and guanine and amide I and III contribution. PC8 peaks are
tentatively assigned to DNA and lipids in the positive direction and glycogen and
amide I and III in the negative direction.
The percentage of spectra assigned to each group is represented by a bar chart
in figure 5.11. The bar chart shows the actual group versus the predicted group,
using a PCA-LDA model. For a perfect model, it is expected that all of the spectra
to be along the diagonal from the top left hand corner to the bottom right hand
corner, as that signifies that the actual and predicted groups are the same. The
chart allows visualisation of where misclassified spectra have been allocated in-
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Figure 5.10: The four most significant principal components as determined by ANOVA
for the 785 nm illumination.
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Figure 5.11: 785nm confusion matrix and PCA-LDA scores plots
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stead. The colour corresponds to the predicted data; those predicted as normal
are shown in green, BO is in orange, dysplasic in blue and those predicted as
cancer are shown in magenta. Each bar represents the percentage of spectra
classified into each group. A percentage is used as there are different numbers of
spectra per group, to give a fairer representation of the distribution as a proportion
of the total number of spectra.The confusion matrix that contains the number of
spectra allocated to each group by the PCA-LDA model can be found in appendix
A.1. From these tables, the sensitivity and specificity can be calculated, using
equations 4.2 and 4.3. Plotting the linear discriminant scores against one another
allows visualisation of the separation of the different pathology types.
The Raman data show good sensitivities (>84%) for all groups apart from dys-
plasia, with a sensitivity of 55%. The specificities across all groups are very
good (>89%). From the linear discriminant score plot, the dysplatic group in
blue appears to have some outliers that sit away from the main clustering of the
group. Normal spectra were mainly misclassified as BO, BO mainly misclassified
as dysplasia, dysplasia mainly misclassified as cancer. This trend follows the
carcinogenesis sequence for this cancer type.
The performance of the model was also tested using baseline subtracted data.
No improvement in model performance was found, but increased computational
time. All future models were analysed using data that had no baseline correction.
Normal BO Dysplasia Cancer
Sensitivity 0.90 0.86 0.55 0.84
Specificity 0.99 0.89 0.91 0.94
Table 5.3: The sensitivities and specificities for four pathology groups for the 785 nm
illumination.
5.4.2 830 nm
Themean spectra for each of the four pathology groups using the 830nm laser are
shown in figure 5.12. Similar spectral differences between pathology groups can
be observed as seen using the 785 nm illumination, figure 5.8. These include the
prominent peaks of glycogen in normal tissues at 484 cm−1 and 935 cm−1 and the
increased amounts of tryptophan, guanine and cytosine at 1552 cm−1, 1578 cm−1
and 1611 cm−1, respectively. There are, however, some more subtle spectral
differences between the two wavelengths, most notable is the background from
the objective contribution. In the 785 nm it increases the height of the 1260 cm−1
and 1331 cm−1, which is not present in the 830 nm spectra. In addition, peaks
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Figure 5.12: Mean spectrum for 4 pathology groups, normal, BO, dysplastia and
adenocarcinoma (cancer) in the oesophagus using the 830 nm illumination, with a 30
s exposure.
associated with β-carotenes at 1154 cm−1 and a shoulder peak at 1362 cm−1
assigned to guanine can be seen using 830 nm.
Figure 5.13 shows the difference spectra for (a) normal versus BO, (b) normal
versus adenocarcinoma (cancer) and (c) dysplasia versus adenocarcinoma for
830 nm. Difference spectra between normal and BO tissues highlight greater
amounts of glycogen, proteins and α-helix in normal tissue and greater amounts of
DNA and unordered proteins in BO tissues. The main difference between normal
and cancerous tissues are greater amounts of glycogen in normal tissues and
greater amounts of collagen, unordered proteins and nucleic acids in cancerous
tissues. The differences between dysplastic and cancerous tissues show greater
amounts of DNA in dysplastic tissues and greater amounts of Amide I and III
associated with proteins and collagen.
Identical to the 785 nm data, the first 25 principal components were selected for
linear discriminant analysis, with a total variance of 97.2%. ANOVA determined
all 25 PCs to be significant with the most significant being PC2 followed by PC
1, PC13 and PC12; the loadings for these PCs are plotted in figure 5.14. PC2
appears to have a similar line shape to that of PC2 from figure 5.9; it separates
peaks associated with glycogen, proteins, lipids and collagen in the positive load-
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Figure 5.13: Difference spectrum for (a) normal versus BO, (b) normal versus
adenocarcinoma (cancer), (c) dysplasia versus cancer for the 830 nm laser.
ings and peaks associated with tryptophan and DNA with negative loadings. PC1,
similar to PC1 for the 785 nm data demonstrates the background associated with
the objective contribution. Note that the position of the slope is towards lower
wavenumbers, which is in agreement with the objective spectra plotted in figure
4.2. PC12 has peaks tentatively assigned to formalin and paraffin, although no
paraffin is expected, as tissues were snap frozen, this may have resulted from
some form of contamination.
Table 5.4 shows the calculated sensitivities and specificities for the PCA-LDA
LOSO cross validation of each pathology group using the 830nm laser. The
830nm laser seems to have a better performance than 785 nm for the dysplastic
group with a sensitivity of 71%; however, the sensitivities for normal and cancer
are lower, with values of 84% and 75%, compared to 90% and 84% for the
785 nm. The sensitivity for the BO group is approximately the same for both
lasers. The specificities for all pathology groups are excellent, with all values
above 91%. These compare favourably with that of the 785nm, providing a slight
improvement for the BO group. From the linear discriminant score plot in figure
5.15, the dysplatic group appears to be more closely clustered and outliers are
now associated with the normal group in green. This may account for the im-
provement in sensitivity for the dysplastic group and a reduction for the normal
group. The groups appear as four distinct clusters. From the confusion matrix
bar chart in figure 5.15, it can be seen that misclassification of normal tissue is
mainly assigned to the BO group, the BO group is misclassified as dysplastic, the
dysplastic group has misclassification in both the BO and cancer group, and the
cancer group is predominantly misclassified as dysplasia. This would be expected
as the cancer progresses in a continuum between groups, without rigid boundaries
for each group.
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Figure 5.14: The four most significant principal components as determined by ANOVA
for the 830 nm illumination.
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Figure 5.15: 830nm confusion matrix and PCA-LDA scores plots
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Normal BO Dysplasia Cancer
Sensitivity 0.84 0.87 0.71 0.75
Specificity 0.99 0.92 0.91 0.92
Table 5.4: The sensitivities and specificities for three pathology groups for the 830 nm
illumination.
5.4.3 Summary
Overall, the two laser wavelengths appear to have comparable performance when
applied to a PCA-LDAmodel for four pathology groups in the oesophagus. 830 nm
appears to have superior performance for the dysplastic group, which is the most
challenging group for pathologists to diagnose. Each has subtle differences in
spectra, but this does not appear to make a significant difference to the diagnostic
classification. To enable a comparison with the CARS/SRS data, it is essential to
use the 785 nm laser line to be able to measure Raman signals from the hwn
region. The CCD has insufficient sensitivity in this region of the spectrum when
using 830 nm illumination.
5.5 Raman fingerprint versus high wavenumber
The ultimate aim of this chapter was to compare the diagnostic potential of sponta-
neous versus coherent Raman. To enable such comparisons the diagnostic ability
of Raman in the hwn region needed to be determined, as this was the spectral
range able to bemeasured currently on the SRS set-up. Extensive work discussed
in the literature review (section 2.2) has demonstrated the ability to distinguish
different pathology groups in the oesophagus using spontaneous Raman in the
fingerprint region. Here18 oesophageal samples measured from four different
pathology groups are compared, categorised by a pathologist as either normal,
BO, dysplastic or adenocarcinoma. Frozen sections were prepared as described
in section 4.5.1. Annotated digital histology was used to identify the region to be
measured.
A white light montage of the whole tissue area was taken using a lower magnifica-
tion objective to allow a larger field of view to be measured. With reference to the
H&E stained sample, this allowed for the orientation of the tissue to be visualised
and the region of interest identified. Streamline Raman mapping was performed
using the 785nm laser line, on regions of 280µm x 280µm in size, with a step size
of 1.4µm and 30 s exposure. Larger regions were measured here for the 785 nm
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Figure 5.16: Mean spectra of normal, BO, dysplastic and cancerous tissue from the
oesophagus in the fingerprint region.
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Figure 5.17: Two group model, four most significant principal components determined
using ANOVA in the fingerprint region.
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in comparison to the data reported in section 5.4.1. The spectral range of the 300
l/mm grating allows for measurements of the fingerprint and high wavenumber
regions simultaneously. However, to compare regions data were truncated after
measurements to 450 cm−1 to 1850 cm−1 for the fingerprint region and 2800 cm−1
to 3050 cm−1 for the hwn region.
The Raman data was subject to the following preprocessing methods, cosmic
ray removal using a two dimensional median filter, interpolation to 1 cm−1 spac-
ing, instrument response correction, truncation to 450 cm−1 to 1850 cm−1 for the
fingerprint region or 2800 cm−1 to 3050 cm−1 for the high wavenumber region,
Savitzky-Golay filtering (fp:2nd order, 9 point window; hwn:2nd order, 25 point
window) and vector normalisation. A larger Savitzky-Golay filter was applied to
spectra in the hwn region, to better average over the broader Raman peaks. Data
were mean centred before PCA analysis. No baseline correction was applied.
5.5.1 Fingerprint region
The mean spectra for each pathology group were baseline subtracted using an
asymmetric least squares smoothing and vector normalised prior to comparison in
figure 5.16. The mean spectra were made up from all spectra from all samples in
each group totalling 200,000 spectra per subgroup. The signal to noise ratio of the
spectra was relatively low, as measurements were conducted as quickly as pos-
sible to allow for a higher sample throughput. For a tentative list of Raman band
assignments, refer to table 5.1. There were subtle changes in the spectra between
pathology groups, which can be seen from the mean spectra. To highlight these
differences further, multivariate analysis in the form of PCA was used, to look at
the variance within the data. ANOVA was then used to determine the significance
of the each principal components, with a p value of 0.001 (99.9% significance).
The four most statistically significant principal components according to ANOVA
are PC1, PC6, PC3 and PC2. These four PC loadings are plotted in figure 5.17.
To further enhance differences between groups, a PCA fed LDA was used, with a
leave-one-sample-out cross validation. The diagnostic performance of Raman in
the fingerprint region was assessed for a two groupmodel (normal versus cancer),
a three group model (normal, BO, cancer) and a four group model (normal, BO,
dysplasia, cancer). Score values from first 25 PC’s were fed into the LDA model.
Two group model
The two group PCA-LDA model consisted of normal versus cancer pathologies,
with five samples in each group, so 10 samples in total. These two groups rep-
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Figure 5.18: PCA-LDA for Raman in the fingerprint region for a (a) two, (b) three and (c)
four group model.
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resented the outer most extremes in pathology. To demonstrate the separation
between the two groups, the LDA scores can be plotted as a histogram, with green
bars representing normal and magenta bars cancer. The number of spectra allo-
cated to each group by the PCA-LDA model can be found in appendix A.2. From
these tables, the sensitivity and specificity can be calculated, using equations 4.2
and 4.3. The first 25 principal components entered into the LDA model accounted
for 95.2% of the total variance. Normal tissues have been well categorised with
a sensitivity of 94% and specificity of 81% and excellent separation is shown in
the histogram in figure 5.18(a). This is lower for the cancer group, but this is not
unexpected. As the progression of cancer goes through a continuum of stages, it
is possible that there are mixed cells in the cancerous sample, which may include
some normal cells, especially as due to the step size of the map at 1.4µm, some
image pixels are smaller than the size of an individual cell.
Three group model
Normal BO Cancer
Sensitivity 0.83 0.55 0.68
Specificity 0.91 0.79 0.85
Table 5.5: The sensitivities and specificities for
three pathology groups in the fingerprint region.
The three group model consisted of,
normal, BO and cancer pathologies,
with five, four and five samples in
each group respectively, so 14 sam-
ples in total. The cross validated
LDA scores are plotted against one
another as a scatter graph in figure
5.18(b). Each point is allocated a
colour that is associated with the actual group it belongs to. With green circles
corresponding to normal, orange to BO and magenta to cancer. 95.3% of
spectra were correctly predicted by the model. Plotting the linear discriminant
function scores against one another allows visualisation of the separation between
different pathology types. From figure 5.18(b), it is apparent that there is a good
separation for all three groups. A cross validation leave-one-sample-out analysis
produced the sensitivities and specificities shown in table 5.5.
Four group model
The four group model consisted of normal, BO, dysplasia and cancer pathologies,
with five, four, four and five samples in each group respectively, so 18 samples in
total. A cross validated leave-one-sample-out analysis produced the sensitivities
and specificities shown in table 5.6. The LDA scores are plotted against one
another in figure 5.18(c). There seems to be a clustering of pathology groups,
but in comparison to the three group model, the inclusion of the intermediate
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dysplastic group, significantly reduces the performance of the PCA-LDA model.
This is also the group that proves most challenging for pathologists too. So it
could either be the case that there are mixtures of different cells in the samples,
as they progress through the continuum of stages in cancer progression or that
the pathology the samples are being compared too is incorrect. Furthermore the
sensitivities and specificities are much lower for this data set, compared to the
oesophageal samples measured at 785 nm in section 5.4.1. For the larger maps
shown in this section, some normal tissue samples had a particularly thin layer
of squamous epithelium, which inadvertently resulted in some maps including
regions of the stroma, this has a different Raman spectra, due to the presence
of connective tissue. This may be the reason why the smaller maps performed
in section 5.4.1 resulted in better sensitivities and specificities for the four group
model, as they weremore homogeneous and only included spectra from the squa-
mous cells. Different optimisation methods were attempted to try and improve the
performance of themodel. This included the removal of spectra with a low signal to
noise ratio, to try and avoid misclassification of regions of tissues containing holes.
Holes in tissues appear as a CaF2 spectrum and were much more common in
dysplastic and cancer samples. The PCA-LDA model used here for classification
uses rigid criteria for grouping spectra and all spectra must fit into one of the four
groups. Spectra that included such things as a CaF2 spectrum from a hole, have
to be allocated into a group to which they do not belong, this is likely to cause
classification errors in the model.
Normal BO Dysplasia Cancer
Sensitivity 0.82 0.32 0.41 0.54
Specificity 0.96 0.78 0.81 0.86
Table 5.6: The sensitivities and specificities for four pathology groups in the fingerprint
region.
5.5.2 High wavenumber region
The mean spectra for each of the pathology subgroups in the high wavenumber
region are shown in figure 5.19. The peaks are tentatively assigned in table
5.2. No background subtraction was applied to the data and it appears that
there is a varying baseline between pathologies, with the normal group being
the most different, in comparison to the other three. The chemical differences
are subtle between groups, with no large variations in peak intenisty is observed.
The difference in background could potentially be related to morphological rather
than chemical differences in the tissue [179]. Five principal components, for LDA,
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Figure 5.19: Mean spectra of normal, BO, dysplastic and cancerous tissue from the
oesophagus in the high wavenumber (hwn) region.
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Figure 5.20: Two group model, four most significant principal components determined
using ANOVA in the hwn region.
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were determined to be the most appropriate for this data set, determined to be
significant using ANOVA and from visual inspection of PC loadings containing
spectral like features.
Two group model
The two group PCA-LDA model consisted of normal versus cancer pathologies,
with five samples in each group, so 10 samples in total. For the two group model,
five PCs accounted for 74% of the total variance. The model resulted in a sensi-
tivity of 86% and a specificity of 66%. The linear discriminant function is plotted
as a histogram in figure 5.21(a). A separation between the two groups can be
observed, but there is a larger overlap than is observed in the fingerprint region.
Application of a Savitsky-Golay filter prior to PCA-LDA analysis similar to the
fingerprint region increased the number of spectra correctly classified as cancer,
but decreased the number of spectra classified as normal. As this again adds an
additional processing step that did not have distinct benefits, subsequent models
were run without a correction. When a baseline subtraction was applied to data in
the hwn region, the performance of the PCA-LDA model reduced substantially, for
both the normal and cancerous groups. This again suggests that there is some
diagnostic differences in the background in normal tissues compared to that of
adenocarcinoma. No baseline subtraction was applied to successive models.
Three group model
Normal BO Cancer
Sensitivity 0.77 0.37 0.32
Specificity 0.78 0.71 0.76
Table 5.7: The sensitivities and specificities for
three pathology groups in the hwn region.
The three group model consisted of,
normal, BO and cancer pathologies,
with five, four and five samples
in each group respectively, so 14
samples in total. A cross valida-
tion leave-one-sample-out analysis
produced the sensitivities and speci-
ficities shown in table 5.7. The
resulting linear discriminant functions are plotted in figure 5.21(b). From this, it
can seen that the BO and cancer groups sit on top of each other and also overlap
with some of the normal spectra. The sensitivity and specificity for normal tissues
was good. However, in terms of sensitivity, the model performs badly for BO and
cancer.
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Figure 5.21: PCA-LDA for Raman in the hwn region for a (a) two, (b) three and (c) four
group model..
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Four group model
The four group model consisted of normal, BO, dysplasia and cancer pathologies,
with five, four, four and five samples in each group respectively, so 18 samples in
total. A cross validation leave-one-sample-out analysis produced the sensitivities
and specificities shown in table 5.8. The resulting LD functions are plotted in
figure 5.21(c). There is some separation of normal tissues, but all other groups
overlap. The performance for this four group model is poor for all groups apart
from normal, which was expected as this was also observed in the fingerprint
region. Models combining both the fingerprint and hwn regions did not offer any
increase in sensitivity or specificity than the fingerprint region alone, suggesting
that the most diagnostic information is coming from the fingerprint region. From
the confusion matrix, it can be seen that cancer spectra are now being classified
as dysplastic and dysplastic spectra as cancer or BO.
Normal BO Dysplasia Cancer
Sensitivity 0.77 0.30 0.05 0.16
Specificity 0.82 0.76 0.80 0.75
Table 5.8: The sensitivities and specificities for four pathology groups in the hwn region.
5.5.3 Summary
The most significant spectral changes can be observed in the fingerprint region
between normal tissues and the other pathology groups. The most predominant
change is in the level of glycogen, which has distinctive peaks in normal tissues.
The best discrimination is for the two group model, which is intuitive as these rep-
resent the two pathological extremes. The sensitivity and specificity is significantly
reduced with the addition of a dysplatic group. Minimal differences were observed
between groups in the hwn region, which has been shown to be inadequate for
diagnosis in the oesophagus.
5.6 Coherent Raman
5.6.1 SRS
Spectral information was extracted from the SRS images by performing a hy-
perspectral stack. A laser power normalisation described in section 4.3.3 was
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Figure 5.22: MeanSRS spectra for four different pathology groups, normal, BO, dysplasia
and cancer.
performed on the data using ImageJ. Data were then imported intoMatlab (version
2014b) for further analysis. The field of view was reduced to match that of the
Raman, 148µm by 148µm. One pixel corresponds to 0.59µm by 0.59µm, so
3 pixels were removed from the outer edges, to ensure that the same area was
measured using Raman and coherent Raman. Each image was 250 pixels by
250 pixels, four SRS images combined to match the total area sampled using
the Raman. To ensure that the same number of spectra are entered into the
model, the SRS images were further reduced to 202 pixels by 202 pixels, using
the ‘imresize’ function in Matlab and the default bicubic interpolation method,
which reduces the pixels using a weighted average of pixels using the 4x4 nearest
neighbours. Before PCA, each image was interpolated in the spectral dimension
to a spacing of 1 cm−1, to again match that of the Raman after pre-processing,
so a total of 250 spectral data points were inserted into the model, with 62,500
individual spectra in total per sample. Data had a Savitzky-Golay filter applied (2nd
order, 23 point window) and was finally vector normalised. This preprocessing is
performed to ensure that the spectra extracted from SRS matches that from the
Raman, as much as possible.
The mean spectrum for each pathology group measured using SRS is shown in
figure 5.22. The SRS spectra has a similar line shape to that of the Raman in the
hwn region and peaks can be identified at 2850 cm−1, 2884 cm−1 and 2930 cm−1.
The spectrum from the normal samples appears to have a different line shape to
that of the other pathology groups, which is also seen in the Raman in figure 5.19.
However, the SRS spectra does not appear to match that of the Raman identically.
The region between 2800 cm−1 to 2930 cm−1 follows the same pattern, with higher
normalised intensity at the 2930 cm−1 peak and lower at the 2850 cm−1 and similar
amounts at 2884 cm−1 for normal compared to other groups. In the range from
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2930 cm−1 to 3050 cm−1, the spontaneous Raman spectra for all groups appears
to follow the same slope, whereas in SRS, the slope of the normal group is much
steeper than that of the others. The differences may be related to the baseline
in Raman and stimulated Raman scattering (SRS). It is interesting to note that
the baselines, although not identical, reflect the same trend between pathology
groups in SRS as seen in Raman using the hwn. The normal group has a very dif-
ferent baseline to that of the other pathology groups. However, due to the method
of SRS detection, it is unlikely that the background has the same origins as that in
the Raman. The Raman background can originate from autofluorescence, which
is unlikely with a 785 nm excitation or stray light hitting the spectrometer. The SRS
signal, is detected as a loss of pump photons at a set modulation frequency and is
highly directional and coherent, therefore would not be effected by such signals.
There are however, background effects that can occur in SRS. These include
cross-phase modulation, photothermal lensing and two photon absorption [180].
PCA followed by LDA analysis was performed in the same way as for the spon-
taneous Raman results. The first five principal components were selected and
used to create a leave-one-sample out cross validated LDA model. Following the
same analysis performed on spontaneous Raman measurements, the diagnostic
performance of SRS was assessed for a two group model (normal versus cancer),
a three group model (normal, BO, cancer) and a four group model (normal, BO,
dysplasia, cancer).
Two group model
The two group PCA-LDA model consisted of normal versus cancer pathologies,
with five samples in each group, so 10 samples in total. For the two group model,
the SRS data produced a sensitivity of 65% and specificity of 53% for the normal
versus cancer discrimination. This performance is poorer than that of the Raman
in the hwn region and much worse than that of the Raman in the fingerprint region.
The histogram showing the distribution of scores for LD1 in figure 5.23(a) shows
a large overlap between the two groups.
Three group model
The three groupmodel consisted of, normal, BO and cancer pathologies, with five,
four and five samples in each group respectively, so 14 samples in total.For the
three group model, the sensitivities and specificities are shown in table 5.9. Figure
5.23(b) shows a plot of LD1 versus LD2. It can be seen that there is no separation
between the three groups. Similarly to the hwn region, SRS has misclassified
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Figure 5.23: PCA-LDA for SRS for a (a) two, (b) three and (c) four group model.
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Normal BO Cancer
Sensitivity 0.60 0.15 0.15
Specificity 0.60 0.68 0.69
Table 5.9: The sensitivities and specificities
for three pathology groups using SRS.
more BO spectra as cancer. The
majority of normal spectra have been
correctly classified as normal, but in
much lower numbers than in the finger-
print region. This is not unexpected as
there does not appear to be obvious
spectral differences between BO and
cancer groups in the hwn region of SRS.
Four group model
The four group model consisted of normal, BO, dysplasia and cancer pathologies,
with five, four, four and five samples in each group respectively, so 18 samples
in total. For the four group model, the sensitivities and specificities are shown in
table 5.10. With reference to figure 5.23(c), there is no discrimination between
the four pathology groups; the data points for each group show no grouping or
separation. The sensitivities and specificities are very low. The separation in the
hwn region was poor and SRS has demonstrated worse performance.
Normal BO Dysplasia Cancer
Sensitivity 0.53 0.05 0.25 0.09
Specificity 0.63 0.76 0.79 0.79
Table 5.10: The sensitivities and specificities for four pathology groups using SRS.
5.6.2 CARS
The CARS signal is generated simultaneously with SRS, as they result from the
same Raman interactions, but have different detection methods. CARS images
were not used here for spectral analysis due to the presence of the non-resonant
background, that distorts the spectral line shape. The narrow width of the band-
pass filter before the PMT also cuts off the latter part of the hwn region. The laser
power normalisation is also not as simple for CARS, as, unlike SRS, the signal
is not linear with pump power, but quadratic. But CARS still offers morphological
information, which is able to be obtained much faster than SRS, using the current
system. Figure 5.24 shows a mean spectrum from normal oesophagus measured
using CARS, in which the distorted line shape can be observed.
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Figure 5.25: Images of oesophageal tissues from four different pathology groups:
normal, Barrett’s oesophagus (BO), dysplasia and cancer. Images represent intensities at
2930 cm−1, measured using Raman, CARS and SRS. H&E stained sections are included
for comparison (scale bar, 1000µm), the region measured is highlighted by an orange
box.
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NR background filter edge
Figure 5.24: Mean spectra of normal tissues
using CARS.
Figure 5.25 compares the imaging
ability of Raman, CARS and SRS
at the 2930 cm−1 peak, associated
with CH3 symmetric stretching vi-
bration most commonly assigned
to proteins. The H&E image for
the samples are also shown for
comparison. All imaging modalities
show similar cellular features, that
correspond to the features observed
in the H&E. For normal tissues,
Raman and coherent Raman dis-
tinguish the normal squamous ep-
ithelium that make up the lining of
the oesophagus, shown as uniform
circles covering the entire field of view. The epithelial cells are seen around the
edges of the H&E image; the basement membrane and submucosa can be clearly
seen in this sample. For the BO sample, epithelial metaplasia is identified by the
long glandular structure of the BO cells, which surround the outside of the H&E
section; there is still a division between the mucosa and submucosa, which can be
identified by the more pink colour of the H&E stain. The glandular structure of the
columnar epithelial cells can be observed. The same gland was identified in each
sample, but has subtly changed between the two 10µm sections. The dysplastic
sample shows a much more disordered structure, and the adenocarcinoma
(cancer), the normal structure of the oesophagus is no longer recognisable. The
Raman spectra used to generate the images are not baseline subtracted, so the
image pixel intensity is a combination of the Raman signal at that peak and any
contribution from a broadband background. For coherent anti-Stokes Raman
scattering (CARS) the images are also a combination of the Raman peak intenisty,
plus any contribution from the nonresonant background. SRS is assumed to be
background free, as unlike CARS, it doesn’t have any nonresonant contributions.
The influence of the different backgrounds may explain the brighter regions, in
different parts of the tissues using the different techniques.
5.6.3 System variance
Before each tissue measurement, a ‘standard’ was measured to assess the signal
to background ratio of the SRS system. Calibration and alignment of the coherent
Raman set-up is performed daily using corn starch; however, starch grains are not
uniform in size and shape, whichmakes determining the position of the peak signal
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Figure 5.26: Mean spectra of 5 µm polystyrene beads measured using (a) spontaneous
Raman covering both the fingerprint and hwn regions, mounted on CaF2 and (b) SRS,
covering the CH stretch region, mounted on a glass coverslip. Raman spectrum from
reference [181].
difficult. Therefore, once alignment has been performed, 5 µm polystyrene beads
(Sigma Aldrich) weremeasured. This is a well characterised standard for coherent
Raman measurements [132,134,144]. Standards were measured before tissues
to attempt to quantify the system variability on a day to day basis.
Polystyrene beads
Polystyrene is made up from CH groups that have both a chain like (aliphatic)
structure and a benzene (aromatic) ring structure. The molecular structure for
polystyrene is shown in the overlay in figure 5.26(a). Sharp peaks corresponding
to the asymmetric CH2 and the aromatic CH stretch can been seen at 2910 cm−1
and 3054 cm−1, respectively [110,182]. For SRS measurements, the pump beam
was tuned to a wavelength of 784.7 nm to image the 3054 cm−1 peak which,
from figure 5.26, can be seen to provide the strongest Raman peak in the high
wavenumber region. Figure 5.26(b) shows the spectrum from hyperspectral SRS
of the beads, that matches that of the spontaneous Raman. The same sample of
polystyrene was measured before each oesophagus sample to assess the signal
to background for that particular alignment configuration. Figure 5.27 shows three
examples of the signal to background of the beads measured on different days
using SRS. The left of the figure shows the SRS image and the right an average
intensity profile of the region highlighted by the yellow box. The box was selected
to be, as much as possible, three beads in width and to include as many beads in
a row, so a mean peak value could be taken. Measured regions are selected to
include a monolayer of polystyrene beads and a region with no beads to compare
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(a)
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(d)Figure 5.27: Three examples of the same polystyrene 5µm samplemeasured on different
days using SRS at the 3053 cm−1 Raman peak, using the same LIA settings, laser powers
and imaging parameters. The LHS shows the SRS image of the polystyrene sample. The
yellow box overlay indicated the area displayed in the intensity profile on the RHS. The
blue dashed line is the average peak value and the lower pink dashed line the average
noise.
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Figure 5.28: Assessing the perfomance of the OPO. (a) The pump wavelength produced
by the OPO as a function of scan number, the dashed line shows the ideal tuning
wavelengths for a function of the number of scans and (b) the OPO power output as
a function of scan number for a hyperspectral stack.
to the background noise. The intensity profile, plotted as a function of the number
of pixels across the image, as the solid black line in figure 5.27. The mean peak
signal from a collection of beads is plotted as a blue dashed line and the average
background noise as a dashed pink line. A ratio between the average signal and
background is shown for each measurement. As can been seen, this ratio ranges
from 6 to 48. These differences are not obvious from looking at the SRS images
of the polystyrene. The differences are as a result of the quality of the system
alignment. With a complex piece of equipment such as that of the coherent
Raman set-up, one of the challenges for long comparative studies performed on
multiple samples is consistent alignment. Factors such as the spatial and temporal
overlap of the two beams, the fine focus of the objective and the height of the
condenser lens can affect alignment, with fine tolerances for optimum signal to
background of the order of microns. The signal to background of the polystyrene
appears to increase over time suggesting improvements in alignment due to a
more experienced user.
Performance of the OPO
During the course of this work, the OPO developed a fault, which hindered the
automated tuning across the hwn region. Figure 5.28(a). shows the wavelength
produced by the OPO as a function of the scan number. When the OPO is
operating correctly, the plot should be that of a diagonal line, which indicates that
the wavelength being produced is decreasing with an equal step size. The plot
instead highlights the instability of the tuning, whereby the pump wavelength pro-
duced is both increasing and decreasing with uneven step sizes. This significantly
increased measurement times as the scans required either manual intervention
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Figure 5.29: Comparison of the changes in laser power from the OPO whilst tuning. (a)
The actual recorded power recorded using the power meter before the scan unit on the
optical bench (b) the OPO power units displayed on the screen whilst tuning. Error bars
are the standard deviation for measurements
or for the whole scan to be repeated. This ultimately limited the total number of
samples able to be measured for this study. In addition to wavelength instability,
the OPO was also producing variable powers, which directly effects the SRS
signal, as it is linearly proportional to the intensity of the pump beam. The power
fluctuations are shown in figure 5.28(b). The power is shown in arbitrary units,
but it becomes more apparent if the power drops by more than 100 units, this had
a detrimental effect on the spectral information that could be recovered, and that
data point had to be removed. The SRS signal is not able to be recovered from the
system noise, and the power normalisation technique described earlier is unable
to correct for this. This again meant that measurements had to be repeated.
Figure 5.29 compares the actual power from theOPO during a hyperspectral stack
compared to the arbitrary power units displayed on the screen of the OPO. A clear
correlation between the two values was not able to be established; therefore, for
laser power normalisation, it was essential to use the recorded transmitted light
power on the diode, to accurately reflect power fluctuations.
5.6.4 Summary
SRS has not been shown to be able to discriminate between different pathology
groups in the oesophagus. This has been concluded to be due to a series of
factors relating to the sample molecular properties and complexity of the daily
operation of the coherent Raman system. Although spontaneous Raman mea-
surements have shown limited changes in the hwn region between pathology
groups, large variations due to alignment and system stability in SRS, may over-
shadow any subtle changes between groups. Morphological changes in tissues
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are able to be rapidly identified without the need for staining using coherent Raman
techniques and are in good agreement with the corresponding H&E samples.
5.7 Discussion
This chapter investigated the potential for spectral information from spontaneous
and coherent Raman techniques to be used to create a classifier model using a
PCA-LDA approach. Four pathology groups from the oesophagus that represent
major diagnostic stages in adenocarcinomawere used, including BO oesophagus,
which is linked to a higher prevalence of cancer.
Comparisons between spontaneous and coherent Raman techniques required the
use of two different instruments. The optimal measurement parameters were first
established for each technique. Raman measurements required Raman grade
CaF2 to avoid a large background from the substrate. SRS on the other hand
required a substrate that had a thickness of <0.2mm, as high numerical aperture
objectives were used, which consequently have a very short working distance.
Glass coverslips were therefore used as substrates for SRS. This meant that
the same section was not able to be used on both instruments, so contiguous
sections were cut for comparison from biopsy blocks. A reproducible method
for identification of sample ROI was designed, which also allowed us to see the
differences between serial sections. All tissues closely matched that of the his-
tology. Ideally to draw a direction comparison, the sections should be mounted
on the same substrate for both techniques. However, this would have required
custom made CaF2 slides with a thickness less than 0.2 mm, which makes them
incredibly fragile and difficult to work with. Applying methods of image registration
may also speed up the process to identify the FOV for measurements on multiple
instruments [183].
Fresh frozen tissues were used throughout this chapter. Measurements have
shown no change in spectral features over a 14 day period, which allows for some
flexibility with measurements and also highlights that spectral changes should not
occur during long extensive Raman maps that could take days. Repeated laser
exposure most significantly resulted in a reduction in the background of tissue
spectra can be achieved by scanning the laser over the sample prior to Raman
mapping, to improve the signal to background for measurements. However, this
would have significantly increased mapping times and was not available in the
Wire software for streamline mapping on the Raman instrument. Immersion of the
sample in water and use of an immersion lens may reduce background effects by
offering improved refractive index matching which reduces scatter and enhances
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Raman spectral features [179]. However, this was not available on the system at
the time. The pre-processing background correction seems to have provided re-
producible results between measurements and was subsequently used to correct
for future measurements. The running time in Matlab is approximately a minute
for the size of the maps used here (3800 points).
A comparative study of the different NIR laser wavelengths available showed
comparable results for four pathology groups using a leave-one-sample-out cross
validation. 830 nm was shown to have a better sensitivity for dysplastic samples.
The 785nm laser also has a large objective contribution that sits in the middle
of the spectra that still remained after baseline subtraction. Both wavelengths
are NIR so suitable for tissue applications. The CCD is more sensitive to the
785 nm laser as there is a higher quantum efficiency for this wavelength range,
so this wavelength was required to measure the hwn region. Wavelength choice
is therefore more dependent on application.
The highest sensitivities and specificities were achieved using spontaneous Ra-
man in the fingerprint region. Notable spectral changes occurred between nor-
mal and cancerous tissues with a reduction in peaks assigned to glycogen and
an increase in those associated with DNA for cancerous tissues. Sensitivities
across all measurements are reduced with the inclusion of dysplastic tissues.
These intermediate groups are also what pathologist find difficult to diagnose.
This reduction in sensitivity could therefore be as a result of a misclassification
by an imperfect ’gold standard’, which could be improved by utilising consensus
pathology, whereby at least two pathologists must agree on a classification before
the sample is included in the study. This has been shown to improve Raman
classifications [9]. It may also be necessary to use less rigid group pathology
labels on samples. LDA used for classification is a supervised technique that
requires samples to be allocated to predetermined groups and samples can only
belong to one group. By using a ‘soft’ learning approach which allows samples
to be members of more than one group, the model may be able to better assign
spectra especially of the dysplastic group. This also allows for uncertainties in the
original pathology, so doesn’t require a consensus opinion [184].
Pre-processing steps applied to spectra before any form of multivariate analysis
influence the end result. The application of a Savitsky-Golay filter improved clas-
sification for noisy spectra until the data were overfiltered and diagnostic spectral
information lost. The number of principal components also changed the sensitivity
and specificity values. Too many PCs and too much of the noise was included in
the model, too little and not enough valuable spectral information remained. So a
compromise is required.
This chapter somewhat highlights some of the limitations of coherent Raman
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techniques, predominantly the complexity and reproducibility of the system. Mid-
way through the solid state (1064 nm, 7 ps) laser, used for coherent Raman, was
no longer stable enough or able to produce enough power to pump the OPO.
The replacement laser was a fibre laser (1032 nm, 2 ps) with shorter pulses and
a shorter wavelength. This in theory should have increased the resulting SRS
signal. However, in practice there was increased photodamage due to the shorter
wavelengths of the pump and Stokes beams, so lower laser powers had to be used
and more laser noise at the same modulation frequency (1.7MHz), that inherently
reduced the signal to noise able to be achieved by the system and limited imaging
times. Attempts to apply post measurement SRS noise corrections such as total
variation minimization [185] proved to be ineffective as a background region con-
taining no tissue was required, which was not possible from the tissue data set. It
is suggested that, by modulating at much higher frequencies (20MHz), one should
be able to overcome this and produce a signal to noise comparable to that of the
previous laser at 1.7MHz [186]. With a reduction in the amount of laser noise
and improvements in signal from the shorter pulses, there should be an overall
improvement in sensitivity, making measurements in the fingerprint region viable.
This will allow access to the abundance of diagnostically significantly peaks in this
region, although the bandwidth of the laser may be a limitation, with a spectral
resolution of 10 cm−1, which may not be sufficient for the sharper peaks in the
fingerprint region.
It has been demonstrated that there are minimal differences between pathology
groups in the hwn region for the oesophagus. It may therefore be of interest to con-
sider other tissue types that have larger changes in lipid to protein concentrations
as cancer progresses, such tissues include the brain and breast [136]. Discrim-
ination in the hwn region has however, been shown in the bladder [76], which is
more similar to tissues of the GI tract; using a k-means clustering approach, which
is explored in the next chapter using colon tissues. It may also be a case that the
analysis techniques are not appropriate for the methods used. It has been shown
that PCA-LDA is appropriate and effective for Raman, but it may be the case that
as CARS/SRS is primarily an imaging technique, image analysis maybe a more
appropriate method for analysis. Ji et al. [138] performed quantitative analysis
in the brain using SRS and classifier models in the brain, using visual features
identifiable by SRS to decide the pathology of tissues, such as the axon density,
nuclear ratio, protein to lipid ratio, to study tumour infiltration. Something similar
may be more applicable to SRS measurements of the oesophagus.
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5.8 Conclusion
Comparisons of 785 and 830 nm illumination demonstrated that there were clear
differences between normal tissue spectra and spectra of the other three pathol-
ogy groups, which seems logical, as BO is the transformation of the normal squa-
mous cells into columnar epithelium and then a continuum of stages as tissues
progress towards carcinoma. This differencewas seen for both laser wavelengths.
Also common to both were differences in the amounts of glycogen, which PCA
analysis showed to be significant for diagnostic discrimination. Wavelength se-
lection is dependent on application; for these experiments it was essential to use
the 785 nm laser. 830 nm can be used to further suppress background effects.
Comparisons of the discriminatory ability of the fingerprint versus hwn region
showed the best performance was in the fingerprint region using a two group
model. The hwn region has a limited amount of spectral information available
and, whilst differences can be observed between normal and cancerous tissues,
this is not sufficient to discriminate in a four group model that includes BO and
dysplatic tissues in addition to normal and adenocarcinoma. Similar results were
found using SRS, which is expected to have a spectrum that matches that of the
spontaneous Raman. A further reduction in discrimination was observed using
SRS. This is thought to be due to smaller variations in the background, but also
the complexity of the instrument and being unable to reduce instrument variance.
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6.1 Introduction
This chapter focuses on spontaneous Raman and coherent Raman measure-
ments of colon tissues. Section 1.1.2 introduced the morphology of colon tissues
and highlighted the differences to that from the oesophagus, containing columnar
epithelial cells and mucosal glands. Similarly to the oesophagus, the wall of
the colon is made up of four different layers. Again the focus is on the most
inner layer, the mucosa, that is the site for the most common form of cancer
progression, adenocarcinoma. The structure of the wall of the colon is more
complex than that of the oesophagus. Here, the aim was to demonstrate the
ability for Raman techniques to identify different colonic structural features that
are currently used as markers for diagnosis using the current histological ap-
proach. The work undertaken briefly looked at the viability to perform Raman
measurements using paraffin embedded samples and the ability of stimulated
Raman scattering (SRS) to rapidly produce images of unstained tissues over a
large area. Finally, compared spontaneous and coherent Raman techniques, with
regards to the spatial and spectral information available, and identified chemical
signatures that were can be used to identify different regions of the tissue using a
k-means clustering approach.
6.2 Paraffin embedded samples
Initial measurements were conducted, to determine whether paraffin embedded
tissue sections would be a viable option for future measurements in the high
wavenumber (hwn) region, using hyperspectral SRS. The ability to use paraffin
embedded sections is particularly attractive, as this method of tissue preservation
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makes up part of the current histopathological workflow, previously described in
section 1.2.2, and as a result would allow access to large supplies of tissues
stored in this way at tissue banks. Prior to measurements, samples were de-
paraffinised using a xylene protocol [187]. The spontaneous Raman spectrum of
pure paraffin in the high wavenumber region is show in figure 6.1. Paraffin has
a strong Raman signal in the hwn region, as its chemical structure contains only
CH bonds. With reference to figure 6.1, two sharp peaks can be observed, at
2846 cm−1 and 2881 cm−1, which can be assigned to the CH2 symmetric and
asymmetric stretches, respectively [173]. Colon tissues have broad peaks at
2850 cm−1 and a stronger contribution at 2930 cm−1. It is apparent that the peaks
from paraffin overlap with the CH contribution from tissues, making it difficult
to separate spectral contributions from tissue and the paraffin itself. Chemical
deparaffinisation is not able to remove all of the paraffin from the sample, and the
deparaffinisation process involves the use of harsh chemicals that can disrupt the
lipids in the tissue [188], potentially removing some of the molecules that provide
chemical contrast.
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Figure 6.1: Spontaneous Raman spectrum of
paraffin in the high wavenumber region, taken
using a 5 s exposure.
Deparaffinised colon sectionsmounted
on glass coverslips were measured
using SRS1. Figure 6.2(b) shows the
extracted mean SRS spectrum for
a hyperspectral stack for the whole
field of view. The paraffin peaks
at 2846 cm−1 and 2881 cm−1 are
prominent in the spectrum, with a
tissue peak visible at 2930 cm−1. In
figure 6.2(c) SRS image snapshots
at each of the three peaks are
shown. Image (i) and (ii) highlight
the distribution of remaining paraffin
in the sample along with the contribution from the tissue. Image (iii) shows the
contribution from the tissue only at 2930 cm−1. It can be seen that the images
of tissue containing paraffin have a much stronger signal concentrated in more
localised areas, and image (iii) corresponding to tissue alone, has a much more
uniform signal across the gland. Figure 6.2(a) is a composite image. To try and
identify contributions from paraffin alone, the difference between image (i) and
image (ii) was calculated. A cyan look up table (LUT) is applied to this difference
image and overlaid onto image (ii). From the images, it can be concluded that
contributions from paraffin still remain in a large part of the sample and distributed
1The pump laser for these measurements was a Nd:Vandium laser (High-Q Laser Production
GmbH), with a wavelength of 1064 nm and 6 ps pulses.
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Figure 6.2: SRS measurements of deparaffinised colon tissue. (a) composite image
showing the tissue peak at 2930 cm−1 in magenta overlayed by the paraffin peak at
2846 cm−1 in cyan, (b) the extracted mean SRS signal, (c) SRS images at 2846 cm−1,
2881 cm−1 and 2930 cm−1
across the whole surface. Furthermore, it was noted that remaining paraffin in
the tissue also resulted in burning of the sample, which can be identified in the
images by bright spots that increase in size over laser exposure time; so lower
laser powers were required which inherently reduces the SRS signal. For these
reasons, it was decided that snap frozen tissue sections were more appropriate
and were subsequently used for further experiments.
6.3 Large area montage
Current diagnostic approaches based on histology, assess the overall appearance
of tissue structures for whole tissue sections. One criteria for a cancer diag-
nosis, is the invasion of the submucosa by abnormal cancer cells. The degree
of this invasion, determines the tumour grade in the tumour, node, metastasis
(TNM) classification (section 1.3), and is used to establish the stage of the cancer.
Therefore, being able to rapidly scan large areas of unstained tissue offers a
clinical benefit. Large scale imaging, using coherent Raman, is achieved by
forming a montage constructed from several smaller field of views. This method
has already been described in section 4.3.4. Figure 6.3(a) shows the resulting
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Figure 6.3: SRS images illustrate a macroscopic structure similar to that of H&E (a) Large
area montage of colon tissue at 2930 cm−1 measured using SRS, (b) Inserts show more
detailed images of individual glands for both CARS and SRS at 2930 cm−1 using a higher
magnification objective, (c) contiguous H&E stained section for comparison.
image from a large area montage, measured using SRS at the CH3 vibration at
2930 cm−1, most commonly associated with proteins, of a section through the
crypts in the mucosa of the colon. This montage is constructed of 27 individual
images, allowing visualisation of a section of tissue that is just over 3 mm in width.
Each frame took 52 s to acquire, with a total acquistion time for the whole sample
of less than 25 minutes. By acquiring images at a single wavelength, large areas
of tissue are able to be more rapidly scanned, in comparison to spontaneous
Raman. To reveal structural features of colon tissue on a macro scale, without the
need for staining. The montage shows well defined glands with a regular shape,
characteristic of colonic mucosa. Regular columnar epithelial and goblet cells can
be distinguished along with the lamina propria between glands, which is in good
correlation to the contiguous haematoxylin and eosin (H&E) section, shown in
figure 6.3(c) for comparison. A large scale coherent anti-Stokes Raman scattering
(CARS) montage shows identical feature resolution to that of SRS (montage not
shown here). Using a higher magnification 60x lens and selecting a particular
gland, more defined cellular features are able to be seen from the insets in figure
6.3(b). This also demonstrate the similarity between the CARS and SRS images,
for three different glands. However, there are slight differences, which arise from
the detection method for each of these techniques, as CARS is detected in the
epi-direction and SRS in the forwards direction. Edges in tissues effectively act
as small scatterers that are able to produce a backwards generated CARS signal,
in addition to the backscattered forwards generated CARS, from the rest of the
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tissue, this results in bright prixels round the edges of gland structures and at
cracks in tissues, which are not present in SRS images. As both CARS and SRS
are non-linear techniques, signal is only generated in the plane of focus, therefore
large scaled imaging can be performed easily on samples with an uneven surface,
by focusing just below the surface. It can also be noted that there are folds at the
left and right hand ends of the tissue, which slightly distort the SRS image.
6.4 Raman of the colon
A typical mean Raman spectrum of normal colon tissue in the fingerprint region
is shown in figure 6.4. The prominent Raman peaks have been labelled and are
tentatively assigned in table 6.1. Figure 6.5 summarises the wealth of information
available using Raman in the fingerprint region for two examples of normal colon
tissue. A region of interest is selected from the H&E stained section, for subse-
quent Raman mapping and is indicated by a black box in figure 6.5(a). A closer
view of the region of interest (ROI) can be seen in figure 6.5(b), accompanied by
a white light image of the region measured using Raman, an area of 280µm by
280µm. The mean of all spectra making up this area is plotted in figure 6.5(c)
Differences in the mean spectra between samples (i) and (ii) can be observed.
The most apparent is the peak at 1248 cm−1, tentatively assigned to the amide
III band of collagen. With reference to the H&E images, this difference may be
accounted for by a smaller gland to connective tissue ratio in sample (i) compared
to sample (ii).
The H&E sample is used to identify the structural elements of interest, and corre-
sponding areas are identified in Raman with the help of the white light image.
Mean spectra of regions identified to be either lamina propria, inner mucosal
area of the gland or the outer epithelial part have been plotted. Clear spectral
differences can be seen between the different regions. For the lamina propria,
prominent peaks are at 1248 cm−1 and 1578 cm−1, tentatively assigned to amide
III of collagen and guanine, respectively. Epithelial tissues appear to have impor-
tant peaks at 1445 cm−1 and 1658 cm−1, tentatively assigned to CH2 bending of
proteins and lipids and amide I, respectively. For the inner glandular regions there
is a distinctive peak at 829 cm−1, tentatively assigned to DNA. The area fromwhich
the mean spectrum is taken is highlighted by the box in the Raman image to the
left of the spectra. Pseudocolour Raman maps are plotted in 6.5(d), (f) and (h), for
829 cm−1, 1248 cm−1 and 1445 cm−1, respectively. These Raman maps plotted
at single wavenumbers provide snapshots of the chemical information available
at individual peaks and seem to also highlight the different structures within the
colon.
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Figure 6.4: Mean spectrum of colon tissue in the fingerprint region using a 785 nm
excitation, 30 s exposure time using the 300 l/mm grating. Baseline subtracted.
Peak
position
(cm−1)
Vibrational mode Assignment
622 C-C twisting phenylalanine/proteins
672 ring breathing tryptophan
722 C-H bending adenine
749 symmetric breathing tryptophan
824 out of plane breathing/O-P-O stretch tyrosine/DNA
853 ring breathing/C-C stretch tyrosine/proline
934 C-C stretch proline/valine/glycogen
1000 symmetric ring breathing phenylalanine
1099 C-N
1122 C-C stretching/ C-N stretch lipids/proteins
1257 amide III/ring breathing protein/DNA bases
1333 CH3 CH2 wagging collagen/nucleotide
1447 CH2 bending proteins/lipids
1555 amide II proteins
1577 N3 guanine
1615 C=C proteins,tyrosine,tryptophan
1657 C=O/C=C stretching amide I/lipids
Table 6.1: Tentative peak assignments of the most prominent peaks in the Raman
spectrum for colon tissue [172,173].
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100 µm
829 cm-1 1248 cm-1 1447 cm-1inner crypt outer cryptlamina propria
(i)
(ii)
H&E (entire sample) Sampled area Mean spectrum
(a) (b) (c)
(d) (e) (f) (g) (h) (i)
829 cm-1 1248 cm-1 1447 cm-1inner crypt outer cryptlamina propria
H&E (entire sample) Sampled area Mean spectrum
(a) (b) (c)
(d) (e) (f) (g) (h) (i)
100 µm
Figure 6.5: Two colon tissue samples, sample (i) and sample (ii) measured using Raman
with a 785 nm excitation. (a) Whole tissue section stained with H&E and imaged using
a standard white light microscope with a 10x magnification, the black box indicates the
position of the 280x280µm area sampled using Raman, (b) top: zoomed in H&E section,
bottom: transmitted light image of the sample area, (c) mean spectrum from the area
sampled. (d,f,h) Raman images at 829 cm−1, 1248 cm−1 and 1445 cm−1 respectively.
(e,g,i) Mean spectrum from the regions highlighted in d, f and h, respectively.
141
Colon
6.5 K-means cluster analysis
The aim of this experiment was to compare the spatial and spectral resolutions,
the time for exposure and ability to determine structural features of colon tissues
of three imaging modalities, spontaneous Raman, CARS and SRS on normal
colon tissue samples. Each sample has a corresponding H&E sample. First,
a comparison is made of k-means clustering of spontaneous Raman data in the
fingerprint region vs that in the hwn region. Secondly, a comparison of hwnRaman
with that of spectra extracted SRS measurements by performing hyperspectral
scanning.
6.5.1 Raman
Spontaneous Raman measurements were performed using the 785 nm laser ex-
citation to allow comparison of the fingerprint and hwn regions, using the 300
l/mm grating, with a 30 s exposure time. Again, they are divided into two separate
regions, to allow a comparison to be made with SRS later in the chapter, section
6.5.2.
Fingerprint region
K-means clustering is a popular unsupervised multivariate technique which aims
to partition data into meaningful groups, based on their spectral similarity. K-
means clustering was applied to the data sets to segment differences in the bio-
chemical information between tissue structures found in normal colon, such as
the epithelial cells and lamina propria, that could be of diagnostic importance. All
k-means were performed using the in-built ‘kmeans’ function in Matlab (version
2014b). Clustering is initialised with a number of starting points or centroids,
the positions of which are randomly assigned to the data set. The number of
clusters selected by the user determines the number of initial centroids. The
quality of the clustering is somewhat dependent on the initial centroid positions
and, because of their random assignment at initialisation, clustering is not always
reproducible. The information from clustering is represented by pseudocolour
images of clusters, the mean spectra of centroids, and a dendrogram. Dendro-
grams are calculated by hierarchical cluster analysis using a Ward’s algorithm
and provide a visual representation of the similarity of clusters to one another.
The distance along the x axis signifies the similarity between clusters, the longer
the line the bigger the difference. The percentage of spectra assigned to each
cluster is displayed to the right of the dendrogram LUT.
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Figure 6.6: Determining the most suitable number of clusters for k-means clustering of normal colon tissue measured using Raman in the fingerprint
region. Examples using (a) four, (b) seven, (c) ten and (d) thirteen clusters. Using random pseudocolour images to make comparisons to H&E images
with corresponding dendrograms and mean spectra of clusters.
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Each pixel in a Raman image contains a spectrum. The cluster assigned to this
spectrum can be given a colour and plotted as a pseudocolour map to identify the
spatial positioning of clusters. The pseudocolour map provides the morphological
information about the tissue and this can be directly compared to the histological
information available from the H&E stained reference tissues.
As the number of clusters is determined by the user, it is important to establish
the most appropriate number to use. Figure 6.6 compares the results of k-means
clustering on colon tissues with different numbers of clusters. Four, seven, ten
and fourteen clusters were selected for comparison. Each colour assigned to a
cluster in the map corresponds to the centroid spectrum of the same colour. Note,
colours are arbitrarily assigned to clusters and are not the same for all samples
shown. Four clusters seems to clearly separate the glandular structures from
those of the lamina propria. Cluster 2 is assigned to the inner gland and cluster
4 the outer gland. Clusters 1 and 3 describe the tissue surrounding the glands.
From the dendrogram, it is apparent that clusters 2 and 4 are most similar to one
another, and clusters 2 and 4 have more in common with each other rather than
the other two clusters. From the centroid spectra, the most apparent difference
in spectra is the sloping baseline. Seven clusters identify additional features on
the tissue in comparison to four clusters, such as a ring around the glands; cluster
3 could be a basement membrane. But there is also some subclustering of the
connective tissue forming the lamina propria, shown in cluster 6. Ten clusters
do not seem to reveal any more structural information, and more subclustering
of the glands and connective tissues is apparent. For thirteen clusters, there is
still a clustering of the glandular and non-glandular regions in the tissue, but the
dendrogram becomes much more difficult to interpret and there are lots of clusters
with very slight spectral differences.
A baseline correction applied to the data essentially removes the broadband back-
ground and also reduces some of the background effects from the objective contri-
bution for the 785 nm laser line. The baseline correction changes the appearance
of the spectra and is somewhat subjective as the user selects the parameters for
correction. Figure 6.7 compares the result of k-means clustering on data before
and after a baseline subtraction. Before correction, the biggest contribution is un-
surprisingly from the shape of the baseline. It is difficult to clearly identify spectral
differences, but the pseudocolour cluster plot appears to have identified different
structures in the colon. The corrected spectra appears to show similar cluster
patterns in the pseudocolour image. However, it appears more ‘pixelated’. The
spectral information however is much clearer, which allows spectral differences
between clusters to bemore easily identified. For further clustering, it was decided
that 7 clusters and baseline subtracted data produced the best results. Figure
6.8 shows two further colon examples using the optimised k-means clustering
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Figure 6.7: Comparison of k-means clustering of normal colon tissue measured using
Raman in the fingerprint region, (a) before and (b) after the application of a baseline
correction. Random coloured pseudocolour images and corresponding dendrograms and
mean clusters spectra are used for comparison.
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Figure 6.8: Optimised k-means clustering of normal colon tissues using Raman in
the fingerprint region with 7 clusters and baseline subtracted data. Comparison of
morphological features are made with H&E stained sections. Random pseudocolour
images, dendrograms and mean spectra of clusters are included.
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parameters. Reproducible results were seen for all three samples.
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Figure 6.9: Mean spectrum of colon tissue
in the high wavenumber region using a 785
nm excitation, 30 s exposure time using the
300 l/mm grating.
To enable comparisons with SRS, k-
means cluster analysis was performed
using spontaneous Raman in the hwn
region. Due to the large spectral
range of the 300 l/mm grating used,
the fingerprint and hwn regions are
able to be acquired in the same
spectral measurement. The spectra
are then truncated to either the finger-
print or hwn regions for comparison
and also for ease of analysis. The
spectral region between the fingerprint
and hwn regions, from approximately
1800 cm−1 to 2800 cm−1, is termed the
biologically silent region, as it contains no peaks of biological origin. This
region therefore provides no additional tissue information, so it was removed.
Furthermore, by removing this region, the number of spectral data points is
reduced which shortens processing time. As seen for the oesophagus in section
5.5.2, the hwn region contains peaks associated with the different vibrations
of the CH bonds, abundant in proteins and lipids that form the structures in
tissues. The spectral shape is of broadband peaks that overlap one another.
Differences between the colon and the oesophagus spectra could be observed
in the fingerprint region, but in the hwn there are no apparent spectral differences.
The mean spectrum of normal colon tissue in the hwn region is plotted in figure
6.9, with a tentative assignment of Raman peaks in table 6.2.
Peak position (cm−1) Vibrational mode Assignment
2845 CH2 symmetric stretch lipids
2875 CH2 asymmetric stretch lipids
2930 CH3 symmetric stretch proteins
2958 CH3 asymmetric stretch proteins
Table 6.2: Tentative peak assignments of the most prominent peaks in the Raman
spectrum for normal tissue in the high wavenumber region [173]
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Figure 6.10: Determining the most suitable number of clusters for k-means clustering of normal colon tissue measured using Raman in the high
wavenumber region. Examples using (a) four, (b) six and (c) eight clusters. Using random pseudocolour images to make comparisons to H&E images
with corresponding dendrograms and mean spectra of clusters.
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K-means optimisation
Just as for the fingerprint region, it is important to determine the optimum number
of clusters to be able to distinguish the structural features of interest. In the hwn
region, there are considerably fewer peaks, so it is intuitive that the number of
clusters required will be less. Four, six and eight clusters were applied to the data
to determine optimum cluster number; the results are compared in figure 6.10.
With reference to this figure, four clusters appear to clearly identify the glandular
regions in clusters 3 and 4 from that of the surrounding lamina propria in clusters
1 and 2. The dendrogram shows that the most similar clusters are 3 and 4 in the
glandular region and this can also be observed in the mean spectra of the cluster
centroids below. Unlike the fingerprint regions, the spectral differences appear
to be more of a result of the shape of the outer extremes from approximately
2800 cm−1 to 2850 cm−1 and 2970 cm−1 to 3050 cm−1 rather than a change in the
contribution to each peak. This line shape is most probably due to a combination
of the baseline within the spectra, as no baseline correction was performed on
this data set, and the vector normalisation. It would appear that clusters 1 and
2 of the surrounding tissue area have lower signals across all peaks in the hwn
region, which are most apparent at the 2930 cm−1 peak. Suggesting a higher
concentration of proteins in the gland compared to the surrounding lamina propria.
This is also suggested by the spectral differences shown for these regions in
the fingerprint region. The outer gland region has a strong contribution at the
1446 cm−1 that is tentatively assigned to the CH2 deformations of proteins. This
contribution is significantly lower in the Raman spectrum of the connective tissue
in the lamina propria.
The effects of the background are expected to be minimised in the hwn region.
However, to determine the effects of this baseline on clustering, a baseline sub-
traction was applied to data. Figure 6.11 compares k-mean clustering using 6
clusters for normal colon tissues, with andwithout a baseline correction. Glandular
features are still visible in cluster 6, and the inner parts of the crypt have been
assigned to cluster 2 and the lamina propria clusters 4 and 5. The general ability
to determine the entire glandular size and shape has been reduced significantly
in comparison to the data without a baseline correction. The structural outline are
no longer well defined and the image appears ‘pixelated’. This suggests that the
shape of the baseline contains information that relates to the morphology of the
different structures in the colon, which is more pronounced in the hwn region due
to more subtle changes in chemical information described by the Raman peaks
there. In baselined data, there is also not a cluster assigned to the basement
membrane surrounding the gland, which can be seen in cluster 6 in the hwn
region with no baseline correction, and this was also identified in the fingerprint
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Figure 6.11: Comparison of k-means clustering of normal colon tissue measured
using Raman in the high wavenumber region, (a) before and (b) after the application
of a baseline correction. Random coloured pseudocolour images and corresponding
dendrograms and mean clusters spectra are used for comparison.
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Figure 6.12: Optimised k-means clustering of normal colon tissues using Raman in
the high wavenumber region with 6 clusters and data without a baseline correction.
Comparison of morphological features are made with H&E stained sections. Random
pseudocolour images, dendrograms and mean spectra of clusters are included
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region. From the dendrogram, clusters 4 and 5 in the lamina propria are the
most similar. Cluster 2, making up the inner crypt, has the most distinct spectral
signature, shown both in the dendrogram and the mean spectra of clusters. This
cluster appears to have spectra with a low signal to noise ratio. hwn spectra, is
subject to changes in background. With reference to the mean spectra of clusters,
for spectra before and after correction in figure 6.11, baseline subtraction data
removes the effects on the outer left edge of the spectra. All spectra now sit
on the same baseline and subtle differences can be observed between clusters.
The effects in the data set before baseline correction may be emphasised by
vector normalisation. A min/max normalisation was also tried, but this offered
no improvements in clustering and resulted in worse spectral components. The
spectral differences observed in the hwn region are incredibly subtle. Differences
at the 2930 cm−1 peak can be observed and also at 2945 cm−1 and 2875 cm−1,
although it is difficult to assign these changes to any structural features. Figure
6.12 is included to show two further examples using the optimised parameters
decided for k-means clustering.
6.5.2 CARS and SRS
Contiguous sections of normal colon tissue initially measured using spontaneous
Raman were then measured using coherent Raman, the results of which are
presented here. Contiguous sections were necessary due to different substrate
conditions for optimal sampling on the two instruments. As far as possible, the
same ROI was selected for coherent Raman measurements as had previously
beenmeasured using Raman. To identify the ROI on the sample, a montage of the
whole tissue section was performed using the transmitted light on the CARS/SRS
microscope. Transmitted light images from Raman and coherent Raman systems
were overlaid to establish the coordinates for the glands of interest. The electronic
stage was then moved to that position for imaging.
Figure 6.13 compares images of normal colon tissues using Raman, CARS and
SRS at the CH3 stretch vibration most commonly assigned to proteins. Each of the
crypts imaged have their corresponding H&E to the left, shown for morphological
comparison. It can be noted that there are subtle differences in the appearance
of the glands for each of the tissue slices, as three contiguous sections have
been used, one for H&E, Raman and coherent Raman, respectively, over a total
depth of 30 µm. Sampled areas for Raman are 140x140µm, and 152x152µm for
coherent Raman, which is the field of view (FOV) of the objective lens. Raman
mapping required 2.5 hours to produce these images, whereas the coherent Ra-
man images were acquired in less than 14 seconds at a single wavenumber or
15 minutes for the whole hyperspectral stack. In addition to more rapid imaging,
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Figure 6.13: Images of colon tissue at 2930 cm−1 for Raman, CARS and SRS which
corresponds to the CH3 stretch vibration, most commonly associated with proteins. In
addition to faster exposure times, the CARS and SRS images are of a much higher
resolution, so more of the glandular structures are able to be distinguished in comparison
to that of the Raman images.
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coherent Raman also has submicron resolution, so glandular features are able
to be resolved with much finer detail than that of spontaneous Raman. In the
first example from figure 6.13, it can be seen that in the Raman image there is
a strong contribution at 2930 cm−1 in the lamina propria, whereby a bright pixel
suggested high concentration of that molecule. The Raman images shown here,
however, are not baseline subtracted, so each pixel intensity is a combination of
the Raman signal at the 2930 cm−1 peak on top of varing background, the origins
of which were discussed in section 5.3. From the images it is apparent that the
majority of the tissue background originates from the lamina propria. When the
background is subtracted from spectra, some morphological information is lost
and images do not show structural features as clearly. CARS and SRS are not
effected by any background fluorescence that could be in the sample, this is as
a result of CARS measuring a blue-shifted signal with enhancement by actively
driving Raman vibrations, and SRS measured as a change in intensity of the
pump beam, rather than a Stokes shifted signal, so effectively suppresses the
one-photon autofluorescence background [189]. SRS is also not distorted by a
non-resonant signal that affects CARS, therefore provide an image that in principle
is virtually background free. From the SRS image of the first example, the highest
concentration of CH3 still originates from the lamina propria, lower amounts in the
glandular region and the least in the inner part of the gland forming the lumen of
the crypt. The CARS and SRS images are very similar; any differences are due
to CARS being measured in the epi-direction and SRS in the forwards direction.
There are additional bright pixels at tissue edges and holes in the CARS images.
These effectively act as small scatterers that are able to produce a backwards
generated CARS signal, in addition to the backscattered forward generated CARS
from the rest of the tissue. This is not seen in SRS, as the signal is detected in
the forwards direction.
K-means clustering
Hyperspectral stacks were performed using CARS and SRS over a region from
2800 cm−1 to 3050 cm−1 to interrogate the vibrations predominantly fromCHbonds,
to extract further biochemical information. Following the same procedures as for
Raman, k-means clustering was performed on SRS data. K-means clustering
was not performed on CARS data due to the distorted spectral shape. Figure
6.14 shows a comparison of k-means cluster analysis for a sample measured
using Raman in the hwn region and a contiguous section measured using SRS.
The sample is clustered using 6 clusters. Similar regions can be identified both
in Raman and SRS. Cluster 3 in the Raman and cluster 1 in SRS highlight the
connective tissues surrounding the two glands in the field of view. The epithelial
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cells that form the gland are identified by clusters 1 and 6 in the Raman and
clusters 4 and 6 in SRS. In Raman, the inner gland and potentially the goblet
cells are assigned to cluster 5, with clusters 2 and 4 occupying the rest of the
inside of the gland. Cluster 2 could be identifying a hole in the tissue, as the
centroid spectra appears to be noisy in comparison to the other centroids and
not following the expected tissue peaks. Using SRS on the other hand, cluster
2 is tentatively assigned to the goblet cells, with clusters 3 and 4 making up the
remaining clusters inside the gland. From the dendrograms in the Raman, the
two most similar clusters are 6 and 1 that form parts of the gland; looking at the
mean spectra of the centroids, the spectral similarity of these two clusters is also
apparent. Cluster 2, appears to be different from the other two clusters making
up the inner gland, again suggesting a different structure, possibly a hole. With
comparison to figure 6.13, it can be observed that by using the spectral information
in addition to imaging, additional morphological information can be obtained, as
in the k-means pseudocolour image the connective tissue is able to be separated
from that of the epithelial cells that form the crypt. Cluster 5 represents spectra
with the lowest signal; it is apparent that as the signal reduces, the effect of noise
becomes more significant. This can be seen from the centroid plot of this cluster,
with the bump appearing at the 2930 cm−1 peak. This is emphasised by the vector
normalisation process, which in effect can create a signal, where there otherwise
would not be any to normalise the area under the curve. The mean spectra from
the uncorrect Raman spectra look most similar to that of SRS. This suggest that
some background effects may be present in the sample. Due to the modulated
detection method used in SRS it is unlikely that this background is from stray
light in the sample. The SRS signal is highly directional and coherent and would
overwhelm such signals. There are however, background effects that can occur
in SRS. These include cross-phase modulation, photothermal lensing and two
photon absorption [180].
Both methods demonstrate the ability to distinguish the glandular structure from
the surrounding connective tissue, but each technique has its benefits and limi-
tations. Table 6.3 compares the important measurement parameters for Raman
and SRS. Raman may be slower, but it provides higher quality spectra over a wide
range of wavenumbers and considerably more spectral information than SRS.
SRS, however, is effective for identifying morphological changes more rapidly,
but only at a single wavenumber. From measurements in the hwn region using
spontaneous Raman, it has been shown to be possible to visualise the complex
structure of colon tissues and these images match well to the structures observed
in contiguous histological samples. To measure a region 140x140µm requires 2.5
hours of measurement time for Raman and 15 minutes for SRS. Raman, however,
contains significantly more spectral information over the fp and hwn regions.
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Figure 6.14: Comparison of the results of k-means cluster analysis for normal colon measured using spontaneous Raman in the hwn region with (a) no
baseline correction, (b) baseline correction and (c) using SRS. Raman and SRS are measured using contiguous sections.
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Raman SRS
pixel size 1.4µm 0.59µm
image size 140x140µm 152x152µm
number of pixels per image 100x100 256x256
spectral range 30 cm−1 to 3880 cm−1 2800 cm−1 to 3050 cm−1
wavenumber step size 3.8 cm−1 8.3 cm−1
wavenumbers sampled 1015 30
total pixel dwell time 30 s 3 s
total imaging time 2.5 hrs 15 mins
Table 6.3: Comparision of the various experimental parameters used for spontaneous
Raman and SRS measurements.
6.6 Discussion
In this chapter, the application of Raman and coherent Raman techniques to colon
tissues have been discussed. Raman in the fingerprint region has been demon-
strated to be a good technique for distinguishing different morphological regions
of colon tissues that are of clinical relevance. These include identifying spectral
signatures of the lamina propria, and the inner and outer regions of the crypts that
form the top layer of the colon and where the majority of colonic adenocarcinomas
are found. Distinct peaks corresponding to proteins, collagen and DNA where
found. Raman mapping was also able to replicate the complex morphology seen
in the corresponding H&E images for each of the samples measured. To further
segment the data, k-means clustering was performed. For this data set, seven
clusters was determined to be the optimum number, and baseline subtracted
data produced the best spectral differences. Comparing data with and without a
baseline applied, it was found in general that the effects of the baseline correlated
well with structural features. Consistent spectral trends were found for the three
examples shown.
In addition to the fingerprint region, the hwn region was measured to enable a
direct comparison with data acquired using SRS hyperspectral stacks. There is
considerably less information available in the hwn region, with peaks correspond-
ing to CH vibrations of proteins and lipids. K-means clustering was performed in
the hwn on the same samples previously shown using Raman in the fingerprint
region. Similar morphological features were seen in the pseudocolour images of
clusters as to that in the fingerprint region, and identified glandular from surround-
ing connective tissues. The spectral differences between different morphological
regions of the colon are limited, and it would appear that the biggest differences
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originate from the broad band background. There are differences in the amount of
CH in different regions, but this changes the height of the whole CH region rather
than observing changes in ratios between individual peaks. This is also supported
by the application of a baseline correction to the data after which a fair amount of
the morphological information is lost.
The final comparison was between spontaneous Raman in the hwn region and
SRS. Similar morphological features were identified at the 2930 cm−1 peak cor-
responding to the CH3 symmetric stretch vibration. SRS identified glandular fea-
tures with higher spatial resolution than spontaneous Raman. Fluorescence is
an incoherent process and therefore has a much smaller signal compared to the
amplified coherent SRS signal [67], furthermore SRS is measured as a change
in intensity of the pump beam, rather than a Stokes shifted signal, so effectively
suppresses the one-photon autofluorescence background [189]. The spectra re-
covered from the SRS images, therefore, do not have a baseline that correlates
with any autofluorescence. K-means clustering was performed on SRS samples,
whereby glandular regions were able to be distinguished from the lamina propria.
6.7 Conclusion
Both techniques have shown promise for identification of structural regions of
colon tissues used in the current diagnostic technique and images correlated well
with morphological features able to be seen in the H&E stained sections. SRS
demonstrates higher spatial resolution and faster acquisition times in comparison
to spontaneous Raman.
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CHAPTER 7
Discussion, conclusions and future
perspectives
7.1 Discussion
The aim of this work was to assess the potential for coherent Raman techniques
to provide a method of rapid diagnosis for cancers that occur in the gastroin-
testinal (GI) tract. As coherent Raman probes inherent molecular vibrations, this
technique is particularly suited to biological applications, as it is label-free, non-
invasive and provides an enhancement in the inherently weak Raman signal.
This offers a significant reduction in measurement times. This work focused on
the spectral signatures and morphological information from both spontaneous
and coherent Raman techniques, from two different tissues, the oesophagus and
colon.
For Raman to be successful as a potential clinical tool, it is important to consider
the requirements of the end user, in this case a pathologist. A Raman spec-
trum offers a less subjective approach to diagnosis, using models such as PCA-
LDA to aid classification, however, to a pathologist who is not knowledgeable in
spectroscopy, it may not be clear how a diagnosis is being determined. Current
pathological decisions are made based on visual interpretations of morphological
features from tissues. Integrating new techniques into the clinic may be less
challenging if they enabled trained pathologists to make a diagnosis by a familiar
means, but offered a reduction in patient waiting times by removing the need
for sectioning and staining of biopsies, required currently for histological sample
preparation. Coherent Raman has the potential to fulfil these criteria. However, it
may still be beneficial to utilise both spectral and spatial information. Coherent Ra-
man is able to provide spatial information based on chemical contrasts in tissues,
in several seconds, however, performing a hyperspectral stack to gain spectral
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information significantly increase measurement times. Spontaneous Raman, on
the other hand, is able to provide a spectrum in less than a minute. Combining
spontaneous Raman and coherent Raman in one systemmay provide the answer
for rapid spatial and spectral information, to locate suspicious regions of tissues
using imaging and then if needed acquire a spectral comparison. Such techniques
have been discussed in the literature [190].
Another application may be to use Raman techniques as an initial screening pro-
cess, in an attempt to reduce the number of samples looked at by pathologists, to
rapidly separate the normal from diseased tissue. Raman has been shown to have
a high sensitivity and specificity for distinguishing between normal and cancerous
tissues. For oesophageal adenocarcinoma the biggest spectral changes can
be identified between normal tissues and all other pathologies, it may therefore
offer a method of identifying normal tissues and excluding them. For Barrett’s
oesophagus (BO) surveillance programs especially, large numbers of tissue biop-
sies are removed, the majority are pathologically normal, so by excluding these,
pathologists would potentially be able to spend more time focusing on the higher
risk, more complex, dysplastic samples.
As coherent Raman is still emerging as a clinical technique, large scale studies,
with large sample numbers, are somewhat lacking. Such studies to look at repro-
ducibility are essential to be able to continue to implement coherent Raman tech-
niques into a clinical setting. One of the major drawbacks of stimulated Raman
scattering (SRS) are the high initial costs of equipment, as currently expensive
pulsed lasers are necessary. Furthermore, the current set-up has a large physical
footprint that requires an optical bench several metres long. The complexity of
the current bench top system is such that they require highly trained users. In its
current state, this is clearly not suitable for clinical translation. Methods to improve
the appeal of coherent Raman have included encasing the system in a portable
box [191], this reduces the physical footprint and includes auto-alignment, that
minimise the overall complexity of the system for the user. Other methods include
using cheaper components, such as low-cost continuous wave lasers to produce
SRS signals [192,193].
For the experiments presented here the variability of the coherent Raman set-up
on a day to day basis was one of the main limitations. There will be inherent
variations within tissues and from patient to patient, so instrumental variations
need to be minimised. The alignment of the system determines the quality of
the SRS signal. The highest signal to background ratio is always trying to be
achieved. The SRS system needs to be relatively stable and the signal needs to
be reproducible to measure the subtle spectral changes that have been identified
using spontaneous Raman. Care is needed, to avoid various imaging artefacts
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that arise, primarily due to system alignment. These can reduce the overall quality
of the SRS images and hence the extracted spectral quality. These artefacts
are not always apparent when measuring the images, but can be noted post
measurement, during analysis. These can include uneven illumination across
the image, as a result of condenser alignment and beam collimation. This was
noted to be most apparent when performing cluster analysis, as areas with better
laser illumination had a better signal to background and can result in clustering
according to signal to background rather than spectral differences.
(a) Stimulated Raman scattering
(b) Cross-phase modulation
(c) Photothermal lensing
Figure 7.1: Imaging artefacts that can occur
in SRS measurements. Energy diagrams and
spectral responses for (a) Stimulated Raman
scattering, (b) cross-phase modulation and (c)
photothermal lensing. Figure from reference
[180]
Although one of the advantages
of using SRS over coherent anti-
Stokes Raman scattering (CARS)
is the absence of a nonresonant
background, SRS is not completely
background free. Recall from sec-
tion 3.4, the SRS signal is detected
as a loss of pump photons, at
the modulation frequency of the
Stokes beam. Optical processes
that also result in the absorption
of a pump photon, or occur at
the same modulation frequency as
the Stokes beam, can be recorded
by the lock-in amplifier (LIA), in
addition to the actual SRS signal.
Such effects include, two-photon
absorption, photo-thermal lensing
and cross-phase modulation [133,
180]. Figure 7.1, illustrates the response as a function of wavelength for photo-
thermal lensing and cross-phase modulation. As can be observed from the figure,
unlike SRS, these effects don’t have a dependence on the Raman resonance
and are therefore, wavelength independent. They result in a relatively constant
background. During measurements at Raman resonances, these effects are
not always apparent, but can be observed during a hyperspectral stack. For
two-photon absorption, there must be molecules in the sample that absorb
photons at the pump wavelength. One such absorber, strong in the visible
range, is haemoglobin, found in red blood cells. Haemoglobin is a chromophore,
so absorbs photons, but without fluoresence emission [85], it is the main
chromophore that absorbs in the visible range, in the oesophagus. This may be
able to identify increasing vasculature associated with tumour development, but
this may also act as a limitation for future applications of SRS in vivo [135,194].
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Figure 7.2: A summary of different Raman
techniques detailing their spectral content vs
acquisition time. Figure from reference [150].
This work has highlighted a need
for rapid, full spectrum SRS to
include the fingerprint region. For
applications of coherent Raman of
the oesophagus this is critical, as
it appears that spectral differences
that are of diagnostic importance,
are in the chemical rich, fingerprint
region. The current SRS system is
limited to measurements in the hwn
region as peaks in the fingerprint
region are less abundant and less
polarisable [66] and the speed of
hyperspectral measurements is fun-
damentally limited by the speed at
which the OPO is able to be tuned. Access to chemical information provided in
the fingerprint region is currently below the sensitivity limit of the system and can’t
be detected above the laser noise. Other SRS systems have been used in the
fingerprint region, as imaging techniques, measuring at single wavenumbers [65].
The cumbersome tuning method for the SRS system fundamentally limits the
speed at which a hyperspectral stack can be acquired. The coherent Raman
set-up described here uses two narrowband picosecond lasers to excite a small
part of the Raman spectrum, approximately 10 cm−1 in width, that equates to the
spectral resolution of the system. Spectral information is acquired by sequential,
frequency-scanning of the pump beam, across the desired spectral range. This
is time consuming and hyperspectral SRS typically cover a spectral range of up
to 300 cm−1, in the high wavenumber (hwn) region. Measurement in this way for
much larger ranges, such as those sufficient to cover the whole fingerprint region
are just impractical, with regards to measurement times. Alternative methods
that offer more rapid tuning have been developed [144] and such systems can
now achieve 91 spectral images in less than 10 s. However, they still have
a limited spectral range. Another approach has been to use more broadband,
femtosecond (fs) lasers, to achieve larger spectral ranges, without the need for
wavelength tuning [195]. Spectral ranges of up to 500 cm−1 to 3500 cm−1, have
been reported for broadband CARS (BCARS) [68,196], that provide access to the
fingerprint region. However, CARS techniques are still fundamentally limited by
a nonresonant background that results in a distorted spectral line shape and has
the potential to shift peak positions. Broadband techniques originally applied to
CARS spectroscopy are now being applied to SRS. SRS multiplexing uses a fs
laser to allow multiple Raman bands to be measured simultaneously [197, 198].
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This allows rapid imaging of multiple spectral peaks simultaneously, but does
not provide a SRS spectrum. This is still an imaging based method. Spectral
CARS and SRS are still emerging as techniques. Figure 7.2 from reference [150],
summarises some of the spectroscopic CARS and SRS techniques in terms of
their spectral range and imaging speeds, included also is spontaneous Raman.
More progress has been made with spectral CARS, in an attempt to overcome
the nonresonant background, and spectral SRS is still very much in it’s infancy.
Emerging techniques for spectroscopic SRS include, spectral focusing [199]
and Broadband SRS [200], which has reported a spectral range of 750 cm−1 to
3150 cm−1. Further evolution of these techniques are needed to provide rapid full
spectrum SRS, suitable for clinical applications.
7.2 Conclusions
The principal aim of this thesis was to explore the potential for coherent Raman
techniques, primarily SRS, to provide more rapid spectral and spatial information
of GI tract tissues, in comparison to that of spontaneous Raman. Comparisons
were made of the CH stretching region in the high wavenumbers, from 2800 cm−1
to 3050 cm−1. Spectral data in the hwn, were used to build disease discrimina-
tion models, using a principal components analysis (PCA) fed linear discriminant
analysis (LDA) approach, for the four main pathology groups, associated with
oesophageal adenocarcinoma, which are, normal, BO, dysplasia and adenocar-
cinoma (cancer). Further comparisons were made to spontaneous Raman in the
fingerprint region from 450 cm−1 to 1850 cm−1.
It was concluded that the best discrimination was able to be achieved using spon-
taneous Raman in the fingerprint region, for a two group model (normal vs. can-
cer), representing the two pathological extremes. This resulted in a sensitivity of
94% and a specificity of 81%. Lower sensitivities and specificities were reported
for spontaneous Raman in the hwn region, with 86% and 66% respectively. The
worst performance was from hyperspectral SRS, with a sensitivity of 65% and
specificity of 53%. In the fingerprint region, the most significant spectral differ-
ences, between normal tissues and the other pathologies, arise from the presence
of higher levels of glycogen in normal tissues. Minimal spectral differences were
seen between different pathology groups in the hwn region. The biggest difference
derived from the shape of the background, which is suspected to allude tomorpho-
logical rather than chemical information from the tissues, as a result of different
scattering backgrounds and may have provided some diagnostic information to
the PCA-LDAmodel for discrimination. Overall spectral changes in the hwn region
proved to be insufficient for discrimination.
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Throughout this work, CARS and SRS, have been shown to be rapid techniques,
capable of imaging morphological details of tissues that resemble that of haema-
toxylin and eosin (H&E) stained samples, for both oesophageal and colon tissues.
Whole sections of tissues millimetres in width, were able to be measured using
SRS in under 25 minutes, at the 2930 cm−1 peak, primarily associated with the
CH3 symmetric stretch vibration of proteins. For the colon, this meant that SRS
imaging was able to distinguish with sub-micron resolution, structural features
such as the columnar epithelium that make up the glands and surrounding lamina
propria, useful for the diagnosis of colonic cancers.
The main limitations of this study were the restrictions to the hwn region, due
to the sensitivity of the SRS system and slow methods of wavelength tuning.
Furthermore, SRS measurements were hindered by the unreliable stability of
the many components that make up the coherent Raman system and complex
alignment, which consequently affect the reproducibility of large, long term tissue
studies. It is apparent that the system described here for hyperspectral SRS is
currently limited to measurements in the hwn region, going forward there is a need
for a rapid full spectrum SRS that is able to measure in the fingerprint region, to
access the diagnostically significant information there.
7.3 Future perspectives
The oesophageal results presented here represent a small initial study to assess
the viability of the hwn region and hyperspectral SRS for pathological discrimina-
tion of oesophageal adenocarcinoma. Therefore, the sample size is limited. Any
further studies to be more statistically significant require much larger sample num-
bers from all pathology groups. Ideally, these should also have consensus pathol-
ogy to ensure that the discrimination model is being trained using the best possible
pathology decisions for the current ‘gold standard’, which has been shown to
increase the performance of classification models [9]. However, from the work
discussed here, it is apparent that from this small sample set there is little or no
spectral changes of diagnostic significance in the hwn region for the oesophagus,
which was observed both using spontaneous Raman and hyperspectral SRS.
To pursue applications of the hwn region using hyperspectral SRS, future exper-
iments may consider different tissues types that are known to exhibit a transition
from more lipid rich to more protein rich structures, during cancer progression
such as in brain and breast cancers [201]. Changes in the ratios of CH2 peak to
CH3 may then be able to be used as diagnostic markers. Others have performed
measurements using Raman in the high wavenumber region in-vivo on tissues
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such as the cervix [202], mouth [107] and larynx [92]. For cancers of the cervix
and mouth, the spectral range was increased to include the OH vibrations from
water (3400 cm−1 to 3600 cm−1). Changes in the water content between normal
and cancerous tissues was found to be a major diagnostic marker. Such changes
were not able to be identified in samples used here, which were snap frozen and
dried. It would therefore be of interest to measure oesophageal tissues in the high
wavenumber region in-vivo, using an endoscopic Raman probe to see if these
changes are observable in these tissues too.
Due to spontaneous Raman instrument availability and the considerable amount
of time required for Raman mapping, acquisition times were selected to provide a
sufficient signal to noise for the desired mapping area, in the shortest time frame.
For all measurements in this thesis, there is a trade-off between the time taken
for measurements and the signal to noise of the spectrum. The acquisition time
was chosen as it produced results in the fingerprint region that were able to be
analysed using PCA; however, in the hwn region, the sensitivity of the CCD is
much lower, and spectra in this region may have required significantly longer
acquisition times. It may also be of value to repeat experiments using a diffraction
grating with a higher spectral resolution, which was not available at the time of
these experiments, using longer measurement times to see if there are any subtle
changes that may have been masked by the low signal to noise and poor quantum
efficiency of the CCD in this region.
The sensitivity of SRS, in theory should surpass that of CARS, due to the absence
of the nonresonant background; however, this was not observed on the SRS
instrument used for measurements in this thesis. The laser noise on the SRS
signal limits the scanning speeds that are able to be achieved. According to the
literature, SRS is capable of video rate imaging [143], but this is achieved using
home built lock-in amplifiers and alternative tuning methods to an OPO, which
inherently limits the speeds at which samples can be imaged.
It has been demonstrated in this thesis that, in the oesophagus, the spectral infor-
mation for disease discrimination is present in the fingerprint region. Therefore,
hyperspectral measurements using SRS in this region may prove to be beneficial
for a more rapid spectral diagnosis. This is currently limited by the sensitivity of
the current system. Others have demonstrated measurements in the fingerprint
region using coherent Raman at single wavenumbers [203], rather than producing
a SRS spectrum. Once the desired sensitivity is achieved, experiments would
need to be conducted to ensure that the bandwidth of the laser is sufficient to be
able to resolve the sharper peaks in the fingerprint region. It may however, be
that broadband SRS techniques are required instead.
Coherent Raman techniques have been shown throughout this thesis to demon-
165
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strate excellent sub-cellular resolution images of the morphology of tissues. As
a result of the phase matching conditions, coherent Raman has inherent optical
sectioning capabilities, which can be utilised to produce three dimensional images
of unstained whole biopsies, such as those removed from the oesophagus and
colon, therefore, reducing tissue preparation even further. Images are able to
be produced up to depths of 500µm, which is enough to be able to identify any
potential invasions into themucosa. Only epi-CARSwas available on the coherent
Raman system, but the implementation of epi-SRS may be useful for thicker
samples.
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[76] S. Koljenović, T. C. Bakker Schut, R. Wolthuis, B. de Jong, L. Santos, P. J.
Caspers, J. M. Kros, and G. J. Puppels, “Tissue characterization using high
wave number Raman spectroscopy,” Journal of Biomedical Optics, vol. 10,
no. 3, p. 031116, 2005. 40, 41, 43, 133
[77] I. Barman, N. C. Dingari, A. Saha, S. McGee, L. H. Galindo, W. Liu,
D. Plecha, N. Klein, R. R. Dasari, andM. Fitzmaurice, “Application of Raman
spectroscopy to identify microcalcifications and underlying breast lesions
at Stereotactic core needle biopsy,” Cancer Research, vol. 73, no. 11,
pp. 3206–3215, 2013. 40
[78] A. S. Haka, K. E. Shafer-Peltier, M. Fitzmaurice, J. Crowe, R. R. Dasari, and
M. S. Feld, “Identifying microcalcifications in benign and malignant breast
lesions by probing differences in their chemical composition using Raman
spectroscopy,” Cancer Res, vol. 62, no. 18, pp. 5375–5380, 2002. 40
[79] B. Brozek-Pluska, M. Kopec, I. Niedzwiecka, and A. Morawiec-Sztandera,
“Label-free determination of lipid composition and secondary protein
structure of human salivary noncancerous and cancerous tissues by Raman
microspectroscopy,” The Analyst, vol. 140, no. 7, pp. 2107–2113, 2015. 40,
43
[80] N. Magee, J. Villaumie, E. Marple, M. Ennis, J. Elborn, and J. McGarvey,
“Ex vivo diagnosis of lung cancer using a Raman miniprobe,” The Journal
of Physical Chemistry B, vol. 113, no. 23, pp. 8137–8141, 2009. 40
174
[81] G. R. Lloyd, L. E. Orr, J. Christie-Brown, K. McCarthy, S. Rose,
M. Thomas, and N. Stone, “Discrimination between benign, primary and
secondary malignancies in lymph nodes from the head and neck utilising
Raman spectroscopy and multivariate analysis,” Analyst, vol. 138, no. 14,
pp. 3900–3908, 2013. 40
[82] J. Wang, K. Lin, W. Zheng, K. Y. Ho, M. Teh, K. G. Yeoh, and
Z. Huang, “Simultaneous fingerprint and high-wavenumber fiber-optic
Raman spectroscopy improved in vivo diagnosis of esophageal squamous
cell carcinoma at endoscopy,” Scientific Reports, vol. 5, no. 12957, 2015.
40, 43
[83] A. Molckovsky, L. M. Wong Kee Song, M. G. Shim, N. E. Marcon, and
B. C. Wilson, “Diagnostic potential of near-infrared Raman spectroscopy
in the colon: Differentiating adenomatous from hyperplastic polyps,”
Gastrointestinal Endoscopy, vol. 57, no. 3, pp. 396–402, 2003. 40
[84] M. S. Bergholt, W. Zheng, K. Lin, J. Wang, H. Xu, J. L. Ren, K. Y. Ho, M. Teh,
K. G. Yeoh, and Z. Huang, “Characterizing variability of in vivo Raman
spectroscopic properties of different anatomical sites of normal colorectal
tissue towards cancer diagnosis at colonoscopy,” Analytical Chemistry,
vol. 87, no. 2, pp. 960–966, 2015. 40
[85] M. Kara, R. S. DeCosta, B. C. Wilson, N. E. Marcon, and J. Bergman,
“Autofluorescence-Based Detection of Early Neoplasia in Patients with
Barrett ’ s Esophagus,” Digestive diseases, vol. 22, pp. 134–141, 2004.
40, 102, 161
[86] S. M. Wildi and M. B. Wallace, Barrett’s esophagus and esophageal
adenocarcinoma. Blackwell publishing Ltd., 2006. 40
[87] E. Borisova, L. Plamenova, M. Keremedchiev, B. Vladimirov, and
L. Avramov, “Endogenous and exogenous fluorescence of gastrointesti-
nal tumors: initial clinical observations,” in Proc. SPIE, vol. 8770,
pp. 87701C–87701C–9, 2013. 40
[88] J. Hutchings, C. Kendall, B. Smith, N. Shepherd, H. Barr, and N. Stone,
“The potential for histological screening using a combination of rapid Raman
mapping and principal component analysis,” Journal of biophotonics, vol. 2,
no. 1-2, pp. 91–103, 2009. 41, 42
[89] L. M. Wong Kee Song, A. Molckovsky, K. K. Wang, L. J. Burgart,
B. Dolenko, R. L. Somorjai, and B. C. Wilson, “Diagnostic potential of
Raman spectroscopy in Barrett’s esophagus,” Proc. SPIE 5692, Advanced
175
References
Biomedical and Clinical Diagnostic Systems III, vol. 5692, pp. 140–146,
2005. 41
[90] C. Krafft, A. Ramoji, Anuradha, C. Bielecki, N. Vogler, T. Meyer, D. Akimov,
P. Rösch, M. Schmitt, B. Dietzek, I. Petersen, A. Stallmach, and J. Popp,
“A comparative Raman and CARS imaging study of colon tissue,” Journal
of biophotonics, vol. 2, no. 5, pp. 303–12, 2009. 41, 45
[91] T. C. B. Schut, N. Stone, C. A. Kendall, H. Barr, H. A. Bruining, and G. J.
Puppels, “Progress in the detection of neoplastic progress and cancer
by Raman spectroscopy,” BiOS 2000 The International Symposium on
Biomedical Optics, vol. 3918, pp. 106–113, 2000. 41
[92] K. Lin, D. L. P. Cheng, and Z. Huang, “Optical diagnosis of laryngeal
cancer using high wavenumber Raman spectroscopy,” Biosensors and
Bioelectronics, vol. 35, no. 1, pp. 213–217, 2012. 41, 43, 165
[93] G. R. Lloyd, J. Hutchings, L. M. Almond, H. Barr, C. Kendall, and N. Stone,
“Assessing the performance of spectroscopic models for cancer diagnostics
using cross-validation and permutation testing,” in Proc. SPIE, vol. 8219,
pp. 82190C–82190C–6, 2012. 41
[94] T. C. Bakker Schut, M. J. H. Witjes, H. J. C. M. Sterenborg, O. C. Speelman,
J. L. N. Roodenburg, E. T. Marple, H. A. Bruining, and G. J. Puppels, “In vivo
detection of dysplastic tissue by raman spectroscopy,” Analytical Chemistry,
vol. 72, no. 24, pp. 6010–6018, 2000. 41
[95] M. S. Bergholt, W. Zheng, K. Lin, K. Y. Ho, M. Teh, K. G. Yeoh, J. B. So,
and Z. Huang, “In vivo diagnosis of esophageal cancer using image-guided
Raman endoscopy and biomolecular modeling,” Technology in cancer
research & treatment, vol. 10, no. 2, pp. 103–12, 2011. 41, 43
[96] M. J. Baker, G. D. Sockalingum, C. Hughes, and R. A. Lukaszewski,
“Developing and understanding biofluid vibrational spectroscopy: a critical
review,” Chem. Soc. Rev., vol. 45, pp. 1803–1818, 2016. 42
[97] J. Pichardo-Molina, C. Frausto-Reyes, O. Barbosa-Garcìa, R. Huerta-
Franco, J. Gonzàlez-Trujillo, C. Ramìrez-Alvarado, G. Gutièrrez-Juàrez,
and C. Medina-Gutièrrez, “Raman spectroscopy and multivariate analysis
of serum samples from breast cancer patients,” Lasers in medical science,
vol. 22, pp. 229–236, 2007. 42
[98] X. Li, T. Yang, and S. Li, “Discrimination of serum raman spectroscopy
between normal and colorectal cancer using selected parameters and
176
regression-discriminant analysis,” Applied Optics, vol. 51, pp. 5038–5043,
Jul 2012. 42
[99] J. L. González-Solís, J. C. Martínez-Espinosa, L. A. Torres González,
A. Aguilar-Lemarroy, L. F. Jave-Suárez, and P. Palomares-Anda, “Cervical
cancer detection based on serum sample raman spectroscopy,” Lasers in
Medical Science, vol. 29, no. 3, pp. 979–985, 2014. 42
[100] A. Sahu, S. Sawant, H. Mamgain, and C. M. Krishna, “Raman spectroscopy
of serum: an exploratory study for detection of oral cancers,” Analyst,
vol. 138, pp. 4161–4174, 2013. 42
[101] A. Shapiro, O. N. Gofrit, G. Pizov, J. K. Cohen, and J. Maier, “Raman
molecular imaging: A novel spectroscopic technique for diagnosis of
bladder cancer in urine specimens,” European Urology, vol. 59, no. 1,
pp. 106 – 112, 2011. 42
[102] B. Elumalai, A. Prakasarao, B. Ganesan, K. Dornadula, and S. Ganesan,
“Raman spectroscopic characterization of urine of normal and oral cancer
subjects,” Journal of Raman Spectroscopy, vol. 46, no. 1, pp. 84–93, 2015.
42
[103] N. D. Magee, R. J. Beattie, R. Gray, M. Imrie, M. Ennis, J. McGarvey,
and E. J. S, “Raman spectroscopy analysis of induced sputum in lung
cancer,” American journal of respiratory and critical care medicine, vol. 181,
p. A3492, 2010. 42
[104] L. M. Almond, J. Hutchings, G. Lloyd, H. Barr, N. Shepherd, J. Day,
O. Stevens, S. Sanders, M. Wadley, N. Stone, and C. Kendall, “Endoscopic
Raman spectroscopy enables objective diagnosis of dysplasia in Barrett’s
esophagus,” Gastrointestinal Endoscopy, vol. 79, no. 1, pp. 37–45, 2014.
42
[105] M. S. Bergholt, W. Zheng, K. Y. Ho, M. Teh, K. G. Yeoh, J. B. Yan
So, A. Shabbir, and Z. Huang, “Fiberoptic confocal raman spectroscopy
for real-time in vivo diagnosis of dysplasia in Barrett’s esophagus,”
Gastroenterology, vol. 146, no. 1, pp. 27–32, 2014. 42, 43
[106] R. J. Badreddine and K. K. Wang, “Barrett esophagus: an update,” Nature
reviews gastroenterology and hepatology, no. 7, pp. 369–378, 2010. 42
[107] E. M. Barroso, R. W. H. Smits, T. C. B. Schut, I. Ten Hove, J. A. Hardillo,
E. B. Wolvius, R. J. Baatenburg De Jong, S. Koljenovic, and G. J. Puppels,
“Discrimination between oral cancer and healthy tissue based on water
177
References
content determined by Raman spectroscopy,” Analytical Chemistry, vol. 87,
no. 4, pp. 2419–2426, 2015. 43, 165
[108] P. Maker and R. Terhune, “Study of optical effects due to an induced
polarization third order in the electric field strength,” Physical Review,
vol. 137, no. 3A, pp. A801–A818, 1965. 44
[109] M. Duncan, J. Reintjes, and T. Manuccia, “Scanning coherent anti-Stokes
Raman microscope,” Optics letters, vol. 7, no. 8, pp. 350–352, 1982. 44
[110] A. Zumbusch, G. Holtom, and X. Xie, “Three-dimensional vibrational
imaging by coherent anti-Stokes Raman scattering,” Physical Review
Letters, vol. 82, no. 20, pp. 4142–4145, 1999. 44, 127
[111] J. Cheng, A. Volkmer, L. D. Book, and X. S. Xie, “An epi-detected coherent
anti-Stokes Raman scattering (E-CARS) microscope with high spectral
resolution and high sensitivity,” The Journal of Physical Chemistry B,
vol. 105, no. 7, pp. 1277–1280, 2001. 44, 57
[112] C. Evans, E. Potma, M. Puoris’haag, D. Cote, C. Lin, and X. Xie, “Chemical
imaging of tissue in vivo with video-rate coherent anti-Stokes Raman
scattering microscopy,” PNAS, vol. 102, no. 46, pp. 16807–16812, 2005.
45, 57
[113] Y. Yang, F. Li, L. Gao, Z. Wang, M. Thrall, S. Shen, K. Wong, and S. Wong,
“Differential diagnosis of breast cancer using quantitative, label-free and
molecular vibrational imaging,” Biomedical optics express, vol. 2, no. 8,
pp. 2160–2174, 2011. 45
[114] L. Gao, F. Li, M. J. Thrall, Y. Yang, J. Xing, A. a. Hammoudi, H. Zhao,
Y. Massoud, P. T. Cagle, Y. Fan, K. K. Wong, Z. Wang, and S. T. C.
Wong, “On-the-spot lung cancer differential diagnosis by label-free,
molecular vibrational imaging and knowledge-based classification,” Journal
of biomedical optics, vol. 16, no. 9, pp. 096004 1–10, 2011. 45
[115] T. Meyer, M. Baumgartl, T. Gottschall, T. T. Pascher, A. Wuttig, C. Matthäus,
B. F. M. Romeike, B. R. Brehm, J. Limpert, A. Tünnermann, O. Guntinas-
Lichius, B. Dietzek, M. Schmitt, J. Popp, and C. Matthaus, “A compact
microscope setup for multimodal nonlinear imaging in clinics and its
application to disease diagnostics,” Analyst, vol. 138, pp. 4048–4057, jul
2013. 45
[116] L. Gao, H. Zhou, M. Thrall, F. Li, Y. Yang, Z. Wang, P. Luo, K. K.
Wong, G. s. Palapattu, and S. T. C. Wong, “Label-free high-resolution
178
imaging of prostate glands and cavernous nerves using coherent anti-
Stokes Raman scattering microscopy,” Biomedical optics express, vol. 2,
no. 4, pp. 915–926, 2011. 45
[117] K. König, H. Breunig, R. Bückle, M. Kellner-Höfer, M. Weinigel, E. Büttner,
W. Sterry, and J. Lademann, “Optical skin biopsies by clinical CARS and
multiphoton fluorescence/SHG tomography,” Laser Physics Letters, vol. 8,
pp. 465–468, jun 2011. 45
[118] S. Heuke, N. Vogler, T. Meyer, D. Akimov, F. Kluschke, H.-J. Röwert-Huber,
J. Lademann, B. Dietzek, and J. Popp, “Detection and Discrimination of
Non-Melanoma Skin Cancer by Multimodal Imaging,” Healthcare, vol. 1,
no. 1, pp. 64–83, 2013. 45
[119] T. Meyer, O. GuntinasLichius, F. Eggeling, G. Ernst, D. Akimov, M. Schmitt,
B. Dietzek, and J. Popp, “Multimodal nonlinear microscopic investigations
on head and neck squamous cell carcinoma: Toward intraoperative
imaging,” Head & Neck, vol. 35, no. 9, pp. E280–E287, 2013. 45
[120] M. Weinigel, H. G. Breunig, M. Kellner-Höfer, R. Bückle, M. E. Darvin,
M. Klemp, J. Lademann, and K. König, “In vivo histology: optical biopsies
with chemical contrast using clinical multiphoton/coherent anti-Stokes
Raman scattering tomography,” Laser Physics Letters, vol. 11, p. 055601,
may 2014. 45
[121] T. Huff and J. Cheng, “In vivo coherent anti-Stokes Raman scattering
imaging of sciatic nerve tissue,” Journal of microscopy, vol. 225, no. Pt 2,
pp. 175–182, 2007. 45
[122] X. Nan, E. Potma, and X. Xie, “Nonperturbative chemical imaging of
organelle transport in living cells with coherent anti-stokes Raman scattering
microscopy.,” Biophysical journal, vol. 91, pp. 728–35, jul 2006. 45
[123] S. F. El-Mashtoly, D. Niedieker, D. Petersen, S. D. Krauss, E. Freier,
A. Maghnouj, A. Mosig, S. Hahn, C. Kötting, and K. Gerwert, “Automated
identification of subcellular organelles by coherent anti-stokes Raman
scattering.,” Biophysical journal, vol. 106, pp. 1910–20, may 2014. 45
[124] C. Evans and X. Xie, “Coherent anti-stokes raman scattering microscopy:
chemical imaging for biology and medicine,” Annual review of analytical
chemistry, vol. 1, pp. 883–909, 2008. 45, 58
[125] E. M. Vartiainen, “Phase retrieval approach for coherent anti-stokes raman
scattering spectrum analysis,” J. Opt. Soc. Am. B, vol. 9, pp. 1209–1214,
Aug 1992. 45
179
References
[126] Y. Liu, Y. J. Lee, and M. T. Cicerone, “Broadband cars spectral phase
retrieval using a time-domain kramers–kronig transform,” Opt. Lett., vol. 34,
pp. 1363–1365, May 2009. 45
[127] F. Ganikhanov, C. L. Evans, B. G. Saar, and X. S. Xie, “High-sensitivity
vibrational imaging with frequency modulation coherent anti-stokes raman
scattering (fm cars) microscopy,” Opt. Lett., vol. 31, pp. 1872–1874, Jun
2006. 45
[128] M. Jurna, J. Korterik, C. Otto, J. Herek, and H. Offerhaus, “Background free
cars imaging by phase sensitive heterodyne cars,” Opt. Express, vol. 16,
pp. 15863–15869, Sep 2008. 45
[129] K. Knutsen, J. Johnson, A. Miller, P. Petersen, and R. Saykally, “High
spectral resolution multiplex {CARS} spectroscopy using chirped pulses,”
Chemical Physics Letters, vol. 387, no. 4–6, pp. 436 – 441, 2004. 45
[130] E. Woodbury and W. Ng, “Ruby laser operation in near IR,” Proceedings of
the IRE, vol. 50, no. 11, p. 2367, 1962. 46
[131] C. W. Freudiger, W. Min, B. G. Saar, S. Lu, G. R. Holtom, C. He, J. C.
Tsai, J. X. Kang, and X. S. Xie, “Label-free biomedical imaging with high
sensitivity by stimulated Raman scattering microscopy,” Science, vol. 322,
pp. 1857–1861, 2008. 46, 47
[132] P. Nandakumar, a. Kovalev, and a. Volkmer, “Vibrational imaging based on
stimulated Raman scattering microscopy,” New Journal of Physics, vol. 11,
no. 3, p. 033026, 2009. 46, 127
[133] I. W. Schie, C. Krafft, and J. Popp, “Applications of coherent Raman
scattering microscopies to clinical and biological studies,” The Analyst,
vol. 140, no. 12, pp. 3897–3909, 2015. 46, 47, 161
[134] Y. Ozeki, F. Dake, S. Kajiyama, K. Fukui, and K. Itoh, “Analysis and
experimental assessment of the sensitivity of stimulated Raman scattering
microscopy,” Optics express, vol. 17, no. 5, pp. 3651–8, 2009. 46, 127
[135] C. W. Freudiger, R. Pfannl, D. A. Orringer, B. G. Saar, M. Ji, Q. Zeng,
L. Ottoboni, Y. Wei, W. Ying, C. Waeber, J. R. Sims, P. L. De Jager,
O. Sagher, M. A. Philbert, X. Xu, S. Kesari, X. S. Xie, and G. S. Young,
“Multicolored stain-free histopathology with coherent Raman imaging,”
Laboratory investigation; a journal of technical methods and pathology,
vol. 92, no. 10, pp. 1492–502, 2012. 46, 161
180
[136] M. Ji, D. A. Orringer, C. W. Freudiger, S. Ramkissoon, X. Liu, D. Lau,
A. J. Golby, I. Norton, M. Hayashi, N. Y. R. Agar, G. S. Young, C. Spino,
S. Santagata, S. Camelo-Piragua, K. L. Ligon, O. Sagher, and X. S.
Xie, “Rapid, label-free detection of brain tumors with stimulated Raman
scattering microscopy,” Science translational medicine, vol. 5, no. 201,
p. 201ra119, 2013. 46, 133
[137] J. N. Bentley, M. Ji, X. S. Xie, and D. A. Orringer, “Real-time image guidance
for brain tumor surgery through stimulated Raman scattering microscopy,”
Expert review of anticancer therapy, vol. 14, no. 4, pp. 359–61, 2014. 46
[138] M. Ji, S. Lewis, S. Camelo-Piragua, S. H. Ramkissoon, M. Snuderl,
S. Venneti, A. Fisher-Hubbard, M. Garrard, D. Fu, A. C. Wang,
J. A. Heth, C. O. Maher, N. Sanai, T. D. Johnson, C. W. Freudiger,
O. Sagher, X. S. Xie, and D. A. Orringer, “Detection of human brain
tumor infiltration with quantitative stimulated Raman scattering microscopy,”
Science Translational Medicine, vol. 7, no. 309, 2015. 46, 133
[139] F. Lu, D. Calligaris, O. I. Olubiyi, I. Norton, W. Yang, S. Santagata, X. S.
Xie, A. J. Golby, and N. Y. R. Agar, “Label-free neurosurgical pathology
with stimulated Raman imaging,” Cancer Research, vol. 1962, no. 15,
pp. 3451–3462, 2016. 46
[140] R. Mittal, M. Balu, T. Krasieva, E. O. Potma, L. Elkeeb, C. B. Zachary, and
P. Wilder-Smith, “Evaluation of stimulated raman scattering microscopy for
identifying squamous cell carcinoma in human skin,” Lasers in surgery and
medicine, vol. 45, no. 8, pp. 496–502, 2013. 46
[141] F. K. Lu, S. Basu, V. Igras, M. P. Hoang, M. Ji, D. Fu, G. R. Holtom, V. A.
Neel, C. W. Freudiger, D. E. Fisher, X. S. Xie, A. Victor, C. W. Freudiger,
D. E. Fisher, and X. Sunney, “Label-free DNA imaging in vivo with stimulated
Raman scattering microscopy,” Proceedings of the National Academy of
Sciences, vol. 112, no. 43, pp. E5902–E5902, 2015. 46
[142] Y. Otsuka, S. Satoh, M. Kyogaku, H. Hashimoto, K. Itoh, and Y. Ozeki,
“High-speed stimulated Raman spectral imaging for digital staining of
mouse cancer tissues,” Proc. of SPIE, vol. 8947, p. 89470C, 2014. 46
[143] B. G. Saar, C. W. Freudiger, J. Reichman, C. M. Stanley, G. R. Holtom,
and X. S. Xie, “Video-rate molecular imaging in vivo with stimulated Raman
scattering,” Science (New York, N.Y.), vol. 330, no. 6009, pp. 1368–70,
2010. 47, 165
181
References
[144] Y. Ozeki, W. Umemura, and Y. Otsuka, “High-speed molecular spectral
imaging of tissue with stimulated Raman scattering,” Nature Photonics,
vol. 6, no. December, pp. 845–851, 2012. 47, 127, 162
[145] C. Krafft, B. Dietzek, and J. Popp, “Raman and CARS microspectroscopy
of cells and tissues,” The Analyst, vol. 134, no. 6, pp. 1046–57, 2009. 47
[146] K. Antonio and Z. Schultz, “Advances in biomedical Raman microscopy,”
Analytical chemistry, vol. 86, pp. 30–46, 2013. 47
[147] H. Tu and S. A. Boppart, “Coherent anti-Stokes Raman scattering
microscopy: overcoming technical barriers for clinical translation,” Journal
of biophotonics, vol. 7, no. 1-2, pp. 9–22, 2014. 47
[148] D. Zhang, P. Wang, M. N. Slipchenko, and J.-X. Cheng, “Fast vibrational
imaging of single cells and tissues by stimulated Raman scattering
microscopy,” Accounts of chemical research, vol. 47, no. 8, pp. 2282–90,
2014. 47
[149] M. J. Winterhalder and A. Zumbusch, “Beyond the borders - Biomedical
applications of non-linear Raman microscopy,” Advanced Drug Delivery
Reviews, vol. 89, pp. 135–144, 2015.
[150] C. H. Camp Jr and M. T. Cicerone, “Chemically sensitive bioimaging with
coherent Raman scattering,” Nature Photonics, vol. 9, no. 5, pp. 295–305,
2015. 47, 162, 163
[151] B. R. Masters and P. T. C. So, Biomedical nonlinear optical microscopy.
Oxford university press, 2008. 51, 54, 55, 56, 58
[152] D.J.Gardiner and P.R.Graves, Practical Raman spectroscopy. Springer-
Verlag, 1989. 51
[153] J. Laserna, Modern techniques in raman spectroscopy. John Wiley and
Sons Ltd, 1996. 52
[154] J. Cheng and X. Xie, “Coherent anti-Stokes Raman scattering microscopy:
instrumentation, theory, and applications,” The Journal of Physical
Chemistry B, vol. 108, pp. 827–840, 2004. 54, 58
[155] R. Boyd, Nonlinear optics. Elsevier, 2008. 55
[156] Y. Shen, The principles of nonlinear optics. John Wiley & sons, 1984. 57
[157] A. Alfonso-García, R. Mittal, E. S. Lee, and E. O. Potma, “Biological
imaging with coherent Raman scattering microscopy: a tutorial,” Journal
of biomedical optics, vol. 19, no. 7, p. 71407, 2014. 60
182
[158] G. Schulze, A. Jirasek, M. M. L. Yu, A. Lim, F. B. Turner, and M. W. Blades,
“feature article Investigation of Selected Baseline Removal Techniques as
Candidates for Automated Implementation,” Applied spectroscopy, vol. 59,
no. 5, pp. 545–574, 2005. 72
[159] K. H. Liland, T. Almøy, and B.-h. Mevik, “Optimal choice of baseline
correction for multivariate calibration of spectra,” Applied spectroscopy,
vol. 64, no. 9, pp. 1007–1016, 2010. 72
[160] C. A. Lieber and A. Mahadevan-Jansen, “Automated method for subtraction
of fluorescence from biological raman spectra,” Applied Spectroscopy,
vol. 57, pp. 1363–1367, Nov 2003. 72
[161] N. K. Afseth, V. H. Segtnan, and J. P. Wold, “Raman spectra of biological
samples: A study of preprocessing methods,” Applied Spectroscopy,
vol. 60, no. 12, pp. 1358–1367, 2006. 72
[162] R. Gautam, S. Vanga, F. Ariese, and S. Umapathy, “Review of
multidimensional data processing approaches for raman and infrared
spectroscopy,” EPJ Techniques and Instrumentation, vol. 2, no. 1, p. 8,
2015. 72
[163] P. H. Eilers and H. F. Boelens, “Baseline correction with asymmetric least
squares smoothing,” Leiden University Medical Centre Report, vol. 1, p. 1,
2005. 72
[164] Olympus, “Uplsapo objectives.” url: http://.olympus-lifescience.com/en/ob-
jectives/uplsapo/. Accessed: March 2015. 78
[165] Y. Fu, H. Wang, R. Shi, and J. Cheng, “Characterization of photodamage
in coherent anti-Stokes Raman scattering microscopy,” Optics express,
vol. 14, no. 9, pp. 3942–3951, 2006. 77
[166] T. Vo-Dinh, Laser and optical radiation safety in biophotonics. CRC press,
second ed., 2015. 80
[167] S. Thomsen, “Pathologic analysis of photothermal and photomechanical
effects of laser-tissue interactions,” Photochemistry and Photobiology,
vol. 53, no. 6, pp. 825–835, 1991. 80
[168] B. Everitt and G. Dunn, Applied multivariate data analysis. John Wiley &
sons, 2001. 84
[169] I. Jolliffe, Principal component analysis. Springer, second ed., 2002. 84
[170] P. Sharma and E. I. Sidorenko, “Are screening and surveillance for Barrett’s
oesophagus really worthwhile?,” Gut, vol. 54 Suppl 1, pp. i27–i32, 2005. 91
183
References
[171] A. Watson and J. Galloway, “Heartburn, Barrett’s oesophagus and
cancer: implications for primary care,” British journal of general practice,
pp. 120–121, 2014. 91
[172] S. Li, G. Chen, Y. Zhang, Z. Guo, Z. Liu, J. Xu, X. Li, and L. Lin,
“Identification and characterization of colorectal cancer using Raman
spectroscopy and feature selection techniques,” Optics express, vol. 22,
no. 21, pp. 1720–1725, 2014. 92, 140
[173] A. C. S. Talari, Z. Movasaghi, S. Rehman, and I. U. Rehman, “Raman
Spectroscopy of Biological Tissues,” Applied Spectroscopy Reviews,
vol. 50, no. 1, pp. 46–111, 2014. 93, 136, 140, 147
[174] C. L. Booth and K. S. Thompson, “Barrett’s esophagus: A review of
diagnostic criteria, clinical surveillance practices and new developments,”
Journal of Gastrointestinal Oncology, vol. 3, no. 6, pp. 232–242, 2012. 94
[175] K. Takubo, M. Vieth, G. Aryal, and N. Honma, “Islands of squamous
epithelium and their surrounding mucosa in columnar-lined esophagus:
a pathognomonic feature of Barrett’s esophagus?,” Journal of Human
Pathology, vol. 36, pp. 269–274, 2005. 96
[176] P. Sharma, T. G. Morales, A. Bhattacharyya, H. S. Garewal, and
R. E. Sampliner, “Squamous islands in Barrett’s esophagus: What lies
underneath?,” American Journal of Gastroenterology, vol. 93, no. 3,
pp. 332–335, 1998. 96
[177] D. Wei, S. Chen, and Q. Liu, “Review of fluorescence suppression
techniques in Raman spectroscopy,” Applied Spectroscopy Reviews,
vol. 50, no. 5, pp. 387—-406, 2015. 100, 102
[178] F. Bonnier, A. Mehmood, P. Knief, A. D. Meade, W. Hornebeck, H. Lambkin,
K. Flynn, V. McDonagh, C. Healy, T. C. Lee, and H. J. Byrne, “In
vitro analysis of immersed human tissues by Raman microspectroscopy,”
Journal of Raman spectroscopy, vol. 42, pp. 888–896, 2011. 102
[179] F. Bonnier, S. M. Ali, P. Knief, H. Lambkin, K. Flynn, V. Mcdonagh, C. Healy,
T. C. Lee, F. M. Lyng, and H. J. Byrne, “Vibrational spectroscopy analysis
of human skin tissue by Raman microspectroscopy : Dealing with the
background,” Vibrational Spectroscopy, vol. 61, pp. 124–132, 2012. 102,
116, 132
[180] D. Zhang, M. N. Slipchenko, D. E. Leaird, A. M. Weiner, and J.-x. Cheng,
“Spectrally modulated stimulated Raman scattering imaging with an angle-
184
to-wavelength pulse shaper,” Optics Express, vol. 21, no. 11, p. 13864,
2013. 122, 155, 161
[181] Renishaw, “Raman spectra explained.” url: http://renishaw.com/en/raman-
spectra-explained–25807. Accessed: June 2016. 127
[182] L. Kong, M. Ji, G. R. Holtom, D. Fu, C. W. Freudiger, and X. S. Xie,
“Multicolor stimulated Raman scattering microscopy with a rapidly tunable
optical parametric oscillator,” Optics letters, vol. 38, no. 2, pp. 145–7, 2013.
127
[183] V. Naranjo, E. Villanueva, G. R. Lloyd, N. Stone, F. López-Mir, and
M. Alcaniz, “Stained and infrared image registration as first step for cancer
detection,” in IEEE-EMBS International Conference on Biomedical and
Health Informatics (BHI), pp. 420–423, June 2014. 131
[184] G. R. Lloyd, L. M. Almond, N. Stone, N. Shepherd, S. Sanders, J. Hutchings,
and C. Kendall, “Utilising non-consensus pathology measurements to
improve the diagnosis of oesophageal cancer using a Raman spectroscopic
probe,” Analyst, vol. 139, pp. 381–388, 2014. 132
[185] C. S. Liao, J. H. Choi, D. Zhang, S. H. Chan, and J. X. Cheng, “Denoising
stimulated Raman spectroscopic images by total variation minimization,”
Journal of Physical Chemistry C, vol. 119, no. 33, pp. 19397–19403, 2015.
133
[186] I. Rimke, G. Hehl, M. Beutler, P. Volz, A. Volkmer, and E. Büttner,
“Tunable dual-wavelength two-picosecond light source for coherent Raman
scattering microscopy,” Proceedings of SPIE, vol. 8948, pp. 894816–1,
2014. 133
[187] F. Lyng, E. Gazi, and P. Gardner, Biomedical Applications of Synchrotron
Infrared Microspectroscopy (Moss, D. ed). Royal Society of Chemistry,
2011. 136
[188] E. O. Faoláin, M. B. Hunter, J. M. Byrne, P. Kelehan, H. a. Lambkin, H. J.
Byrne, and F. M. Lyng, “Raman spectroscopic evaluation of efficacy of
current paraffin wax section dewaxing agents,” The journal of histochemistry
and cytochemistry : official journal of the Histochemistry Society, vol. 53,
no. 1, pp. 121–9, 2005. 136
[189] J. C. Mansfield, G. R. Littlejohn, M. P. Seymour, R. J. Lind, S. Perfect, and
J. Moger, “Label-free chemically specific imaging in planta with stimulated
raman scattering microscopy,” Analytical Chemistry, vol. 85, no. 10,
pp. 5055–5063, 2013. 154, 158
185
References
[190] M. N. Slipchenko, T. T. Le, H. Chen, and J. X. Cheng, “High-speed
vibrational imaging and spectral analysis of lipid bodies by compound
Raman microscopy.,” The journal of physical chemistry. B, vol. 113,
pp. 7681–6, may 2009. 160
[191] S. Saint-Jalm, P. Berto, L. Jullien, E. R. Andresen, and H. Rigneault,
“Rapidly tunable and compact coherent Raman scattering light source for
molecular spectroscopy,” Journal of Raman Spectroscopy, vol. 45, no. 7,
pp. 515–520, 2014. 160
[192] Z. Meng, G. I. Petrov, and V. V. Yakovlev, “Microscopic coherent Raman
imaging using low-cost continuous wave lasers,” Laser Physics Letters,
vol. 10, no. 6, p. 065701, 2013. 160
[193] Z. Meng, G. I. Petrov, and V. V. Yakovlev, “Stimulated Raman microscopy
without ultrafast lasers,” SPIE BiOS, vol. 8588, pp. 858810–858821, 2013.
160
[194] J. Moger, N. L. Garrett, D. Begley, L. Mihoreanu, A. Lalatsa, M. V. Lozano,
M. Mazza, A. Schatzlein, and I. Uchegbu, “Imaging cortical vasculature
with stimulated Raman scattering and two-photon photothermal lensing
microscopy,” Journal of Raman Spectroscopy, vol. 43, pp. 668–674, may
2012. 161
[195] K.Wang, D. Zhang, K. Charan, M. N. Slipchenko, P.Wang, J.-x. Cheng, and
C. Xu, “Spectroscopic SRS imaging with a time-lens source synchronized
to a femtosecond pulse shaper,” in Proc. of SPIE, pp. 85880B 1–6, 2013.
162
[196] S. H. Parekh, Y. J. Lee, K. a. Aamer, and M. T. Cicerone, “Label-free
cellular imaging by broadband coherent anti-Stokes Raman scattering
microscopy.,” Biophysical journal, vol. 99, pp. 2695–704, oct 2010. 162
[197] E. Ploetz, S. Laimgruber, S. Berner, W. Zinth, and P. Gilch, “Femtosecond
stimulated Raman,” Applied Physics B, vol. 87, pp. 389–393, 2007. 162
[198] D. Fu, F.-k. Lu, X. Zhang, C. Freudiger, D. R. Pernik, G. Holtom, and
X. S. Xie, “Quantitative chemical cmaging withmultiplex stimulated Raman,”
Journal of the American Chemical Society, vol. 134, pp. 3623–3626, 2012.
162
[199] E. R. Andresen, P. Berto, and H. Rigneault, “Stimulated Raman scattering
microscopy by spectral focusing and fiber-generated soliton as Stokes
pulse,” Optics letters, vol. 36, no. 13, pp. 2387–2389, 2011. 163
186
[200] S. Karpf, M. Eibl, W. Wieser, T. Klein, and R. Huber, “A Time-Encoded
Technique for fibre-based hyperspectral broadband stimulated Raman
microscopy,” Nature Communications, vol. 6, pp. 1–6, 2015. 163
[201] B. Brozek-Pluska, J. Musial, R. Kordek, E. Bailo, T. Dieing, and
H. Abramczyk, “Raman spectroscopy and imaging: applications in human
breast cancer diagnosis,” The Analyst, vol. 137, no. 16, p. 3773, 2012. 164
[202] J. Mo, W. Zheng, J. J. H. Low, J. Ng, A. Ilancheran, and Z. Huang,
“High Wavenumber Raman Spectroscopy for in Vivo Detection of Cervical
Dysplasia,” Analytical Chemistry, vol. 81, no. 21, pp. 8908–8915, 2009. 165
[203] B. Chen, J. Sung, and S. Lim, “Chemical imaging with frequency
modulation coherent anti-Stokes Raman scattering microscopy at the
vibrational fingerprint region,” The Journal of Physical Chemistry B, vol. 114,
pp. 16871–16880, 2010. 165
187
APPENDIX A
PCA-LDA data
A.1 785 nm vs 830 nm
Data corresponding to results discussed in section 5.4.
Predicted group
Normal Barrett’s Dysplasia Cancer
Tr
ue
gr
ou
p Normal 134486 6177 1906 245
Barrett’s 700 113366 7466 880
Dysplasia 513 13843 76136 11518
Adenocarcinoma 53 950 10349 90658
Table A.1: The number of spectra assigned to each pathology group, actual group vs
predicted group for the 785 nm excitation.
Predicted group
Normal Barrett’s Dysplasia Cancer
Tr
ue
gr
ou
p Normal 131202 9688 973 951
Barrett’s 956 115630 4050 1776
Dysplasia 115 4210 88067 9618
Adenocarcinoma 74 2752 14485 84699
Table A.2: The number of spectra assigned to each pathology group, actual group vs
predicted group for the 830 nm excitation.
A1
PCA-LDA data
A.2 Raman vs coherent Raman
Data corresponding to the results discussed in section 5.5 and 5.6.
A.2.1 Two group model
Predicted group
Normal Cancer
Tr
ue Normal 195507 8513
Cancer 40576 163444
Table A.3: The number of spectra assigned to each pathology group, actual group vs
predicted group for the fingerprint region.
Predicted group
Normal Cancer
Tr
ue Normal 175821 28199
Cancer 68591 135429
Table A.4: The number of spectra assigned to each pathology group, actual group vs
predicted group for the hwn region.
Predicted group
Normal Cancer
Tr
ue Normal 133186 70834
Cancer 96577 107443
Table A.5: The number of spectra assigned to each pathology group, actual group vs
predicted group for SRS.
A2
A.2.2 Three group model
Predicted group
Normal Barrett’s Cancer
Tr
ue
gr
ou
p Normal 168404 27083 8533
Barrett’s 25772 89486 47958
Cancer 8327 57408 138285
Table A.6: The number of spectra assigned to each pathology group, actual group vs
predicted group for the fingerprint region.
Predicted group
Normal Barrett’s Cancer
Tr
ue
gr
ou
p Normal 157993 38960 7067
Barrett’s 22447 60671 80098
Cancer 59252 79646 65122
Table A.7: The number of spectra assigned to each pathology group, actual group vs
predicted group for the hwn region.
Predicted group
Normal Barrett’s Cancer
Tr
ue
gr
ou
p Normal 123190 46780 34050
Barrett’s 60383 23660 79173
Cancer 90382 82536 31102
Table A.8: The number of spectra assigned to each pathology group, actual group vs
predicted group for SRS.
A3
PCA-LDA data
A.2.3 Four group model
Predicted group
Normal Barrett’s Dysplasia Cancer
Tr
ue
gr
ou
p Normal 168276 23518 6643 5583
Barrett’s 14148 53094 66373 29601
Dysplasia 1452 55735 66667 39362
Adenocarcinoma 7853 48121 38180 109866
Table A.9: The number of spectra assigned to each pathology group, actual group vs
predicted group for the fingerprint wavenumber region
Predicted group
Normal Barrett’s Dysplasia Cancer
Tr
ue
gr
ou
p Normal 158578 37737 1203 6502
Barrett’s 21798 48580 42726 50112
Dysplasia 19027 57850 8406 77933
Adenocarcinoma 57302 40808 72735 33175
Table A.10: The number of spectra assigned to each pathology group, actual group vs
predicted group for the high wavenumber region
Predicted group
Normal Barrett’s Dysplasia Cancer
Tr
ue
gr
ou
p Normal 108043 25224 46301 24452
Barrett’s 54115 7564 36165 65372
Dysplasia 58302 43227 41472 20215
Adenocarcinoma 82943 67766 35790 17521
Table A.11: The number of spectra assigned to each pathology group, actual group vs
predicted group for SRS
A4
A5
Ethical approval
APPENDIX B
Ethical approval
B.1 Oesophagus
A6
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